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Abstract
The current study evaluated interactions between the mycotoxins aflatoxin 
Bi (AFBi) and fumonisin Bi (FBi) in pure systems as well as in com. During 
storage at 25°C with high moisture (ca. 50%), com contaminated with Aspergillus 
flavus (LI3) and/or Fusarium moniliforme (A00102) presented different aflatoxin 
and fumonisin levels. Toxin production/degradation varied over storage time (0-45 
days). Evaluation of the mutagenicity of unifungal or bifungal com extracts with 
the Salmonella/microsomal assay (tester strains TA-100 and TA-98) with metabolic 
activation (S9) showed positive mutagenic responses.
Different ratios o f pure AFB|/FBi produced divergent mutagenic responses 
(tester strains TA-100 and TA-98) with S9. The mutagenicity of 103 ng AFBi/pIate 
was reduced by addition of 1 to 102 ng FBi/plate. Higher FBi concentrations (103 to 
103 ng/plate) caused an opposite effect. The mutagenic potential of 2- 
aminofluorene (2-AF) was also affected by FB|. This suggested that FBi affects the 
enzyme systems responsible for activating AFBi and 2-AF.
Analysis by liquid chromatography of AFBi/AFBi-metabolites after 
reaction with FBi and S9 showed decreased recovery when 103 ng AFBi were 
exposed to 1 to 102 ng FBi, but at higher FBi levels (103 to 103 ng), recovery was 
increased. Thin layer chromatography analysis of these samples suggested that 
unidentified AFBi-metabolites derivatized with trifluoroacetic acid were indirectly 
detected as AFBi.
xvii
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
FBi (1 to 103 ng/plate) inhibited gap-junction intercellular communication 
of Clone-9 rat liver cells. This could be a possible mechanism by which FBi acts as 
a non-genotoxic carcinogen. Addition of 1 to 103 ng AFBi to 103 ng FBi did not 
change the effect of FBi. An increase in the uptake of neutral red by Clone-9 rat 
liver cells exposed to AFBj/FBi implied that peroxisome proliferation and 
oxidative metabolism may be involved in AFBi/FBi interactions.
H2O2 (3%) and NaHCC>3 (2%) were effective in decontaminating/ 
detoxifying aflatoxin-fumonisin naturally co-contaminated com without generating 
mutagenic by-products.
This study showed preliminary evidence that simultaneous exposure to 
AFB1/FB1 can give different toxicologicai responses than single exposure to either 
of these compounds. More research is needed to better assess the toxicologicai 
impact of AFB1/FB1 co-contamination and to develop possible control strategies.
xviii
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I. Introduction
Aflatoxins and fiimonisins are mold secondary metabolites produced by 
Aspergillus flavus and Fusarium moniliforme. respectively. The potential risks 
associated with these metabolites have long been recognized. However, recent 
reports have shown that aflatoxins and fiimonisins can co-contaminate com. This 
poses new research and regulatory questions because information about the 
potential hazards associated with simultaneous exposure to both toxins is not 
available.
This is not uncommon since availability data on exposure and toxicity of 
most chemical mixtures is limited, and roughly 95% of the research resources in 
toxicology is still devoted to the study of single chemicals (Krishnan and Brodeur, 
1991; Yang, 1994). Concurrent or sequential exposure to a multitude of chemicals,
e., food additives, mycotoxins, pesticides, environmental and occupational 
pollutants, etc., is a real issue and has pointed to the necessity of exposure 
assessment, hazard identification, and risk assessment of chemical mixtures. 
Furthermore, there has been increased public and regulatory concern regarding 
exposure to complex systems that has triggered the interest of scientists and 
toxicologists in this challenging vanguard of toxicology (Cassee, 1998).
The study of chemical mixtures is controversial and has exacerbated debates 
on concepts such as similar joint action and independent joint action versus 
interaction of chemicals, design of experimental studies and analysis of results.
1
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This project has focused on an initial in vitro approach in the study of a 
mycotoxin mixture that frequently occurs in nature. This is a simplistic view 
because these toxins co-exist in com, a more complex matrix that consists of tens, 
hundreds or even thousands o f compounds. However, adequate testing of such 
mixtures is virtually impossible; therefore, choosing a combination of two of the 
compounds that have been recognized as toxic and that have been reported to exist 
in the same commodity could give better information on the activity of the mixture. 
Furthermore, if all possible combinations of all possible compounds present in the 
mixture were to be evaluated, a complete experimental design would grow in 
exponential proportions, making adequate testing virtually impossible.
One of the main interests in the field of combination toxicology is to find 
out whether the toxicity of a mixture is different from the sum of responses to the 
single compounds. The genotoxic nature of aflatoxin Bj (AFBi) coupled with the 
non-genotoxic status of fumonisin Bi (FBi) and their ubiquitous, unpredictable and 
unavoidable occurrence, triggered the interest in this area of research. The overall 
objective of this project focused on studying the interactive effects of AFBi and 
FBt in concentration ranges that can occur naturally as well as mechanisms of 
toxicity and decontamination procedures.
The diverse components of this project concentrated on the study of 
AFBi/FBi co-contamination from different perspectives. The first section focused 
on the mycological aspects o f toxin production. The objective was to do a 
preliminary evaluation of the production/degradation of both, aflatoxins and
2
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fumonisins in the same environment under optimal mold growth conditions. The 
second objective centered on the evaluation of potential toxin interaction by testing 
whether FB| had an effect on the mutagenic potential of AFBi. From this study, 
two approaches were taken and explored. If FB| interacted with AFBi, was it 
directly by chemical reaction of the toxin and/or toxin by-products or were there 
mechanistic implications?
Changes in gap-junction intercellular communication have been proposed 
as a non-genotoxic carcinogenesis mechanism. Since the role of fumonisin in 
carcinogenesis is still unclear, the third objective was to determine whether FBi 
affected gap-junction intercellular communication, and the subsequent role of 
aflatoxin interaction in this toxic response.
Finally, since information on the potential risks associated with AFBi and 
FBi is still limited, decontamination treatments were explored as options in 
mycotoxin risk management. Therefore, the fourth objective of this study was to 
evaluate the effectiveness of H2 O2 and/or NaHCC>3 in decontaminating/detoxifying 
naturally contaminated com.
The toxicology of complex mixtures is still a new research area that poses 
many new research and regulatory concerns. It is important to use an 
interdisciplinary approach to better assess these issues and understand the risks 
posed by simultaneous exposure to two or more mycotoxins.
3
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II. Literature review
A. Historical background
Mycotoxins have played an important role in the history of humankind. 
Although the consumption of moldy food has not always been recognized as a 
health hazard, mycotoxins have been intricately involved in the social, political, 
and economical environment of cultures around the world. The earliest known 
mold-associated disease is ergotism or “holy fire” that resulted from the 
consumption of grains infected by the mold Claviceps purpurea. A gangrenous 
form of ergotism was very common in Europe from the ninth to the fourteenth 
centuries. The victims of this poisoning complained of numbness in the limbs, 
intense sensations of heat and cold, followed by gangrene; and eventually the loss 
of the extremity. At this point in history, such afflictions were associated with 
religious events rather than dietary practices. Thus, this mycotoxicosis was known 
as St. Anthony’s fire and was associated with sinful behavior (Smith and Moss, 
1985). Later, between the sixteenth and the nineteenth centuries, a form of 
convulsive ergotism was described. This type of intoxication was also noted in the 
United States where it was implicated in the Salem witchcraft trials of 1692 
(Matossian, 1982). During the seventeenth century, a form of cardiac beriberi 
associated with yellow rice toxins was described in Japan (Ueno, 1983). Also, other 
diseases such as “red mold” or “scabby disease” have also been associated with rice 
and rice products (Beuchat, 1978).
4
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Wars have shaped world history. As they bring about violent change, they 
also make obvious alterations in the behavioral pattern of the population. Since 
dietary practices are strongly related to this kind o f event, some wars have shaped 
our understanding of the impact of mycotoxins on human health. A particularly 
severe mycotoxicosis, alimentary toxic aleukia (ATA), was first recognized in 
Russia in 1913 where food shortages near Siberia forced the consumption of over­
wintered grains (wheat, millet, and barely). The melting snow raised the moisture 
content of the grains and favored mold growth and toxin production (Smith and 
Moss, 1985). ATA has had a constant place in Russian history. In the twentieth 
century, it reached epidemic proportions during and after World War II. In this 
outbreak, mortality was as high as 60%. Highly toxic T-2 toxin and other 
trichothecenes toxins were later confirmed to be the cause of the epidemic 
(Bullerman, 1979; Ueno, 1987). Although mycotoxins have played an important 
role in history, awareness of mold-related diseases was practically non-existent 
until the 1960s. During this time, scientific attention focused in England where a 
hepatotoxic disease in turkeys was reported. Thousands of poults died of an 
unknown hepatic disease (Asplin and Camaghan, 1961; Blount, 1961; Lancaster et 
al., 1961). This syndrome was dubbed as turkey "X” disease, and marked the 
initiation of formal research in mycotoxicology. Shortly after the first report of the 
“X” disease, there were other reports of poisoned chickens and ducklings. All of 
these syndromes were characterized by hepatic necrosis, marked bile duct 
hyperplasia, acute loss of appetite, wing weakness, and lethargy (Blount, 1961).
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Later. Asplin and Camaghan (1961) identified the responsible toxins as metabolites 
of Aspergillus flavus. These toxins were chemically characterized by Asao et al. 
(1963) and designated with the term aflatoxins. After this incident, the field of 
mycotoxicology gained the interest of the scientific community, and research on 
this area proliferated. Thus, in the last three decades, many other mycotoxins have 
been identified and related to human and animal health problems.
Fusarium moniliforme is one of the most prevalent fungi associated with 
com (Zea mays) throughout the world (Marasas et al., 1984). Although it has been 
barely a decade since the fumonisins have been characterized as food-bome 
mycotoxins, the toxicities associated with them have long been recognized. In 
1881, Saccardo implicated Oospora verticilloides contaminated com with pellagra 
in Italy. Years later, in 1902, Butler successfully reproduced equine Ieuko- 
encephalomalacia (ELEM) in horses by feeding them with naturally contaminated 
moldy com. Sheldon (1904) identified F. moniliforme as the causative agent of 
com toxicoses in farm animals in the United States. Much later, in South Africa, 
Kellerman et al. (1972) induced a hepatotoxic syndrome by feeding horses with F. 
moniliforme culture material. In 1976, Marasas and collaborators reproduced 
ELEM in horses by feeding pure F. moniliforme culture material. Marasas (1981) 
also reported that F. moniliforme is significantly more prevalent in com from 
geographical areas with a high incidence of human esophageal cancer than in those 
with low incidence. Subsequently, Marasas et al. (1984) were able to induce liver 
cancer in rats by feeding a pure culture of F. moniliforme from South African com.
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Four years later, in 1988, Gelderblom demonstrated the cancer promotion activity 
of F. moniliforme cultures in a rat short-term cancer initiation/promotion assay. 
That same year, Gelderblom et al. isolated fumonisins Bi (FBi) and B2 (FB2 ) from 
cultures of F. moniliforme MRC 826. The chemical structures of these toxins were 
elucidated by Benzuidenhout et al. (1988). In 1988, intravenous injection of FBi 
resulted in a syndrome resembling ELEM (Marasas et al., 1988). Thus, there was 
evidence that FBi was the etiological agent of ELEM. In 1989, confirmation was 
provided when Laurent et al. isolated and characterized two new mycotoxins from
F. moniliforme: macrofusin and micromonilin. The structure of one these toxins, 
macrofusin, proved to be identical to FBi. In 1989, com screenings caused 
widespread ELEM and porcine pulmonary edema (PPE) outbreaks in the United 
States (Harrison et al., 1990; Ross et al., 1990; Wilson et al., 1990). After these 
outbreaks, the scientific community gained interest in the recently characterized 
mycotoxins.
Molds and mycotoxins have a considerable impact worldwide in terms of 
public health, agriculture and economics. Naturally occurring toxicants are 
unavoidable, unpredictable and pose a unique challenge to food safety. The Food 
and Agriculture Organization of the United Nations has reported that the 
production of agricultural commodities is barely sustaining the world's increasing 
population; and every year, at least 25% of the world’s food crops are contaminated 
with mycotoxins. Mycotoxigenic fungi and their control pose a serious economic 
impact around the world. They assert discernible costs to farmers, livestock and
7
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poultry producers, grain handlers, and food and feed processors. However, it is 
difficult to estimate the actual economical losses due to the large variability of 
incidence of mycotoxins among commodities, years and seasons. Roughly, the 
Council for Agricultural Sciences and Technology (CAST) has estimated that in the 
United States alone, twenty million dollars is lost annually on peanuts 
contaminated with aflatoxin (CAST, 1989). The ubiquity of toxigenic molds (i.e.,
A. flavus and F. moniliforme), the importance of com as human food and animal 
feed, reports of possible co-contamination with aflatoxins and fumonisins and the 
implication of these toxins with diverse toxicological syndromes, has provoked an 
increased scientific and regulatory interest. To date, there are still many questions 
without answers. Thus, research in this area is abundant.
B. Aflatoxins
1. Mycology and occurrence
The ubiquity of A. flavus, as well as, its ability to colonize multiple 
commodities has prompted a vast amount of work on the causes, course and 
prevention of contamination. Earlier studies assumed that invasion was a function 
of inadequate storage conditions (i.e., drying, temperature, and moisture). 
However, newer studies have shown that, invasion before harvest is equally or 
more important (McDonald and Harkness, 1967; Petit et al., 1971; Cole et al., 
1982; Klich et al, 1984). In com, pre-harvest invasion is primarily dependent on 
insect damage of the developing cobs. The fungus can also invade by growing 
down the silks of the developing ears (Jones et al., 1980; Lillehoj et al., 1980). The
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ability to grow as a non-destructive pathogen in the tissues of a variety of plants 
over the normal range of food storage temperatures as well as the capacity to grow 
at low water activities give A. flavus the potential to grow in the vast majority of 
commodities if pre-harvest, harvest and storage conditions are less than ideal.
Weather conditions also play an important role in aflatoxin formation. Since 
A. flavus is considered an opportunistic pathogen, any factor that affects the normal 
development of the plant, will favor fungal invasion; and subsequently, toxin 
production. Payne et al. (1986) showed that irrigation helped reduce aflatoxin 
formation; and reported that drought stress led to an increased number of infected 
kernels in silk-inoculated ears. Other environmental factors that affect toxin 
production and accumulation include lack or excess of nitrogen, excessive plant 
populations, and poor irrigation practices (Payne et al., 1989; Fortnum and 
Manwiller, 1985; Anderson et al., 1975).
The aflatoxigenic species of the Aspergillus group include A. flavus, A. 
parasiticus, and A. nomius. A. flavus and A. parasiticus may colonize the food/feed 
and produce mycotoxins. The role of A. nomius in aflatoxin contamination of crops 
is still unknown. Specific strains of A. flavus and A. parasitucus are capable of 
producing aflatoxins Bi, B2 , G|, G2 , and Mi, and other related compounds (Wilson 
and Payne, 1994). At the present time, the taxonomy of the A. flavus group is 
uncertain. The differences between these fungi are often inconclusive, so it is 
difficult to identify distinct species. According to Wicklow (1983) and Klich and 
Pitt (1988), A. flavus and A. parasiticus are taxonomically distinct species.
9
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
However, previous reports by Hesseltine et al. (1970) have described several 
isolates with intermediate taxonomic characteristics between A. flavus and A. 
parasiticus. In 1986 Kurtzman et al., complicated matters by proposing that both, 
A. flavus and A. parasiticus were so closely related; so they should be considered 
varieties of the A. flavus group. Therefore, they should be classified as A. flavus 
var. flavus and A. flavus var. parasiticus. However, these classifications are only of 
concern to the pure taxonomist. Most o f the literature refers to the toxigenic species 
as the A. flavus group without further specifications.
Aspergillus flavus and Aspergillus parasitucus grow in Czapek yeast extract 
agar (CYA) showing colonies o f 60-70 mm in diameter, plane, sparse to 
moderately dense. The colonies are characteristically greyish green to olive yellow, 
sometimes only yellow and become green with age. They are distinguished by their 
rapid growth both at 25 and 37°C. The difference between these two species is that 
A. flavus produces conidia which are variable in shape and size and have thin walls 
that vary from smooth to moderately rough. In contrast, A. parasiticus conidia are 
spherical with relatively thick, rough walls (Pitt and Hocking, 1997).
Growth temperatures for A. flavus vary from a minimum near 10-12°C, a 
maximum near 43-48°C, and an optimum near 33°C (Domsch et al., 1980; ICMSF, 
1996). The water activity needed for growth also varies in a range of 0.78 at 33°C 
(Ayerst, 1969) to 0.84 at 30°C and 0.80 at 37°C (Pitt and Hocking, 1977). These 
molds can grow in a very wide range of pH. It has been observed that growth can
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occur from pH 2.1 to 11.2 at 25, 30 and 37°C. Optimal growth was recorded from 
pH 3.4 to 10 and a peak near 7.5 (Wheeler et al., 1991; Olutiola, 1976).
A. flavus is adapted to use a broad assortment of organic resources as a 
source of nutrients. It is considered a saprobe, as well as, an opportunistic pathogen 
of plants, insects, domestic animals and humans. In the field, A. flavus populations 
increase during hot and dry conditions. They grow especially well on crop debris, 
on dormant tissues, and or damaged or weakened crops (Asworth et al., 1969; 
Stephenson and Russel, 1974).
2. Toxin production
Aflatoxins B and G are produced by all toxigenic strains of A. parasiticus. 
On the other hand, most, but not all A. flavus isolates produce only the B aflatoxins 
(Pitt, 1989). In general, commodities contaminated with only the B aflatoxins may 
be contaminated with A. flavus. However, there is no real evidence that suggests 
that A. parasiticus is the only source of the G aflatoxins (Wilson and Payne, 1994).
Some strains of A. flavus produce cyclopiazonic acid (CPA). This toxin has 
been reported to be toxic in rats, dogs, pigs, and chickens (Domer et al., 1983; 
Lomax et al., 1984; Nuehring et al., 1985; Purchase, 1971). CPA has metal 
chelating properties, and it has been reported that it can bind physiologically 
important cations such as calcium, magnesium and iron (Gallagher et al., 1978). 
CPA occurs naturally in com, peanuts, cheese and millet and it can be found with 
aflatoxins (Richard et al., 1989; Gallagher et al., 1978; Trucksess et al., 1987). Due 
to this co-contamination, the toxicity of commodities contaminated with A. flavus
11
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can be greater than expected from the levels of aflatoxins. The role of CPA and 
aflatoxin co-contamination should be explored to further understand the 
toxicological implications of consumption of foods/feeds contaminated with A. 
flavus.
3. Chemical characteristics
Aflatoxins (Figure 2.1) are a group of bisfuran coumarin compounds 
produced by mold secondary metabolism and have no obvious physiological role in 
the primary growth and function of the mold (Bhatnagar, 1991). However, 
byproducts of primary metabolism are generally precursors of secondary 
metabolites. Thus, primary and secondary metabolisms are intricately related 
(Drew and Demain, 1977). Aflatoxin biosynthesis is related to mold lipid 
biosynthesis (Townsend et al., 1984). Its basic structure is derived from acetate 
units from the polyketide pathway. Bhatnagar et al. (1991) have suggested that 
AFB1 biosynthesis is based on a C20 polyketide (decaketide) precursor (Bhatnagar, 
1991). Polyketides are a large group of structurally diverse compounds that arise 
from the head-tail condensation of acetate units (Applebaum, 1981). These 
molecules then undergo several transformation reactions where the chain is folded, 
condensed, oxidized, reduced, cleaved and rearranged to produce a wide variety of 
molecules, including the aflatoxins (Bhatnagar, 1991). Hamid and Smith (1987) 
have reported the degradation of aflatoxins in old or aging mycelium. There is 
evidence that suggests the involvement of fungal cytochrome P-450
12
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Figure 2.1 Chemical structiares of most common naturally-occurring aflatoxins 
(Pavao et al., 1995)
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monooxygenease enzyme systems in the degradation of aflatoxin Bi and Gi by 
intact mycelium and cell-free extracts of A. flavus.
Each of the known aflatoxins has a different structure with variable activity 
(Figure 2.1) (Pavao et al., 1995). The names of the most common aflatoxins, B and 
G for blue and green, respectively, refer to their fluorescent colors under ultraviolet 
light. In the case of aflatoxin M. an important aflatoxin metabolite, the letter refers 
to its presence in milk (Bhatnagar et al., 1994).
Aflatoxin Bi is one of the most potent naturally occurring carcinogens. 
Chemically, it has a carbonyl group in a five-membered ring and cross-conjugated 
with an alpha, beta-unsaturated function. Its formula is C 17H 12O6 with a molecular 
weight of 312 (Pavao et al., 1995). Aflatoxins are soluble in a number of non-polar 
solvents and insoluble in water.
4. Metabolism
a. Absorption and distribution
Human exposure to aflatoxins occurs mainly via ingestion of contaminated 
foodstuffs. Thus, most of the pharmacokinetic considerations are associated with 
the chronic administration of relatively low doses of AFBi through the oral route 
(Hsieh and Wong, 1994). AFBi is a relatively low molecular weight (312 g/mole) 
lipophilic compound. This suggests that its absorption after ingestion is efficient. 
Wogan et al. (1967) reported that absorption after oral administration of 0.07
14 •  •mg/kg [ C] labeled AFBi in male Fisher rats was complete when compared to 
intraperitoneal administration. They observed that up to 20 and 60% of the original
14
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dose was eliminated via urinary and fecal routes, respectively. Slow passage 
through the intestinal tract was noted since little radioactivity was excreted in the 
first 8 hours. After 24 hours, the residual radioactivity in the carcass (7.6% of the 
original dose) was found in the liver, indicating that it is the primary site of 
accumulation of AFBi, its metabolites and/or bound material.
Absorption studies by Kumagai (1989) have shown that AFBi is rapidly 
absorbed from the small intestines into the mesenteric venous blood. The 
duodenum was considered the site of most efficient absorption. This study 
suggested that species differences in AFBi uptake may be due to differences in the 
composition of the intestinal epithelium. The author also reported that the degree of 
aflatoxin uptake is proportional to AFBi concentration indicating that it is absorbed 
by passive diffusion. AFGi, a less lipophilic analog, was absorbed at a lower rate, 
indicating the importance of Iipophilicity in aflatoxin absorption.
Excretion of AFBi occurs primarily through the biliary pathway, followed 
by the urinary pathway. From the intestine, AFBi apparently enters the liver 
through the hepatic portal blood supply (Wilson et al., 1985). The liver readily 
concentrates the toxin. Given the high efficiency of the liver to extract free AFBi 
from the blood, the binding of AFBi to serum albumin at the site of intestinal 
absorption has not been considered a major mechanism of detoxification. The 
kidneys also concentrate aflatoxin, but to a lesser extent (Hsieh and Wong, 1994).
15
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b. Phase I metabolism
Cytochrome P-450 (P450) enzymes are involved in the oxidation of 
numerous steroids, eicosanoids, alkaloids, and other endogenous substrates. These 
enzymes also have major involvement in the oxidation of potential toxicants and 
carcinogens such as those encountered among environmental pollutants, solvents, 
pesticides and many natural products like aflatoxins (Guenguerich et al., 1996).
AFBi is considered the most potent of the aflatoxins and related 
benzofurans in most genotoxicity assays; it is also the most hepatocarcinogenic 
(Busby and Wogan, 1984). However, all evidence available to date shows that 
AFBi by itself is not particularly genotoxic, and that the metabolically produced 
8,9-epoxide is the only genotoxic product as evidenced by either base-pair 
mutations, ffameshift mutations or induction of bacterial SOS response (Busby and 
Wogan, 1984; Gamer et al., 1972; Baertschi et al., 1989). The stereochemistry of 
AFBi epoxidation is of considerable significance in determining the course of its 
toxicity. P450 enzymes produce two different stereomeric forms of the 8,9- 
epoxide, the exo-epoxide in which the ring is positioned “below” the plane and the 
endo- 8,9 epoxide in which the ring is positioned “above” the plane. Of these, the 
exo isomer is at least 103 times more genotoxic than its endo counterpart 
(Guenguerich et al., 1996). The bioactive form of aflatoxins is considered a strong 
electrophile that can form covalent adducts with macromolecules such as proteins, 
RNA and the N7 position of guanidine residues in DNA (Figure 2.2) (Foster et al., 
1983; Miller, 1991).
16
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Figure 2.2 Formation o f the aflatoxin Bi- N7 guanidine adduct (Miller, 1991)
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Cytochrome P450 metabolic isozymes render a number of products that can 
be considered activated metabolites (i.e., 8,9-epoxide) or detoxification products, 
such as aflatoxins Mi, Pi and Qi (Figure 2.3) (Langouet et al., 1996). Although 
peroxidases and lipoxygenases have been reported to oxidize AFBi (Battista and 
Mamett, 1985), the P450s are more active in catalyzing the reaction. The relative 
quantities of each metabolite depend largely on the relative activities of different 
P450 isozymes. Among the P450s, CYP3A4, CYP1A2, CYPIA1 and CYP3A5 
have been shown to transform AFBi. Cytochromes 1A2 and 3A4 have been 
considered the most active. However, there is controversial information as to which 
is the dominant enzyme. Ueng et al. (1995) have reported that CYP3A4 appears to 
be the enzyme involved to the greatest extent in AFBi activation. Forrester et al. 
(1990) and Aoyama et al. (1990) previously provided evidence that supports this 
hypothesis. On the contrary, Gallagher et al. (1996) reported that CYP1A2 
contributes to over 95% of AFBi activation in human liver microsomes at 0.1 juM 
AFB i. The discrepancies between these studies may be a result of different sources 
of P450’s used among the different experiments. The reconstitution system of Ueng 
et al. (1995) was rather complex and cannot be considered similar to the in vitro 
system employed by Gallagher et al. (1996). Also, the source of the human 
CYP1A2 cDNAs used in the experiments of Ueng et al. (1995) contained a 
modified N-terminus (Sandhu et al., 1994) and therefore may have exhibited 
somewhat different catalytic activities from the CYP1A2 cDNA -  
expressed microsomes used in the Gallagher et al. (1996) study. This study also
18
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Figure 2.3 Biotransformation pathways for aflatoxin Bi (Eaton et al., 1994)
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reported kinetic models that support CYPlA2’s dominant role in AFBi metabolism 
in vivo.
c. Phase II metabolism
Phase II metabolism leads to the conjugation of phase I metabolites to make 
them less toxic and more available for excretion. Species differences in the 
susceptibility to the toxicity and carcinogenicity of AFBi are determined largely by 
the organism’s ability to biotransform the toxin. The major phase II metabolites are 
the glutathione, glucoronide and sulfate conjugates (Hsieh and Wong, 1994). The 
glutathione (GSH) conjugate of the AFBi 8,9-epoxide has been identified as the 
major phase II reaction. Thus, the sensitivity of a particular species has been related 
to its ability to conjugate the epoxide with GSH. There is some evidence that 
indicates that the various glutathione-S-transferases have differential activity 
toward the endo and the exo forms of the 8,9-epoxide.
Glucoronide conjugation also plays a role in biotransformation and 
excretion of AFBi and/or its metabolites. Loveland et al. (1984) reported that 
glucoronides of aflatoxicol and aflatoxicol-Mi are the principal biliary metabolites 
of AFBi in trout. Phase I metabolites such as aflatoxins Pi, Qi and Mi go through 
glucoronide conjugation. The rate of conjugation of these three metabolites differs. 
According to Metcalfe and Neal (1983), the phenolic hydroxyl group present in 
AFPi is a much better site for glucoronide conjugation than the hydroxyl groups 
present in AFMi and AFQi.
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d. Competitive pathways: activation and detoxification
The fate of AFBi in an organism depends on a delicate equilibrium between 
several pathways. The quantity of aflatoxin available to exert toxic, mutagenic and 
carcinogenic effects will depend on the amount converted to the various 
metabolites and their relative biological activity. Thus, the hydroxylated 
compounds (AFM|, AFPi and AFQO are considered detoxification products due to 
their lower ability to react with DNA and proteins. The 8,9-epoxide is not always a 
toxic product since detoxification of this reactive molecule may occur through 
phase II conjugation with glutathione. Hydrolysis of the electrophilic epoxide to 
form a dihydrodiol also represents a decrease in toxic potential. The dihydrodiol 
can exist in a resonance form as a phenolate ion that is capable of forming SchifF 
base adducts with protein amino groups, particularly lysine (Lin et al., 1978). Even 
if the binding to protein can represent a toxicological risk, the relative toxic, 
mutagenic and carcinogenic effects of protein conjugation is much lower than that 
of the active epoxide.
It is difficult to discuss AFBi activation and detoxification pathways 
without considering the kinetics involved in each reaction. Unfortunately, most in 
vitro studies use AFBi concentrations that surpass the actual dietary human 
exposure. It has been noted that humans and animals are chronically exposed to 
low doses rather than to one acute single dose. Thus, it is difficult to extrapolate 
from in vitro studies. Another factor to consider is that the activity of the different 
metabolizing enzymes varies from species to species. Ramsdell and Eaton (1990)
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demonstrated substantial variations in the patterns of liver microsomal AFBi 
oxidation over a range of concentrations for four species: rat, mouse, monkey and 
human. Affinity to detoxification reactions also plays an important role in AFBi’s 
ultimate toxic effect. As with microsomal activation, the affinity of the enzyme 
glutathione S-transferase to the AFBi-8,9-epoxide varies across species.
The information available to date suggests that the ultimate toxic response 
to aflatoxin is not a univariate process. It is a multivariate equilibrium that depends 
on external factors, such as, toxin concentration, presence of other xenobiotics, 
environmental stress and nutritional status among others; and internal factors that 
can include but are not limited to genetic predisposition, type and activity of 
microsomal enzymes, and availability o f efficient detoxification mechanisms.
5. Toxicity
The liver is considered the primary target organ for aflatoxin toxicity. Since 
its characterization in the early 1960’s, acute structural and functional damage to 
the liver has been reproduced in a wide variety o f species. Acute aflatoxicosis has 
been characterized by vomiting, abdominal pain, pulmonary edema, and fatty 
infiltration and necrosis of the liver (Shank, 1977; 1981). Although there is ample 
evidence for substantial human exposure in certain populations, information on 
clinical aflatoxicosis in humans is still limited (Busby and Wogan, 1984). Review 
of the effects of acute exposure to aflatoxin reveals that a wide variety of 
vertebrates, invertebrates, plants, bacteria, and fungi are sensitive to these toxins, 
but the range of sensitivity is wide. The basis for the species and strain variation in
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the acute toxicity of aflatoxin is not fully understood. As discussed in the previous 
section, two important factors are (1) the proportion of AFBi that is metabolized to 
the 8,9-epoxide relative to other metabolites that are considerably less toxic and (2) 
the relative activity of phase II metabolism, which forms non-toxic conjugates and 
inhibits cytotoxicity (Cullen and Newbeme, 1994).
The aflatoxins have been studied extensively in vitro (IARC, 1987). It has 
been reported that all the members of the family (AFBi, AFB2 , AFGi and AFG2 ) 
produce genotoxic injury. AFBi is considered the most potent genotoxic agent in 
vitro (as it is in vivo) and AFG2 the least potent, but all naturally occurring 
aflatoxins, as well as, the metabolite AFM|, have been reported to produce some 
injury to DNA. AFBj produces chromosomal aberrations, micronuclei, sister 
chromatid exchange, unscheduled DNA synthesis, and chromosomal strand breaks, 
and forms adducts in rodent and human cells (IARC. 1987). AFGi produces 
chromosomal aberrations in Chinese hamster bone marrow cells in vivo. as well as 
chromosomal aberrations and sister chromatid exchange in Chinese hamster cells in 
vitro. AFB2 binds covalently to DNA of rat hepatocytes, produces sister chromatid 
exchange in Chinese hamster ovary cells, and stimulates unscheduled DNA 
synthesis in rat hepatocytes but not in human fibroblasts. AFG2 produces sister 
chromatid exchange in Chinese hamster cells but does not induce unscheduled 
DNA synthesis in human fibroblasts in vitro. Unscheduled DNA synthesis in rat 
and in hamster hepatocytes results following exposure to AFG2 and AFMi in vitro.
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The aflatoxins have been examined for potency in a range of primary 
cultures, as well as, in established cell lines. Liver cell cultures from chick embryos 
demonstrate cytotoxicity of AFBi to both mesenchymal and parenchymal cells 
(Terao, 1967). Zuckerman et al. (1967) reported that 1 pg/ml exhibited cytotoxic 
effects to 50% of human embryo liver cells following 24 hours exposure. Electron 
microscopy revealed nucleolar capping of the chromatin, rounding of the cell, and 
granulation of the endoplasmic reticulum (Zuckerman et al., 1967).
Experimental study of aflatoxin-induced carcinogenesis supports the 
paradigm of cancer as a multistage process. Aflatoxin is considered a potent 
tumorigenic agent, but it has also been shown to have promoting ability (Newbeme 
and Butler, 1969; Busby and Wogan, 1984). Virtually all the toxic effects of AFBi 
are now recognized to be attributable to the action of its electrophilic metabolites 
on macromolecules (DNA and proteins). Aflatoxin carcinogenesis can be promoted 
by a variety of factors, including an enhanced proliferative rate and alterations in 
dietary intake (Rogers, 1994). Since Wogan (1966) reported that continuous 
lifetime exposure to aflatoxin was unnecessary for the development of tumors, 
shorter-term exposure to aflatoxin has been used to assess the risks associated with 
this toxin. The early studies of aflatoxin-induced liver carcinogenesis in rats 
indicated the presence and sequential development of precursor lesions (Lancaster 
et al., 1961). Chronic and subchronic exposure to AFBi is an efficient method to 
produce hepatic cancer. For example, 2 cycles each of 5 days duration with 25 mg 
AFBi per day to young (approximately 100 g) Fischer 344 rats yielded putative
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preneoplastic foci at 2-3 months postdosing (Appleton and Campbell. 1983; 
Roebuck et al., 1991; Kensler et al., 1992). Hepatic cancers arise by approximately 
1 year postdosing (Roebuck et al.. 1991).
C. Fumonisins
1. Mycology and occurrence
Fusarium is the main pathogenic fungal genus found in com. The most 
commonly occurring species are F. graminearum, F. moniliforme and F. 
subglutinans (Burgess et al., 1981; Marasas et al., 1984). Fusarium moniliforme 
and its related species, F. proliferatum, are endemic in com with a worldwide 
distribution occurring not only in the humid and sub-humid temperate zones, but 
also extending into the subtropical and tropical areas of the world. It has been 
isolated from Australia, Brazil, Canada. Central America, China, Egypt, Germany, 
India, Indonesia, Israel, Italy, Jamaica, Japan, Hong Kong, Libya, Nepal, New 
Zealand, Nigeria, Pern, Philippines, South Africa, Switzerland, Taiwan, Turkey, the 
United States of America, Zambia and Zimbabwe (Cole et al., 1973; Marasas et al., 
1978; Marasas et al. 1979; Sydenham et al., 1991; Thiel et al., 1991; Pittet et al., 
1992; Bacon and Nelson, 1994; Burgess et al., 1994; Visconti and Doko, 1994; 
Yoshiazwa et al., 1996). It is found rarely in the cold temperate zones of the world, 
but has been reported from Russia and Iceland (Bacon and Nelson, 1994).
F. moniliforme is an important pathogen of com and sorghum. In addition, 
it is commonly isolated from several other grains including wheat, rice and oats. 
Although there is no evidence that F. moniliforme is a pathogen of wheat, barley or
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oats in nature (Cook, 1981), it can be found as an occasional contaminant of wheat 
and barely stored seed (Bottalico et al., 1989). It also occurs, although infrequently, 
on other food and non-food commodities, such as beans, cotton, green peppers, 
flax, soybeans and sugar cane. F. moniliforme is also found on forage grasses such 
as Panicum coloratum as well as alfalfa, red clover, and pearl millet (Bacon and 
Nelson, 1994). This fungus can also decompose wool, cotton, filter paper and can 
oxidize hydrocarbons and the herbicide, simanzine (Bacon and Nelson, 1994).
F. moniliforme and F. proliferatum in the section Liseola are characterized 
by conidiophores bearing abundant straight, fusiform to obovoid microconidia in 
long chains. The conidia are produced from branched and non-branched 
polyphialides and monophialides in F. moniliforme and in F. proliferatum. These 
fungi also produce falcate microconidia, but do not produce chlamydospores. There 
are four taxa within this section of which F. moniliforme is the most common. 
Another cosmopolitan species of this section is F. proliferatum. Both fungi are 
similar morphologically, but may be readily distinguished by the presence of 
polyphialides in F. proliferatum and their absence in F. moniliforme (Bacon and 
Nelson, 1994).
F. moniliforme grows at a maximum temperature of 32-37°C and a 
minimum temperature of 2.5-5°C with an optimum of 22.5-27.5°C (Armolik and 
Dickson, 1956). The minimum water activity for F. moniliforme growth is 0.87; 
and Marin et al. (1995) have reported that there is production of fumonisins at 0.92 
aw. Moisture and aeration are important factors for fumonisin production. It has
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been observed that fiimonisin production is minimal at low oxygen tension. Thus, 
storage of grains under modified atmosphere conditions, and low kernel moisture 
<22% should reduce or prevent toxin formation (Pitt and Hocking, 1997).
Although F. moniliforme is one of the earliest known examples of a 
mycotoxic and phytotoxic species, its relationship to com is not fully understood 
(Bacon et al., 1992). F. moniliforme is seed and soil bome (Riley, et al., 1993); and 
the association of this fungus in the com plant is considered endophytic, while on 
com kernels it is both external and systemic. The systemic kernel infection does not 
affect the seed germination, but rather seedling vigor and growth can be reduced. 
Within the com kernel, the fungus is associated with the tip cap end. the point of 
attachment to the cob. The fungus is located within this area just below the vascular 
tissue of each kernel. Only small amounts of hyphae are found in sound kernels. 
However, from this location and under improper storage conditions, the small 
amount of inoculum can become highly invasive to the kernel (Bacon and Nelson, 
1994). In addition to kernels, the fungus is also found in com plant residues, 
especially stems and cobs where it can survive in the soil at least a year or more 
(Liddell and Burgess, 1985; Nyvall and Kommedahl, 1970). The systemic location 
of this fungus within the seed provides favorable conditions to maintain virulence 
and viability for years. Bacon and Nelson (1994) reported that in laboratory studies, 
com seeds can still harbor viable F. moniliforme after 8 years. The visual results of 
ear infection vary, some kernels are symptomless while others are obviously 
damaged and infected. F. moniliforme is also believed to infect com by growing
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along the silks, through tip ends of ears, over the kernel surface and into the 
pedicels, into the vascular cylinder of the cob, and finally into the kernels 
(Koehler, 1942; Salama and Mishricky, 1973). In the case of ear infection via an 
external route, insect damage may play an important role by causing wounds on the 
kernel pericarp thus allowing fungal penetration (Koehler, 1942). In kernels 
associated with animal toxicity, the fungus is usually found as an extensive mass of 
sporulating hyphae which colonizes most of the internal section of the kernel, 
including the embryo (Bacon and Nelson,1994).
Both F. moniliforme and F. proliferatum produce two kinds of spores, and 
both of these spores function in the survival and infection aspect of their life cycle. 
These fungi do not produce chlamydospores as survival structures, but they can 
survive in the soil as thickened hyphae within a soil moisture range o f 5 to 35% at 5 
to 10°C for 12 months (Bacon and Nelson, 1994). Macroconidia can survive the 
longest. Thus, they might function to carry these fungi over the seasons while 
microconidia, which are windblown, function as secondary infective propagules, 
infecting plants during the growing season. Dormant microconidia can survive for 
900 days although survivability is inversely related to both high temperatures and 
relative humidity (Liddell and Burgess, 1985).
2. Toxin production
F. moniliforme consists of a complex of biological species or mating 
populations. Currently, it is defined as having six different mating populations 
among which exist bisexual, self-sterile groups (Riley et al., 1993). Only mating
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populations "A" and "F" of this fungus have been found to be toxigenic, producing 
the mycotoxins fumonisins, fusaric acid and fusarin C. These mating populations 
are distributed worldwide and are found primarily on cereal grasses in the warmer 
regions of the world. Although members of all six mating populations can be 
recovered from both com and sorghum, the distribution appears to be host species 
specific. It has been observed that fungi of mating population "A" , "D" and “E” 
are found in com and of mating population “F” are primarily found on sorghum 
(Jardine and Leslie, 1992; Leslie et al., 1992a; Leslie et al., 1992b). Although it has 
not been established whether these two species vary in their pathogenicity or 
specificity for each host, it has been found that the "A" mating population is a 
better producer of fumonisin Bi than the "F" population (Riley et al., 1993). Also, 
the mating population "D" of Giberella fujikori has been reported as being a good 
producer of fumonisin Bi (FBi) (Riley et al., 1993). Recently, it has been reported 
that Alternaria alternata produces FBi (Chen et al.. 1992); and this suggests that F. 
moniliforme might produce the AAL toxins as well. In addition to F. moniliforme 
and F. proliferatum, several other newly described species, not yet placed in any 
Fusarium section, also produce these toxins and include: Fusarium nygamai, 
Fusarium napiforme, Fusarium anthophilum and Fusarium dlamini (Nelson et 
al., 1992). However, since these species are not usually associated with food and 
feed products, they are not considered important as far as the natural production of 
fumonisins on agricultural commodities.
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Little is known about the biology of F. moniliforme and F. proliferatum in 
terms of food contaminants and physiology of toxin production. These fungi 
produce several mycotoxins including: fusarins, fusaric acid and fumonisins 
(Chamberlain et al., 1993). Nelson and collaborators (1983) have discounted 
reports of production of zearalenone and deoxynivalenol by F. moniliforme. More 
recent reports require confirmation Fusarium proliferatum has been found to 
invade com and to produce fumonisins and moniliformin (Bullerman and 
Draughon, 1994). However, due to the increasing concern about fumonisin in foods 
and feeds, more research is being conducted to understand these factors. Since both 
fungi are plant pathogens, they also produce phytotoxins and several of the 
mycotoxins are also phytotoxins. Thus, these fungi produce a series of substances 
toxic to plants and animals. Some of the important mycotoxins/phytotoxins 
produced by F. moniliforme and F. proliferatum include: fusaric acid: A 
phytotoxic, mycotoxic, hypertensive agent as well as a synergist for other 
mycotoxins; fusarin C: A mutagen and macrophage inhibitor; moniliformin: A 
phytotoxic and mycotoxic agent; and fumonisins: A class of compounds that have 
shown to be hepatotoxic, nephrotoxic and hepatocarcinogenic in rats, neurotoxic in 
equines and pulmonary edema inducers in porcine species, and suspected 
carcinogens in man. The fumonisins are also herbicidal to several plant species and 
can induce adventitious root on non-sensitive detached tomato shoots (Bacon and 
Nelson, 1994).
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The fumonisins have been detected in com cobs, bee wings (glumes of old 
com florets) and com screenings. The highest concentrations have been found in 
the bee wings, although com screenings have higher concentrations than whole 
com and have produced the most toxicological concern, particularly to swine and 
horses (Bacon and Nelson, 1994; Ross, 1994). Desjardins et al. (1997), have shown 
that Giberella fiijikori isolated from rice from various geographic areas is capable 
of producing significant levels of FBi (>5 pg/g) and moniliformin (>100 pg/g) 
when grown in autoclaved maize substrate. To date, the occurrence of these 
mycotoxins in rice and rice-based foods has received little attention (Pestka, 1994). 
Other reports indicate that the highest fumonisin concentrations are found in com 
screenings (also called fines) which are generated as com moves through various 
distribution channels (Ross, 1994). Once a plant is infected, the precise timing and 
accumulation pattern of the fumonisins in planta are unknown. Bacon and Nelson 
(1994) have indicated that although a range of 9 to 91% infection is usually 
reported for some seed lots of com, in some years com kernels may be 1 0 0 % 
infected by F. moniliforme indicating that abiotic factors, primarily rainfall might 
be responsible. Biotic factors, such as com cultivar and fungal isolate, might also 
be responsible.
Because Fusaria are generally considered to develop as a result of weather 
and crop stress, local weather conditions were studied by several laboratories. The 
researchers concluded that no single set of weather circumstances were responsible, 
but general drought stress, followed by wet and warm weather was the pattern most
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likely to be involved in fumonisin production (Ross, 1994). There are some 
important factors that have to be considered for post-harvest fumonisin control such 
as:
1. Aeration: There is low production of fumonisins under a low oxygen tension 
and a modified nitrogen, carbon dioxide atmosphere.
2. Moisture: A kernel moisture content of less than 22% will prevent toxin 
production (Riley et al., 1993)
3. Temperature: Le Bars et al. (1994) reported that FBi production rate was 
maximal at 20°C and decreased sharply according to temperature following the 
order: 25, 15, 30 and 10°C
Control of soil-borne and kernel infection may be achieved with the use of 
microorganisms (soil and endophytic bacteria). Control of F. moniliforme on 
foodstuff should focus on its complex infection cycle and/or potential mechanisms 
for developing com resistance (Riley et al., 1993). The successful utilization of 
biocontrol measures must be based on detailed knowledge of the basic biology of 
F. moniliforme and F. proliferatum and their associations with com and other 
agricultural commodities, information, which is not yet available.
3. Chemical characteristics
Chemically, the fumonisins consist of several structurally related 
homologues of which fumonisin Bi (FBi), 2-amino-12,16-dimethy 1-3,5,10- 
trihydroxy- 14,15-propane-1,2,3-tricarboxy eicosane, is of primary concern since it 
is considered the most active cancer promoting component within the fumonisins
32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(Figure 2.4) (Bacon and Nelson, 1994). The other fumonisins are FB2 , FB3 . FB4 , 
FCi, FAi and FA2 and each differ by lacking one of the hydroxyl groups at either 
the C-5 or C-10 position of the 10 carbon aminopentol backbone. The latter three 
fumonisins may be artifacts of isolation. The A series differs from B series by 
possession of a N terminal acetyl group (Tanaka et al., 1993). Hydrolytic removal 
of one of the propanetricarboxylic acid moeities from fumonisins Bi and B2 yields 
partially hydrolyzed fumonisins (PHj and PH2 , respectively). The removal of both 
moeities yields the aminopentol fraction (AP[ and AP2 , respectively) (Sydenham, 
1994).
Gelderblom et al. (1993) studied the relationship between molecular 
structure and biological activity. Their results suggest that the fumonisin molecule 
must be both, intact and have a free amino group to exert its effects. Independent 
studies with synthesized analogues of FBi also indicate that these same structural 
properties are necessary for biological activity of the toxins (Kraus et al., 1992).
Fumonisins Bi, B2 and B3 exist as colorless compounds that are soluble in 
polar solvents such as water, methanol, or acetonitrile and insoluble in non-polar 
solvents (i.e., hexane). FBi has a molecular formula of C34H59NO14 and a molecular 
mass of 721 g/mole, while both, FB2 and FB3 contain one oxygen atom less, having 
similar molecular formulae of C34H59NO14 and molecular mass of 705 g/mole 
(Sydenham, 1994). None of the fumonisin mycotoxins possess chromophores, and 
therefore they do not absorb either ultra-violet (UV) or visible light, nor do they 
fluoresce (Sydenham, 1994).
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f a 2 H OH CH3OH
Figure 2.4 Structures of the fumonisin A and B analogues (Sydenham, 1994)
34
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
4. Metabolism
a. Absorption and distribution
To date, there is limited information on FBi absorption, distribution and 
excretion. However, all studies available (Shephard et al., 1992; Prelusky et al., 
1994; Vudathala et al., 1994; Norred et al., 1996) have indicated that it is poorly 
absorbed and rapidly cleared from the blood. It undergoes both, biliary and urinary 
excretion and it tends to persist in relatively small quantities in the liver and 
kidneys for prolonged periods (>96 hours). It is still unclear if these low persisting 
quantities are responsible for the cascade of biochemical events prompted by FB|, 
or if the short residence time of the higher doses is responsible for eliciting the 
toxic responses. Furthermore, if humans are exposed to FBi through daily 
consumption of contaminated com, there would always be a persisting low dose 
with longer hepatic and renal residence times. This idea is supported by an in vivo 
study in male Sprague-Dawley rats where it was shown that only prolonged 
exposure to an hepatotoxic dietary level (250 mg FBi/kg) that induced 
hepatotoxicity over a period of 14 to 21 days resulted in cancer initiation 
(Gelderblom etal., 1992).
Studies regarding the metabolism of fumonisins by various enzyme 
preparations have shown that they are not substrates for the microsomal 
cytochrome P450, estereases, or hepatic triglyceride lipase systems (Cawood et al., 
1994). Fractionation, purification and analysis of the hepatocyte incubation 
medium treated with fumonisins failed to indicate the presence of any metabolites.
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This information shows that unlike aflatoxin. the intact fumonisin molecule is 
needed for its biological activity (Gelderblom et al., 1993).
b. Mode of action
Chemically, fumonisins have been found to be similar to sphinganine. an 
intermediate in the biosynthesis of complex sphingolipids (Figure 2.5) (Sweeley. 
1991; Bell et al., 1993). Sphingolipids have been reported to play an important role 
in cellular membrane function, regulation of cell growth, differentiation, cellular 
signaling and apoptosis (Mato, 1990; Merrill et al., 1997). This similarity has led to 
the hypothesis that fumonisins interact with sphingolipid metabolism enzymes 
(Merrill et al., 1996). To date, numerous studies have reported that fumonisins are. 
indeed, potent inhibitors of the biosynthesis and turnover of complex sphingolipids 
(Norred et al., 1992; Wang et al., 1992; Merrill and Shroeder, 1993; Merrill et al., 
1993; Abbas et al., 1994; Merrill et al., 1995a; Merrill et al., 1995b; Schroeder et 
al., 1994; Schwartz et al., 1995; Smith and Merrill, 1995; Wu et al., 1995; Yoo et 
al., 1996; Merrill et al., 1997). It has been reported that FBi interferes with 
sphingolipid metabolism by competitively inhibiting the enzyme sphinganine 
(sphingosine) N-acyltransferase (ceramide synthase) with respect to both of its 
substrates, sphinganine and fatty acyl-CoA (Merrill et al. 1995b). In vitro studies 
with diverse cells such as hepatocytes (Wang et al., 1991), neurons (Merrill et al., 
1993a), kidney cells (Riley et al., 1994) and plant cells (Abbas et al., 1994) have 
shown that this enzyme plays a key role not only in sphingolipid biosynthesis, but 
also in their turnover. The inhibition of the turnover pathway results in sphinganine
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Figure 2.5 Structures of fumonisin Bi, sphinganine and sphingosine (Merrill et al.. 
1998)
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accumulation. In the presence of FBi, a portion of the accumulated sphinganine is 
phosphorylated to sphinganine-1-phosphate and then degraded to hexadecanal and 
ethanolamine phosphate, which is incorporated into phosphatidylethanolamine 
(Merrill et al., 1993b) (Figure 2.6). This raises the possibility that fumonisin also 
affects the metabolism of phosphoglycerolipids via this indirect route.
Some of the accumulated cellular sphinganine is released from cells and 
appears in the bloodstream and urine. Therefore, it has been hypothesized that the 
increase of sphinganine in blood and/or urine could be used as a biomarker for 
exposure to fumonisin. The accumulated bioactive compounds, as well as, the 
depletion of complex sphingolipids, may account for the toxicity, and perhaps the 
carcinogenicity, of fumonisins (Merrill et al., 1996). The determination of the 
change in the sphinganine/sphingosine ratio may indicate the amount of liver 
damage and regeneration caused by FBi. The inhibition of sphingolipid 
biosynthesis and turnover has also been proposed as an important factor in FBi 
tumorigenic potential,
c. Carcinogenicity
Gelderblom et al. (1989) observed that fumonisin B( (FBi) is a cancer 
promoter in a short-term cancer initiation-promotion assay using 
diethylnitrosamine (DEN)-initiated rats. FBi is also a cancer initiator as evidenced 
by the induction of resistant hepatocytes in rat liver (Gelderblom et al., 1992; 1994). 
Although FBi has been shown to be a complete carcinogen in rat liver, it is 
considered a poor cancer initiator. In a study reported by Gelderblom et al. (1994),
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The first steps occur in the endoplasmic reticulum (ER), where serine is condensed with palmitoyl-CoA (Pal- 
CoA) to yield 3-ketosphinganine (Ksa), which is reduced to sphinganine (Sa). Sphinganine is acylated to 
hihydroceramides by ceramide synthase using various long-chain fatty acyl Co-A’s. Glycosidic groups and the 
4,5-trans-double bond (of sphingosine -  So) are subsequently added to the 1-hydroxyl group in the Golgi and 
plasma membranes. Sphingolipid turnover is thought to involve the internalization of the sphingolipids, followed 
by their hydrolysis in acidic compartments (lysosomes and endosomes) to ceramides (N-Acyl-So), then to 
sphingosine (So). Sphingosine is cither reacylated or phosphorylated to sphingosine-phosphate (So-P) and 
cleaved to fatty aldehyde and ethanolamine phosphate, which is incorporated into phosphtidylethanolamine (PE). 
In the presence of fumonisin B|, (FBi) sphinganine accumulates and there is also an increase in sphinganine 1- 
phosphate (Sa-P).
Figure 2.6 Sphingolipid biosynthesis and turnover (Merrill et al., 1996)
prolonged exposure (21 days) to a relatively high dietary level (250 mg/kg) resulted 
in tumorigenesis. Thus, it was concluded that a time and dose dependent threshold 
level exists for cancer initiation by FBi. At a dietary level of 1000 mg/kg for 21 
days, only the B fumonisins (FBi, FB?, and FB3) initiated cancer in rat liver, 
whereas, the N-acetylated analogues, FAj and FA2 , and the hydrolysis products 
(aminopentol), AP| and AP2 , and tricarballilic acid (TCA) did not (Gelderblom et 
al., 1993). Thus, it has been considered that the free amino group and the intact 
molecule are required for cancer initiation. However, the mechanism by which 
fumonisin acts as a tumorigenic agent is still unknown.
The role of fumonisin in carcinogenesis is still unclear. Although FBi has 
been reported as a complete carcinogen in rats (Gelderblom et al.. 1988), it is not 
positive results in any of the traditional mutagenicity assays. Several authors 
(Gelderblom et al., 1991, 1992; Park et al., 1992), have reported negative results in 
the Salmonella/microsomal mutagenicity assay with and without metabolic 
activation. FBi does not induce unscheduled DNA synthesis in isolated rat 
hepatocytes (Norred et al., 1991a), and is not genotoxic in the in vivo and in vitro 
DNA repair assays in primary rat hepatocytes (Gelderblom et al., 1992a; Norred et 
al., 1992a,b). The fumonisins also failed to induce any genotoxic effects in the 
DNA-repair assay using Escherichia coli (strains 3431753. uvrB/vecA and 
3431765.uvr+/vec+) and the umu-microtest (with Salmonella TA 1535/pKS 1002) 
with and without rat liver S9 mix (Gelderblom et al., 1996). No micronuclei
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induction by FB| has been observed, and its mitogenic activity is still under debate 
(Gelderblom et al., 1996).
Although the fumonisins were negative in various in vitro genotoxicity and 
mutagenicity assays, short term in vivo studies have shown that FB| mimics 
genotoxic carcinogens with respect to the induction of resistant hepatocytes in rat 
liver (Gelderblom et al., 1992; 1994). Furthermore, it has been observed that FBi 
induces two important enzymes, gamma glutamyltranspeptidase (GGT) and the 
placental form of glutathione S-transferase (GST), which are accepted histological 
markers for preneoplastic lesions initiated by genotoxic carcinogens. Feeding 
experiments with fumonisins in rats indicated that an increase in cell proliferation 
is also likely to play a critical role in the induction of resistant hepatocytes, and the 
resultant regenerative cell proliferation is a prerequisite for initiation (Gelderblom 
et al., 1994). In this regard, regenerative cell proliferation is also a critical event 
during FBi carcinogenesis (Columbano et al, 1991). However, single and/or 
multiple dosages of fumonisins in the presence of a stimulus for regenerative cell 
proliferation fail to cause initiation (Gelderblom et al., 1992).
It has been widely accepted that carcinogenesis is a multiphase process 
where many factors are involved. It would be unreasonable to consider a single 
event on the ultimate carcinogenic outcome. In a real human diet, exposure to FBi 
would not be considered the only event leading to cancer of the gastrointestinal 
tract. An example is the epidemiological and molecular evidence from studies on 
cancer patients, where a close association between aflatoxin B\ (AFBi) and
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hepatitis B virus (HBV) infection with hepatocellular carcinoma was shown. It has 
been reported that a mutation at codon 249 in the p53 gene is commonly detected in 
this type of cancer (Bressac, 1991). FBj has been shown to co-contaminate grains 
with aflatoxin Bi under natural conditions (Chamberlain et al., 1993; Chu and Li, 
1994), so potential interaction and/or synergistic activities could also be related. 
Therefore, the aflatoxin/hepatitis environment could be further complicated by the 
presence of other toxins, such as, the fumonisins. Potential interactive effects need 
to be determined. Studies currently in progress, are investigating the role of p53 
associated mutations in early hepatocyte lesions and the ultimate cancer induced by 
FBi in rats chronically fed 50 mg FBj/kg for two years. DNA from rat liver 
nodules was amplified by polymerase chain reaction (PCR) with gene specific 
primers, corresponding to codon 249 of the human gene. Results from this study 
show that the positive control, AFBi, induced mutations at a very low frequency at 
rat codon 243, the equivalent to codon 249 in humans. No mutations were detected 
after cancer initiation with FBi. Only one rat fed 50 mg/kg for 12 months, showed 
a mutation at codon 243 while none of the rats with hepatic carcinomas after 18 to 
26 months showed any mutations in p53 (Sheffield et al., 1993). More information 
is needed on the mechanism by which fumonisin acts as a tumorigenic agent; the 
factors that affect this process and its relationship with other hepatic carcinogens. 
Furthermore, it has been reported that many of the natural composition diets fed to 
laboratory animals potentially contain fumonisins (Merrill et al., 1997). Merrill et 
al. (1997) performed a pilot feeding study in which female Sprague-Dawley adult
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rats were fed with several standard laboratory diets for 2-3 weeks. Urine was 
collected and analyzed for sphinganine and sphingosine as biomarkers for exposure 
to fumonisin. This study revealed a statistically significant correlation (p=0.042) 
between sphinganinersphingosine ratio and the fumonisin content of the diets; even 
when the fumonisin levels in the diets were fairly low (<4 pg/g). These results 
suggested that the presence of fumonisin in natural composition diets should be 
considered when feeding studies that might be affected by the presence o f this 
mycotoxin are designed and interpreted. Furthermore. Martinova and Merrill 
(1995) have reported that fumonisins alter immune function. Thus, the content of 
fumonisin in laboratory diets might be of particular concern in studies that use 
transgenic and/or immunocompromised animals (Merrill et a l, 1997). 
Sphingolipids are not considered “essential” nutrients and provide few calories. 
However, recent findings have shed new light on the nutritional significance of 
these highly bioactive components of food (Merrill et al., 1997). As new 
information is revealed, it is important to consider that dietary agents that alter 
sphingolipid metabolism, such as the fumonisins, could be implicated in diseases 
other than the epidemiologically related esophageal cancer.
5. Fumonisin Bi related toxicoses
a. Hepatotoxicity
Hepatic injury is a common manifestation of fumonisin toxicoses in many 
species, and seems compatible with the interference of normal biochemical 
processes such as sphingolipid metabolism (Ledoux et al., 1992). This condition
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has been primarily reported in animals with the experimentally produced disease 
(Ledoux et al., 1992). The fumonisin induced liver lesion differs from that of most 
hepatotoxicants including aflatoxins (Ledoux et al., 1992). In this case, 
fumonisins are diffusely distributed throughout the liver. A study conducted in rats 
by Norred and Plattner (1993) found that radioactively tagged fumonisin was 
accumulated in the liver and kidneys. The concentration of radioactivity was low 
but remained constant for at least 96 hours. The sub-acute pathological changes in 
the livers of rats caused by FBi were also similar to those caused by culture 
material of F. moniliforme MRC 826 (Voss, 1994). In a 90-day feeding study 
involving the purified toxin, mouse liver lesions were observed (Gelderblom et al.,
1991). Increased incidence (10 of 15 rats) of hepatocellular carcinoma was shown 
on rats fed FB1 (>90% pure) at 50 pg/g in a semi-purified diet for 18-26 months 
(Jaskiewicz et al., 1987). Hepatotoxicity was evident after 6 months and 
progressed in severity with time. Rats fed com either contaminated with F. 
moniliforme or F. moniliforme culture materials developed liver tumors (Hascheck 
and Haliburton, 1984). The sub-acute pathological changes in the livers of rats 
caused by FBi were also similar to those caused by culture material of F. 
moniliforme (Voss, 1994) In equines, hepatotoxicity is manifested by icterus, 
hemorrhages and edema (Harrison et al., 1990). Hepatic damage has not been 
reported in field cases of fumonisin toxicoses in swine. This may be due to the 
rather subtle nature of the liver lesions compared to the grossly evident pulmonary 
edema (Harrison et al., 1990). Liver lesions were seen only in the swine
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experimentally fed com screenings (Colvin and Harrison, 1992). In a feeding study 
reported by Colvin et al. (1992), liver changes were observed in all pigs. The mild 
lesions were characterized by centrolobular and random hepatocellular cytoplasmic 
vacuolar change, hepatocellular cytomegalia, disorganized hepatic cords and early 
perilobular fibrosis. At lower doses of fumonisin in swine and equines, the most 
prominent feature is slowly progressive hepatic disease. Additional research is 
needed before FBi can be considered a hepatotoxin for swine (Colvin and Harrison, 
1992). Liver is a target organ in most of the affected animals and is involved in all 
fumonisin associated diseases, so analysis of liver enzymes may serve as a 
nonspecific indicator of fumonisin toxicoses,
b. Equine leukoencephalomalacia (ELEM)
ELEM is a syndrome clinically characterized by an acute neurological 
disorder preceded by lethargy and inappetence and presence of Iiquefactive necrotic 
lesions in the white matter of the cerebrum. Necrosis of the gray matter may also 
be involved (Harrison et al., 1990; Shier et al., 1991). It appears that this disease 
occurs only in equines.
ELEM has been recognized since the nineteenth century as a sporadic, 
seasonal, "epidemic-like" condition (Ross et al., 1992). Since its first report in the 
United States in 1891, ELEM has been recognized in South America, China, 
Greece, Egypt, South Africa and Germany (Ross et al., 1992).
Historically, the diagnosis of ELEM has been based on tissue lesions in 
conjunction with clinical signs and the isolation of F. moniliforme from suspected
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feeds (Marasas et al., 1988). Since the recognition of F. moniliforme as the 
causative fungus, ELEM has been reproduced several times under diverse 
experimental conditions. Marasas et al. (1988) produced ELEM in a horse by 
intravenous administration trying to avoid hepatotoxicity as much as possible. 
Research shows that ELEM has been produced in horses given pure FBi by 
stomach tube and by feeding naturally contaminated screenings (monitoring for 
liver toxicity) (Shier et al., 1991). Because of the uncertain reports, it is not 
possible to speculate on what levels of fumonisin contamination may be a problem. 
When FBi levels of feed associated with ELEM were compared to those that were 
not related, a pattern emerged suggesting that concentrations above 10 pg/g in 
horse feed could be involved with ELEM (Marasas et al., 1992). This pattern has 
remained constant in cases where the feed is representative. Marasas et al. (1988) 
succeeded in reproducing ELEM in a horse by intravenous injection of 7 daily 
doses of 0.125 mg FBj/g live mass spread over 10 days. Kellerman et al. (1990) 
induced ELEM in two horses with oral daily dose of 1.25-4 mg FBi/g body weight; 
both animals developed typical symptoms of ELEM in 25 days. Wilson et al. 
(1992) reported that for levels above the 10-20 pg/g range, there should be concern 
for toxicity in horses. However, ponies fed 8 pg/g (Osweiler et al., 1992) did show 
minor non-specific lesions in liver, kidney and brain stem. Current evidence 
suggests that horses that consume feed containing levels as low as 8 pg/g of FB1 
may be at risk for developing ELEM (Wilson et al., 1991), but further evaluation of 
diets at 8 pg/g FBi is needed. Up to this point, researchers have found that in
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equines, high dosage levels cause fatal hepatotoxicity and mild brain lesions while 
low dosage levels produce mild hepatotoxicity and severe brain lesions (Shier et 
al., 1991).
c. Porcine pulmonary edema (PPE)
PPE is a syndrome in which swine experience acute, interstitial pulmonary 
edema, hydrothorax and death. Thoracic cavities are filled with a golden-yellow 
liquid that clots when exposed to atmosphere; trachea and bronchi contain a clear 
foamy liquid (Haliburton and Buck, 1986). Microscopical examination o f sections 
of lung tissue reveal edema so severe that individual lobules and pleura are 
separated from the parenchyma. The alveolar septa are congested but without 
hyperplasia or fibroplasia (Haliburton and Buck, 1986). When the dead swine were 
analyzed, the absence o f epithelial hyperplasia or fibroplasia suggested that these 
conditions were perhaps due to an unusual toxin (Colvin and Harrison, 1992). The 
lesions induced by FBi are remarkably distinctive and should not generally be 
confused with other conditions that induce pulmonary and/or thoracic effusion.
A possible mechanism of the development of PPE is that altered 
sphingolipid metabolism causes hepatocellular damage resulting in release of 
membranous material into circulation. This material is phagocytosed by the 
pulmonary intravascular macrophages (PIM's) thus, triggering the release of 
mediators which ultimately results in pulmonary edema. This is emphasized by the 
fact that studies in swine indicate that at lower doses of FBi, the most prominent 
feature is slowly progressive hepatic disease, while at higher doses, acute
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pulmonary edema is superimposed on hepatic injury and may cause death (Ledoux 
et al., 1992).
The pancreas appears to be similar to the lung in its sensitivity to FBi. 
Pancreatic lesions were present in three cases of experimentally induced acutely 
fatal FBi toxicoses (Colvin and Harrison, 1992). In cases of suspected FBi 
toxicoses in swine, examination of the pancreas should provide valuable diagnostic 
information. In 1989-1990 outbreaks of pulmonary porcine edema (PPE) were 
reported in different parts o f USA (Shier et al., 1991; Bane et al., 1992; Rheeder 
et al., 1992). Two workers from Georgia (Marasas et al., 1988) published the 
initial report on PPE and its association with FBI. In these two field cases, pigs 
consumed com screenings containing 162 and 99 pg/g FBi. Com from the 1989 
crop was associated with deaths of 34 mature swine in Southwest Georgia. To 
confirm that FBi was the causative agent, the syndrome was reproduced using the 
screenings and then intravenous injections of pure FB|. The results of these studies 
showed a strong association between F. moniliforme and PPE (Rheeder et al.,
1992). Chemical and mycological investigations have revealed the presence of FBi 
at concentrations of 20 to 360 pg/g in suspect swine feeds (Marasas et al., 1988). 
Animals fed with com screenings naturally contaminated with 175 pg/g 
fumonisins developed PPE, but presented hepatotoxicity when fed doses higher 
than 23 pg/g for 14 days (Ledoux et al., 1992; Colvin and Harrison, 1992; Ross et 
al., 1991). Purified FBj administered intravenously has been shown to produce 
PPE (Ledoux et al., 1992; Colvin and Harrison, 1992; Ross et al., 1991).
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Harrison et al. (1990) induced pulmonary edema in a pig by injection of 0.4 mg 
FBi of body weight daily for 4 days. As with ELEM. a strong correlation exists 
between the fumonisin content of feed obtained from different farms and outbreaks 
of PPE. More studies are required in order to obtain the necessary information to 
treat and to prevent the disease (Haschek et al., 1992).
d. Human esophageal cancer
Fusarium moniliforme infection of com has been correlated with human 
esophageal cancer (EC) risk in Transkei, South Africa where com is a dietary staple 
and in China (Haschek et al., 1992). Esophageal cancer also occurs in higher than 
normal concentrations in portions of Iran (Kmet and Mahboubi, 1972) and the 
Charleston, South Carolina area of the United States (Fraumeni and Blot, 1977). 
Transkei has been the most studied region due to the fact that its rate of EC is 50- 
100 per 100,000 population while normal occurrence for esophageal cancer 
elsewhere is less than 5 cases per 100,000 population (Shier et al., 1992). In this 
region, the com is grown locally, harvested and stored in open cribs; and 
frequently, it is visibly moldy. A retrospective study of com samples collected over 
the period 1976-1989 from Transkenian areas of high esophageal cancer showed 
higher levels of fumonisins in com than samples from areas with low incidence 
(Rheeder et al., 1992). Contamination of com with Fusarium moniliforme and 
fumonisins in the areas of high EC is statistically higher than that found in areas of 
the Transkei with lower cancer incidence (Hascheck et a l ,  1992; Sydenham et al., 
1990; Bane et a l ,  1992). Thiel et al. (1992) reported that based on a daily
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consumption of 460 g com/day by a 70 kg person, the estimated intake of FBi was
0.44 mg/kg/day. This daily dose is alarmingly high when compared to daily 
intakes of 0.6-4.0 mg/kg/day that give rise to ELEM in horses or 3.75 mg/kg/day 
that produce hepatocarcinogenesis in rats (Hascheck, et al., 1992). It is important 
to point out that com samples from high and low cancer rate areas in the Transkei 
are not commercial com but rather home-grown, produced, harvested, stored and 
consumed by the people living in rural areas. Laboratory studies have shown a 
high correlation between the cancer promoting activity and toxicity of different 
strains of F. moniliforme. There is evidence that fumonisins are neither genotoxic 
nor mutagenic and do not appear to be metabolized to a significant extent in vivo, 
so the mechanism of carcinogenicity is difficult to ascertain (Shier et al., 1992). 
Nonetheless, the carcinogenic potential has been shown in laboratory rats (Voss, 
1994; Jaskiewicz et al., 1987). Gelderblom et al. (1992) demonstrated 
hepatocarcinogenicity in rats by incorporating 50,000 ng/g to the diet in a 26 month 
period. In other cancer experiments in rats, approximately 66% of the animals 
developed hepatocellular carcinoma while a cancer rate as low as 0.02% can be 
considered a significant risk to a human population (Haschek et al., 1992). Results 
of experiments with rats imply that FBi is a complete carcinogen and, together with 
other related compounds, might be responsible for the hepatocarcinogenicity of F. 
moniliforme (Voss, 1994). FBi and FB2 pose a potential risk to humans as they 
occur in food and have been shown to be statistically correlated with the prevalence 
of human esophageal cancer in Transkei. However, it is important to establish that
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cancer manifestation may take a lifetime and the presence of fumonisin has only 
been analyzed recently. It is necessary to follow the EC rate and fumonisin 
contamination in time to assess if the population develops this condition. On the 
other hand, there are social economic, cultural, genetic and a diverse scope of 
factors that can contribute to a high cancer rate. Whether the high rate of EC in 
regions of the Transkei is caused by fumonisins cannot be determined conclusively, 
but the available evidence suggests that their presence may be at least partly 
responsible.
e. Developmental toxicity
The developmental toxicology of FBi has been evaluated in different 
species. In vivo studies with culture material extracts have reported embryotoxic 
effects in hamsters (Floss et al., 1994a,b), mice (Gross et al., 1994), and rats 
(Lebepe-Mazur et al., 1995. Studies using purified FBi rather than culture material 
reported embryotoxicity to hamsters in vivo (Floss et al., 1994b) and to chick 
(Zacharias et al., 1996) and rat embryos in vitro (Johnson et al., 1993; Flynn et al., 
1996). However, FBi embryotoxicity has been questioned by other studies that 
have shown negative results. LaBorde et al. (1997) reported lack of embryotoxicity 
in New Zealand white (NZW) rabbits at 0.5-1.0 mg/kg/day doses. However, they 
reported that FBi was quite toxic to NZW rabbits at doses as low as 0.5 mg/kg/day. 
In this study, adverse developmental effects (decreased fetal weight) were observed 
only at doses producing maternal toxicity. Another study by Ferguson et al. (1997) 
reported minimal maternal or offspring toxicity in rats. This study suggested that
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doses <9.6 mg purified FB|/kg body weight and/or <1.6 mg FBi/kg body weight 
obtained from culture material caused minimal maternal toxicity and produce few 
developmental functional alterations. In addition, potential FBi related functional 
alterations were prevalent only in males suggesting that there is a mild sex-specific 
effect of fumonisin. In developing rats, Kwon et al. (1997) observed that FBi alters 
brain sphinganine levels and myelination. These diverse reports emphasize the need 
to do more research to understand FB| mechanism of action and its potential risk to 
human fetuses.
In addition to high rates of esophageal cancer, it has been reported that the 
incidence of neural tube defects (NTDs) in the Transkei is significantly higher than 
in other areas of South Africa (Ncyiyana, 1986; Viljoen et al., 1995). The incidence 
of NTDs has also been reported to be higher in the Hebei province of the People’s 
Republic of China than the average for the rest o f the country. This province 
contains the Cixian county that is also one of the areas of China having a high 
incidence of esophageal cancer (Chinese Birth Defects Monitoring Program, 1990). 
In the United States, high rates o f NTDs have been observed in Cameron County, 
Texas from 1990 to 1991 (Texas Department of Health, 1992) and in Harris 
County, TX from 1989 to 1991 (Canfield et al., 1996). The prevalence of these 
defects was high among Hispanics (Canfield et al., 1996) for whom com and com 
products represent a dietary staple. In 1989-1990 there were reports of clusters of 
horse fatalities due to ELEM in this same area in Texas. This event established that 
the com crop in that area was contaminated with fumonisins during this period.
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Moreover, recent findings have reported that fumonisin Bi induces depletion of 
cellular sphingolipids and interferes with folate uptake (Stevens and Tang, 1997).
Folate and its derivatives are vitamins that function as coenzymes in several 
metabolic reactions. They are considered essential for the biosynthesis of molecules 
such as thymidine and purines, as well as, the conversion of homocysteine to 
methionine (Wolf, 1998). It has been reported that dietary folate is taken up by 
cells by two mechanisms. The first one uses a high capacity, low affinity protein 
transmembrane transporter known as the “reduced folate carrier”. The second one 
is a membrane-anchored receptor protein with high affinity for both, folic acid and 
reduced folates denominated as “membrane folate receptor” (MFR). The MFR is 
important in tissues, such as, the kidneys, the placenta and breast where high folate 
levels are required. This receptor is attached to the plasma membrane through a 
covalent link to a glycosylphosphatidylinositol anchor (GPI) in a membrane 
domain that is rich in cholesterol and sphingolipids. Folate uptake by MFRs 
appears to take place by the classical endocytosis process. The MFR on the plasma 
membrane is bound and the folate is internalized by invagination that forms 
vesicles that are pinched off and enter the cell. After the folate has been unloaded, 
the MFR is recycled back to the membrane. It has been suggested that 
sphingolipids, particularly glycosphingolipids interact through hydrogen bonding 
with the GPI anchor of the membrane protein to localize it in a particular 
membrane domain (VanMeer, 1992).
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The involvement of sphingolipids in the folate uptake mechanism led to the 
hypothesis that factors affecting sphingolipid metabolism could be involved in 
defective cellular folate uptake. Stevens and Tang (1996) reported that intestinal 
cells (Caco-2 cells) are depleted of sphingosine after treatment with FBi. Uptake 
into the cells of the folate derivative 5-methyltetrahydrofolate was virtually 
eliminated by FBi. When ceramide was added to these cells, the folate uptake was 
renewed. In this study, the authors concluded that the inhibition of the folate uptake 
was caused by the loss of the receptor rather than by its redistribution within the 
membrane. The authors showed that the MFR is critically dependent on the 
sphingosine and cholesterol levels on the membrane. There is evidence that the GPI 
anchor requires a sphingolipid/cholesterol-enriched domain, possibly to target the 
receptor to a particular site on the membrane. These results are important since the 
risk of fetal NTDs is known to be associated with dietary folate deficiency (Creizel 
and Dudas. 1992). Stevens and Tang (1996) considered that inhibition of folate 
uptake through dietary exposure to FBi could be related to the high incidence of 
NTDs among Texas’ Hispanic population. Furthermore, D’Angelo and Selhub 
(1997) have reported a correlation between increased risk of heart disease and 
elevated blood levels of homocysteine associated with folate depletion. These 
findings have focused attention on fumonisins’ potential role in other human health 
problems.
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f. Other diseases
There are several non-specific syndromes that affect other species exposed 
to fumonisin. Many reports implicate F. moniliforme with poultry diseases and wild 
bird mortality (Voss et al., 1989; Shier et al.. 1992). A 21-day feeding study in 
broiler chicks reported that dietary fumonisin resulted in depressed weight gains, 
increased organ weights, diarrhea, thymic cortical atrophy, multifocal hepatic 
necrosis, biliary hyperplasia, and rickets (Voss et al., 1989). Other researchers 
report that com cultures fed to chicken and birds produce immunosuppression. 
According to the actual evidence, the level necessary to promote toxicosis in 
poultry is below 100 mg/kg (Voss et al., 1989). During 1988 and 1989, a distinct 
swine disease syndrome (Mystery Swine Disease - MSD), characterized by 
epidemics of prenatal and neonatal mortality and respiratory diseases and immune 
system dysfunction in older swine was reported in North America (Gelderblom et 
al., 1992). The etiology of this disease is unknown at this time, but Bane et al. 
(1991) reported that the distribution of MSD in Illinois was the same as for PPE. 
The results of one study (Gelderblom et al., 1992) do not indicate a direct cause 
and effect relationship, but show a strong relationship between MSD and feeding 
com contaminated with fumonisin at concentrations o f 20 pg/g or greater. 
Fumonisin may be the initiating "trigger" factor leading either directly or indirectly 
to MSD.
Studies in rats show that the kidney is also a sensitive target organ for FB| 
fed either as contaminated com or pure FBi (Fincham et al., 1992; Shier, et al.,
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1991). Other studies suggest that the kidney is not an important target organ for 
this toxin (Jaskiewicz et al., 1987). The reason for this difference has not yet been 
explained. Recently, it has been reported that intravenous injection of FBi at doses 
of 1 mg/kg for five days can cause severe and acute kidney damage in rabbits 
(Gumprecht et al., 1994). Vervet monkeys, that were fed low levels (0.25-1%) of 
F. moniliforme culture material in a diet based on com, low in fat and high in 
carbohydrates for up to two years, showed atherosclerosis (Riley et al., 1993). 
Research showed that atherogenic potential is secondary to chronic hepatotoxicity 
(liver fibrosis) (Riley et al., 1993).
Fumonisins seem to affect an important metabolic pathway in several 
animals. This is evidenced by the generalized presence of several degrees of 
hepatotoxicity in all the fumonisin-associated diseases that have been studied. 
Each species will react in different ways to these alterations, so most of the 
toxicoses are species-specific and present a wide variety of syndromes in different 
target organs.
D. Inhibition of gap-junction intercellular communication as a non- 
genotoxic mechanism in carcinogenesis
The general concept of traditional chemical carcinogenesis mechanisms has 
relied on the genotoxicity of xenobiotics. The idea that non-genotoxic pathways 
can induce cancers has not even been considered until recently. Recently, a 
considerable amount of data has been presented on the carcinogenic potential of 
compounds with no apparent genotoxic potential. Thus, the scientific community
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has been faced with the challenge to understand the process of carcinogenesis from 
a non-genotoxic point of view, since these compounds pose significant regulatory 
dilemmas relating to the risk assessment of human exposure (Ricci and Melton, 
1985).
In a simplistic approach, cancer can be regarded as a rebellion in an orderly 
cellular society. Cancer cells disregard their neighbors and grow autonomously 
over surrounding normal cells. Intercellular communication is considered to play an 
important role in maintaining an orderly society through control of cell growth, cell 
differentiation and homeostasis (Yamasaki, 1987). Thus, it has been proposed that 
disruption of cell-cell communication could be involved in carcinogenesis 
(Loewenstein, 1979; Murray and Fitzgerald, 1979; Yotti et al., 1979).
Most cells have two different ways to communicate with other cells. One is 
communication mediated by growth factors or hormones where direct cell contact 
is not needed. Since this type of communication depends on extracellular factors 
that are easily identified, the involvement of these factors in carcinogenesis has 
been recognized. There have been several reports showing that many oncogenes 
encode growth factors or growth factor receptors (Bradshaw and Prentis, 1987). 
The second type of communication is cell contact-mediated intercellular 
communication or gap junction intercellular communication (GJIC). During this 
type of contact, cells exchange signals directly from the inside of one cell to the 
inside of a second cell (Yamasaki, 1996, 1990; Bennett et al., 1991).
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In tissues, cells communicate directly by exchanging low molecular weight 
molecules (<1000 daltons) through gap junctions (Simpson et al., 1977). Some of 
these exchanged molecules may include sugars, nucleotides, amino-acids and ions 
that are important in normal cell function. Second messengers, i.e. calcium, cAMP 
and inositol triphosphate can also be exchanged through gap junctions and 
participate in tissue control (Saez et al., 1989).
GJIC is mediated by gap junction channels that are composed o f protein 
channels comprised of connexin molecules. Six connexin molecules form a 
connexon in a cell. A gap junction channel is formed when a connexon from a 
neighboring cell is aligned and linked (Yamasaki, 1996). These six monomers form 
a channel that closes by twisting of the six units (Zampighi and Unwin, 1979). Gap 
junctions in different tissues are not always identical. So far, 12 cDNAs coding for 
different connexin molecules have been cloned (Beyer, 1993). Connexins are 
composed of four transmembrane domains with their C- and N- terminals in the 
cytoplasm. The amino acid sequences on the terminal cytoplasm portions vary 
significantly between different connexins while the transmembrane and 
extracellular portions are more conserved (Zhang and Nicholson, 1989;
Goodenough et al., 1988; Milks et al., 1988). Protein kinase regions are present at 
the C-terminal end of some of the connexins, and phosphorylation has been 
considered to play an important role in regulating gap junction function (Moreno et 
al., 1992). Since connexins are proteins, they are regulated by the usual regulatory 
mechanisms that apply for most proteins. These include transcription, mRNA
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stabilization and translational control, and post-translational phosphorylation. Other 
control levels that affect connexin function include, change in cell adhesion 
molecules, change in membrane structure and conformation, and growth factors 
(Musil and Goodenough, 1995; Meyer et al., 1992; Jongen et al., 1991; Spray et 
al., 1987; Zampighi and Unwin, 1979).
The discovery that many tumor promoting agents can block GJIC is the 
most supportive evidence of its involvement in carcinogenesis (Trosko and Chang, 
1983; Enomoto et al, 1981; Bradshaw and Prentis, Murray and Fitzgerald, 1979; 
Yottie et al., 1979). In addition, it has also been shown that inhibition of GJIC by 
phorbol esters can be antagonized by various mouse skin anti-promoting agents 
such as retinoic acid, glucocorticoids and cAMP (Yamasaki and Enomoto, 1985). 
To further support this concept, there are also other lines of evidence that tumor 
promoter mediated inhibition of GJIC is associated with enhancement of cell 
transformation (Yamasaki and Katoh, 1988). Although there have been studies that 
contradict the involvement of GJIC in carcinogenesis, it can be considered as a 
plausible mechanism for certain tumor promoters. It is conceivable that multiple 
mechanisms are involved and that different chemicals will affect cells through 
diverse pathways that will ultimately result in cancer.
While the relevant mechanism that causes the opening and closing of gap 
junction channels remains obscure, the involvement of protein kinase C action in the 
regulation of intercellular communication has been implicated. It has been 
hypothesized that the intercellular protein kinase C is related to the inhibition of gap
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junction function. Moreover, complex sphingolipids have many important functions in 
cell membranes. The regulated breakdown and turnover of complex sphingolipids, 
such as, sphingomyelin, are known to result in the formation of lipid "second 
messengers". These second messengers act as intracellular signals for turning on and 
off cellular processes including the expression of genes and activation or inactivation 
of specific proteins, such as, protein kinase C (Riley et al., 1994). The fumonisin- 
related inhibition of de novo sphingolipid biosynthesis and transformation may play 
an important role in disrupting the production of protein kinase C. Which in turn, 
results in disrupted gap-junction cell communication and, ultimately, in cancer 
promotion. The simultaneous exposure to a genotoxic carcinogen (aflatoxin) and a 
non-genotoxic carcinogen (fumonisin) may have a synergistic effect on the complex 
carcinogenesis process.
E. Effects of processing on mycotoxin-contaminated foods*
Mycotoxins comprise a structurally diverse and chemically complex group 
that can contaminate a wide variety of food products. Table 2.1 presents a summary 
o f some of the most commonly affected commodities, the potential toxic mold 
genera/species, and the mycotoxins that contaminate them.
Most of the research on the effects of processing has been related to the 
aflatoxins, but some processing and stability experiments have been done on other
* This section has been reprinted from Ref. (98-160), p. (407) by courtesy of Marcel 
Dekker, Inc. (See Appendix C)
60
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 2.1 Summary of selected reports o f potentially toxic molds from various food 
or agricultural commodities (CAST, 1989)
C o m m o d ity P o te n tia lly  to x ic  g en era /sp ec ies  
fou n d
P o ten tia l
m y co to x in s
















ochratoxin A  
sterigm atocystin  
patuiin
pen ic illic  acid  
d eoxyn ivalen ol 
zearalenone  
fum onisin

















M eat p ies, cooked  m eats, cocoa  









ochratoxin A  
patuiin
p en ic illic  acid
A ged m eat products, cured ham  









ochratoxin A  
patuiin
p en ic illic  acid
sterigm atocystin
penitrem
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C om m od ity P o te n tia lly  tox ic  g e n e r a /sp e c ie s  
fou n d
P o ten tia l
m y co to x in s
Dry beans, soybeans, com , Aspergillus Penicillium afatoxins
sorghum , barley Flavus cyclopium ochratoxin A
Ochraceus viridicatum sterigm atocystin
Versicolor citrinum pen ic illic  acid





Refrigerated and frozen pastries Aspergillus Penicillium aflatoxins









ochratoxin A  
patuiin
p en ic illic  acid
citrinin
penitrem











Foods stored in hom es, both Penicillium Aspergillus aflatoxins
refrigerated and nonrefrigerated sp. sp. kojic acid  
ochratoxin A  
penitrem  
patuiin
pen ic illic  acid
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Aspergillus and Penicillium metabolites, such as, ochratoxin A, citrinin, penicillic 
acid and patuiin. More recently, research has been conducted on the effect of 
processing on the Fusarium toxins, i.e.. trichothecenes, fumonisins, deoxynivalenol 
(DON), T-2 toxin and zearalenone (Scott, 1984). Research in this area is extensive 
and beyond the scope of this publication. This section will only discuss a few 
examples pertinent to the effectiveness of normal processing operations in reducing 
the risks associated with mycotoxin contamination and the industrial applicability 
of selected decontamination procedures.
1. Physical methods of mycotoxin removal
a. Cleaning and segregation
Once a contaminated product has reached a processing facility, cleaning and 
separating are the first alternatives of control. These procedures are usually non- 
invasive; and, except for milling, will not significantly alter the product. In some 
cases, these are the best methods to reduce mycotoxin presence in the finished 
products, i.e., a significant amount of aflatoxins in shelled peanuts can be removed 
by electronic sorting and hand-picking (Dickens and Whitaker, 1975). However, 
complete removal of all contaminated particles or aflatoxin cannot be expected 
with physical methods of separation. Since the toxin can diffuse into the interior of 
the kernel, residual contamination may be present at very low levels in the final 
product. If there is a high level of residual contamination, other procedures must be 
used to manage the contamination in the final product.
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Floatation and density segregation of aflatoxin-contaminated com and 
peanuts have been reported to significantly reduce aflatoxin concentrations (Cole, 
1989). Kirskey et al. (1989) reported that 95% of the aflatoxin in 21 of 29 samples 
of peanuts was contained in kernels that floated in tap water. Furthermore, Phillips 
et al. (1994) reported that the mean aflatoxin level was decreased from 301 ng/g to 
20 ng/g using floatation as a separation mechanism. Although there is still an 
aflatoxin residue, separation has been shown to significantly reduce aflatoxin 
contamination and can be considered as an effective first line of defense for certain 
products.
Separation of fumonisin-contaminated com, particularly screenings, based 
on size has been reported as a possible candidate for decontamination. Com 
screenings are broken com kernels that usually contain about 10 times the 
fumonisin content of intact com (Murphy et al., 1993). However, screenings 
represent a significant proportion of the com used for feed, so it is not possible to 
segregate fumonisin contents by screening size without compromising the feed 
supply. Further decontamination procedures need to be used to treat com 
screenings used for feed.
Although significant quantities (ca. 25%) of deoxynivalenol (DON) can be 
removed by cleaning and polishing, the toxin remains in wheat flour at levels 
ranging from 60-80% of original toxin levels from the starting wheat (Seitz et al., 
1986; Trenholm et al., 1991). Another study on wheat samples from several states 
showed a reduction in deoxynivalenol content in flour from spring wheat that had
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been cleaned by aspiration prior to milling into flour (Bennett et al., 1992). 
However, the toxin residues found in the flour indicate that physical separation 
should only be considered a step in a more elaborate risk management plan.
If apples rotted with Penicillium expansum are used for commercial juice 
production, the final product may contain patuiin. It has been reported that 
trimming of apples to remove the rot reduces the patuiin content by 93 - 99% 
(Lovett et al., 1975). In general, physical separation or trimming of apples before 
processing is the best method to reduce patuiin contamination. In this case, physical 
separation should be considered the focal point of the risk management plan. The 
correct use of trimming and separation will render safe high quality commercial 
juice.
Cleaning and segregation represent a primary source of the removal of 
hazard in mycotoxin contaminated food. In some cases, these procedures will 
eliminate the problem. However, in most cases, further processing is needed to 
reduce the risks associated with mycotoxin contamination. Although some 
contamination may persist, physical separation is a good alternative for industry. 
These processes require an initial investment to purchase adequate equipment, but 
their maintenance is rather inexpensive. Furthermore, physical removal will not 
affect the product's characteristics; so after the initial separation stage, there is no 
other significant alteration of the product. With well-calibrated separating 
equipment and appropriate planning, this method is a good choice for products such
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as peanuts, and other tree nuts (aflatoxin), com (aflatoxin and fumonisin), and 
apples (patuiin).
b. Wet milling
Wet milling is a process widely used for com. Thus, there have been several 
studies that evaluate the effects of this process on mycotoxins associated with this 
grain. In this case, an established processing method can be used to manage 
contaminated grains. It is important to identify the fraction(s) that remain toxic. 
These fractions may then be diverted to less risk uses or subjected to 
decontamination procedures. Laboratory studies have reported that during wet 
milling of inoculated com, aflatoxin Bi was distributed in the milling fractions. It 
went primarily into the steep water (39 to 42%) and fiber (30 to 38%), with the 
remainder found in gluten (13-17%), germ (6 - 10%) and starch (only 1%) (Bennet 
et al., 1978; Wood et al., 1982). The distribution of mycotoxins in the different 
fractions poses new concerns. In a good risk management plan, an individual 
contaminated fraction needs to be considered as a new product because it will have 
its own unique characteristics. Some of the factors to be considered for a particular 
milling product include: the end use, the chemical properties, and the level and type 
of contamination. Each product or by-product should be approached differently, 
and risk management decisions should be made on an individual basis.
Other mycotoxins are also distributed during wet milling of com. 
Zearalenone concentrates in the gluten (49 to 56%) and milling solubles (17 to 
26%), but is absent in the starch (Bennett et al., 1978; Bennett and Anderson,
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1978). Recent wet milling laboratory-scale studies on naturally-contaminated com 
have shown that zearalenone remains mostly in the gluten and the germ remains 
relatively free of the toxin. The starch fractions, which account for 65-71% of 
milled products, were free of detectable zearalenone. Milling solubles contained 
one to four times the levels of zearalenone in the starting com and gluten fractions. 
The most contaminated fraction contained two to seven times the levels in starting 
com. Although these fractions account for only 14-19% of the com, they account 
for 72-75% of the zearalenone. Fiber and germ fractions contained up to three times 
the levels of zearalenone in the starting com and these fractions account for 15- 
16% of the milled product. These results show that if a mycotoxin-contaminated lot 
of com is processed by wet milling, toxin free starch is produced; however, other 
products generally used in animal feed have much higher levels of toxin than the 
starting com (Bennett and Anderson, 1989). The concentration of toxin in a 
particular fraction simplifies the process of risk management. The other milling 
fractions can be considered safe, and decisions need to be taken on a single product. 
The management of only one toxic fraction can be simpler than the handling of 
several contaminated milling products.
An advantage o f wet milling is that additional chemicals can be added to the 
steeping solution. So, a modified process could be used to ensure the safety of the 
final products. Bennet and Richard (1996) have conducted traditional wet milling 
(using lactic acid-sulfurous acid steeping) of two samples of fumonisin B1 
naturally-contaminated com. In com containing 13.9 pg/g of fumonisin B|, a
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portion (22%) of recoverable toxin was found in the steep and process waters. 
Other fractions contained fumonisins with gluten having the highest concentration 
followed by fiber and finally germ with the lowest concentration. The gluten and 
fiber from com contaminated at 13.9 gg/g could pose a risk because they contain 
toxins at levels considered to be harmful to certain animals (Ross et al., 1991).
In wet milling of deoxynivalenol-contaminated com, much of the DON 
went into the steep liquor, although measurable amounts remained in the starch 
(Scott, 1984). Experimental wet-milling of com contaminated with T-2 toxin 
showed that 67% of the toxin was removed by the steep and process water (T-2 
toxin is more water soluble than aflatoxin or zearalenone). Wet-milling of com 
containing ochratoxins A and B showed that 43% of ochratoxin A remaining in the 
steeped com went into the process water and solubles on subsequent processing, 
with 4% remaining in the germ and 51% in the grits (Wood, 1982).
Mycotoxins have diverse chemical characteristics, so the distribution during 
wet milling will vary according to the commodity and the type and level of 
contamination. Each case should be considered separately when developing a risk 
management plan for wet milling operations,
c. Dry milling
Dry milling will also fractionate the toxin(s). Thus, the identification of the 
toxic fractions is needed to adequately use milling as a decontamination procedure. 
In dry milling of naturally contaminated com, aflatoxin B| concentrated in the 
germ and hull fractions; but distribution varied with the contamination levels. The
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grits, low-fat meal and low-fat flour (the prime products) contained only 6 to 10% 
of the aflatoxin Bi. In artificially contaminated rice aflatoxin was greatly reduced 
by milling, with more than 95% in the bran and polish fraction (Achroder, 1968). In 
durum wheat, aflatoxin Bj was determined to be in peripheral parts of the kernel. 
Upon milling, the aflatoxin concentration in the flour varied according to the 
quality of the final product and was maximal in the bran. Prior conditioning 
reduced the aflatoxin content by 47% (Scott, 1984).
For zearalenone-contaminated com, all dried milled com fractions 
contained zearalenone and only 3 to 10% was removed (Scott, 1984). Dry cleaning 
(screening) of the zearalenone-naturally contaminated com does not significantly 
reduce toxin levels in com lots. Bennet et al. (1976) reported that all mill fractions 
from laboratory scale and commercial processes were contaminated with 
zearalenone. The highest levels of toxin were found in the hull and high fat 
fractions. Prime product mix (grits, low-fat meal, and flour, which account for 57- 
63% of product yield) contained about 20% of the zearalenone from the starting 
com samples (Bennett et al. 1976).
No specific dry milling studies have been conducted on fumonisin- 
contaminated grains. However, assays on com based foods have shown that the 
toxin is present in human foodstuffs, i.e., com grits and com meal (Bennett and 
Richard, 1996; Sydenham et al., 1991; Stack and Eppley, 1992). On the industrial 
perspective, milling can be used as an effective method of separation. If the 
distribution of the toxin is determined, and alternate management of the toxic
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fraction is developed, milling can be considered a good cost/benefit method. A 
combination of cleaning, sorting and milling can significantly reduce the risks 
associated with mycotoxins.
2. Physical methods of detoxification
a. Thermal inactivation
Thermal inactivation is a good alternative for products that are usually heat 
processed. However, some of the mycotoxins are chemically stable at processing 
temperatures. Thermal inactivation should be evaluated for the conditions of a 
particular process. Additional processing steps, i.e., use of compounds that would 
promote the chemical degradation of a toxin, could be employed to ensure the 
safety of the procedure. In some cases, a change in conditions such as pH or 
moisture content will contribute to the chemical modification of a particular toxin.
Aflatoxins are resistant to thermal inactivation, and are not destroyed 
completely by boiling water, autoclaving or a variety of food and feed processing 
procedures (Christensen et al., 1977). Aflatoxins may be destroyed partially by oil- 
and dry roasting of peanuts. However, Stoloff (1982) reported that aflatoxins are 
generally stable in peanut materials at room temperature. Baur (1975) found no 
significant changes in levels of aflatoxins Bi, B2 , G| and G2 in peanut meals, and 
raw and roasted peanut butter stored at 23° C for two years. Lutter et al. (1982) 
reported that alternative peanut roasting methods, i.e., microwave roasting, destroy 
aflatoxins almost completely. Unfortunately, this process would involve an
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increase in processing cost, making it commercially impractical. Thus, microwave 
roasting is not a good industrial solution, even if it yields a safe product.
Roasting has been a good method for certain commodities, i.e., peanuts. As 
mentioned before, if an operation that is regularly used in processing is an 
effective decontamination procedure, then that operation would be the first choice 
to manage that particular product. This would provide a safe, inexpensive risk 
management method. An example of roasting as an effective means of control is its 
use in coffee processing. It has been reported that roasting green coffee beans 
containing added aflatoxin Bi at 200° C produced a 79% toxin loss after 12 min. 
and more than 94% loss after 15 min. (Levi, 1980). Furthermore, roasting of green 
coffee beans at 200° C for 20 min. destroyed 6 8 % of added sterigmatocystin under 
laboratory conditions (Levi et al., 1975). It is important to mention that these 
studies were performed with spiked coffee beans. The use o f spiked material for 
experimental processes gives useful information. However, the effects of roasting 
should be confirmed with naturally-contaminated green coffee beans because 
naturally occurring toxins may have different interactions with the food matrix. It is 
important to confirm the effectiveness of a processing operation under industrial 
conditions before using it as part of a risk management plan.
Several studies have reported that aflatoxin Bi is moderately stable in 
heated peanut oil, com oil and coconut oil. Therefore, flying in unrefined oils 
could add aflatoxin during processing (Dawarkanath et al., 1969; Peers and Linsell, 
1975). Fortunately, oils are not of concern because only a small percentage of
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aflatoxin Bi present in oilseeds passes into extracted or pressed oil; and refining 
and bleaching operations essentially eliminate it (Parker and Melnick, 1966). 
Gracian (1980) reported that the average loss of total aflatoxin concentration in 
pressed olive oil was 76% .
Conway et al. (1978) reported that roasting com (145-165° C) yielded a 
reduction of 40-80% of the original aflatoxin Bj. Studies on cooking of aflatoxin- 
contaminated rice found that normal cooking of rice destroyed about 49% of 
aflatoxin B§; pressure cooking and cooking with excess water destroyed more of 
the aflatoxin Bi in the rice (73 and 82%, respectively). These results provide 
evidence of the influence of water on stability of aflatoxin during heat processing. 
Furthermore, when pasta products contaminated with aflatoxins were cooked for 10 
min. in boiling water, 29% of the aflatoxin was found in the drained water and 6 6 % 
in the cooked pasta (Stoloff et al., 1978).
Surveys have shown that thermally processed com products, i.e., canned 
com, tortillas, and ready to eat cereals generally have lower concentrations of FB| 
than do unprocessed products, i.e., com meal and grits (Parker and Melnic, 1966; 
Pittet et al., 1992; Doko and Visconti, 1994). Since most corn-based foods receive 
some sort of thermal processing, it has been suggested that this kind of procedure 
could have an effect on the fumonisin content in food. However, results reported 
by Jackson et al. (1995), Alberts et al. (1990), Dupuy et al. (1993), and Scott and 
Lawrence (1994) indicate that the fumonisins are fairly heat stable compounds. In 
general, it has been reported that the loss of FBi and FB2 was more rapid and
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extensive in alkaline or acidic environments than at neutral pH. Thermal processing 
operations, such as, boiling or retorting, which occur at temperatures <125°C, have 
little effect on the fumonisin content of food; however, foods that reach 
temperatures >150°C during processing may have significant losses of fiimonisins. 
Although some of these studies show decomposition of fiimonisins, the toxic 
potential is not necessarily eliminated (R. Lopez-Garcia and D. L. Park, 
unpublished data); therefore, detoxification of these compounds cannot be 
assumed. Further work is needed to determine the toxicity of thermally processed 
fumonisin-contaminated foods (Jackson et al., 1996). In this case, thermal 
processing is not a good choice for industry. Alternative methods for fumonisin 
decontamination need to be applied.
Studies on the effect of heat processing of ochratoxin A-contaminated flour 
have reported that considerable reduction of ochratoxin A (76%) occurred in 
samples of white flour heated to 250°C for 40 minutes. Ochratoxin A appears to 
be more readily destroyed in dry cereal than in the presence of water (unlike 
aflatoxin Bi and patuiin) (Scott, 1984). This was also evident in a study reported by 
Osbome where ochratoxin A was not degraded during breadmaking, but 62% was 
lost after baking o f biscuits, which have a lower water content (Osbome, 1979).
Processing of other commodities naturally contaminated with ochratoxin A 
have shown that after blanching, salting and heat processing beans, about 53% of 
ochratoxin A remained (Harwig, 1974). In this case, it is important to determine if
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the heat processing will yield products with unchanged technological 
characteristics.
Several authors have studied the effect of making bread on aflatoxin present 
in w'heat flour or in maize flour (El-Banna et al., 1983; Reiss, 1978). Variable 
destruction levels have been observed, but there are still conflicting results. Bennett 
and Richard (1996) reported that baking does not destroy or significantly reduce 
levels of deoxynivalenol. DON has proven to be more heat stable during food 
processing than any other mycotoxin tested. No DON was destroyed during the 
baking of different ethnical products such as Egyptian bread. Western style bread 
or cookies baked from hard wheat flour (Scott, 1984).
b. Irradiation
The effects of irradiation on most mycotoxins is relatively unknown. 
However, with the state of today's processing facilities, irradiation does not seem to 
be a good commercial method. The cost involved in setting up an irradiation 
facility and the reluctance of the consumer to accept irradiated products makes this 
method inaccessible to most industries.
Feuell (1966) reported that gamma irradiation (2.5 Mrad) did not degrade 
aflatoxin in contaminated peanut meal, and UV light produced no observable 
change in fluorescence or toxicity of the treated sample. However, exposure to 
contaminated peanut oil to short-wave and long-wave UV light resulted in a 
reduction of aflatoxin levels (Feuell, 1966; Shantha and Sreenivasamurthy, 1977).
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c. Adsorption from solution and covalent binding
Adsorption from solution or covalent binding of aflatoxins to non-biological 
materials are good methods for aflatoxin decontamination. In industries such as the 
oil refineries, the use of adsorbent materials is readily available and is part of 
normal processing operations. A variety of adsorbent materials; i.e., activated 
carbon and clays, has been shown to bind aflatoxins in aqueous solutions, and 
certain aluminosilicates have been reported to bind aflatoxins in peanut oil and 
animal feeds. The long-term effects and safety of the aluminosilicates has not been 
determined (Mansimanco et al., 1973; Decker, 1980; Machen et al., 1988). 
However, a phyllosilicate clay (HSCAS or NovaSil™) that is currently used as an 
anti-caking agent in the feed industry has been studied for its ability to bind 
aflatoxin and reduce the toxicity/mutagenicity of the final product. Phillips et al. 
(1994) have reported that this clay [1] tightly binds aflatoxins in aqueous 
suspensions; [2 ] markedly diminishes aflatoxin uptake by the blood and 
distribution to target organs; [3] prevents acute aflatoxicosis in farm animals; and 
[4] decreases the levels of aflatoxin Mi residues in milk. In this case, phyllosilicate 
clay is an effective decontamination agent that is readily used in the feed industry. 
However, its only approved use is as an anti-caking agent and its use for removal of 
aflatoxin from feed is not permitted in certain countries including the United States 
of America. Thus, its beneficial effects are limited to a particular industrial process. 
The bentonite clays used in oil purification (to remove pigments) seem to adsorb 
aflatoxins present in the unrefined oil. Activated charcoal has also proven to be
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effective in reducing the patuiin in naturally contaminated fruit juices (Sands et al., 
1976; Chu et al., 1975). More research is needed for the application of this method 
with other mycotoxins and commodities.
3. Biological decontamination
Biological methods are a good option for the fermenting industry, i.e., 
breweries. In this case, however, it is important to determine the yeast's viability in 
the presence of mycotoxins. It is also important to determine the effect of 
mycotoxins on the yield and development of secondary characteristics associated 
with the final product. It is relevant to note that biological methods demonstrating 
effective decontaminating properties are usually the result of specific compounds 
produced by selected microorganisms. When this occurs, it is usually more efficient 
and economical to add the active agent directly.
Chu et al. (1975) reported that aflatoxin Bj is not completely removed 
during the beer brewing process, i.e., 18 and 27% remained from two 
contamination levels of starting material, 1 and 10 ng/g, respectively. It was 
relatively stable in the cooker mash treatment, but significantly lost in the wort 
boiling and final fermentation steps. Dam et al. (1977) found that aflatoxin B[ is 
reduced by 47% after cooking and fermentation of com, wheat or com:milo. 
Following distillation, a concentration effect was observed more aflatoxin B| was 
present in the wet solids (dry weight basis) than in the starting com (Lindroth, 
1980). Aflatoxin from contaminated com does not go into the alcoholic distillate, 
but accumulation of aflatoxin in spent grains is a potential problem when using this
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material as animal feed. Further decontamination procedures must be used if these 
by-products are to be used as animal feed (Dam et al.,\911\ Lindroth, 1980).
Bennet and Richard (1996) reported that although pure fumonisins exhibit 
considerable water solubility, residues of toxin remain in the distillers’ dried grains. 
This fermentation product accounts for 31-35% of the total fumonisin B|, in the 
starting com. Facilitated by solubility in water, 51-54 % of fumonisin Bi, in 
starting com was extracted into whole stillage. No toxin could be detected in 
distilled ethanol. The fermentation process did not destroy fumonisin and 85% of 
the toxin could be recovered in the products. Products from ethanol fermentation of 
fumonisin-contaminated com generally used as animal feeds could be detrimental if 
consumed by pigs or horses, animals sensitive to relatively low levels of this toxin.
The use of zearalenone contaminated com for ethanol production was 
investigated by Bennet et al. (1981). The presence of toxin had no apparent effect 
on ethanol yields and there was no carry-over from zearalenone to distilled ethanol. 
However, the fermentation process did not destroy the toxin and recovered solids 
contained 2 to 2.5 times the level of zearalenone in the starting com. Traditional 
fermentation for brewing o f com beer has shown 51% carry-over of zearalenone 
into the finished product (Okoye, 1987). Fermentation by Saccharomyces 
cerevisiae of wort containing zearalenone resulted in conversion of 69% of the 
toxin to beta-zearalenone, a metabolite with less activity than the parent compound 
(Scott et al., 1992). Chu et al. (1975) reported that 91 to 96% of ochratoxin A
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remained after the cooker mash treatment of the beer brewing process and none 
was destroyed during pasteurization and boiling of beer itself (Chu et al., 1975).
Almost complete destruction of patuiin occurs during alcoholic 
fermentation of apple juice (Burroughs, 1977). Fermentation of juice containing 
patuiin at a level of 40 pg/mL using S. cerevisae effectively eliminated patuiin in 2 
weeks (Harwig et al., 1973). Winemaking has also been reported to destroy patuiin 
(Scott, 1977).
In a survey performed by Scott et al. (1993), deoxynivalenol was found in 
29 of 50 samples of Canadian and imported beers. Nine samples contained greater 
than 5 ng/mL deoxynivalenol. There are conflicting results on DON stability during 
the beer making process. Data is dependent upon the extraction and the analytical 
method.
4. Chemical inactivation
Ammoniation of com, peanuts, cottonseed, and meals to alter the toxic and 
carcinogenic effects of aflatoxin contamination has been subject to intense 
research efforts. Results of these studies have been summarized by Park et al. 
(1988). Reports on the extensive evaluation of this procedure demonstrate support 
for the efficacy and safety of ammoniation as a practical solution to aflatoxin 
decontamination in animal feeds. This process has been successfully used for many 
years in the U.S., France, Senegal, Sudan, Brazil, Mexico and South Africa. The 
practical applications along with research results strongly support the use of the 
ammonia treatment to reduce risks posed by aflatoxin contamination. Particularly
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in the high temperature/high pressure where process parameters are clearly defined 
and followed. With the ambient temperature/atmospheric pressure method, caution 
must be exercised to assure even distribution of ammonia gas/water or aqueous 
ammonia solution in the product. This process is limited to whole kernel seed/nut 
products and has not been successful for ground or meal products due to the 
inability of the ammonia to penetrate the commodity. Norred et al. (1991) found 
that atmospheric pressure/ambient temperature ammoniation reduced fumonisin 
content of F. moniliforme culture material but did not reduce the toxicity of 
material when fed to rats. Park et al. (1992) reported 79% reduction of fumonisin 
levels in com after high pressure/ambient temperature ammoniation followed by a 
low-pressure/high temperature treatment.
Nixtamalization, the traditional alkaline heat treatment of com used in the 
manufacture of tortillas, reduces significantly the levels of aflatoxin (Ulloa and 
Herrera, 1970; Ulloa Sosa and Schroeder, 1969). However, subsequent studies have 
shown that much of the original aflatoxin is reformed on acidification of the 
products (Price and Jorgensen, 1985). This treatment has also been proposed as a 
method to detoxify fumonisin-contaminated com (Sydenham et al., 1991). A 
feeding study reported by Hendrich et al. (1993) showed that nixtamalization 
greatly reduces FB i content. However, when nixtamalized com was fed to weaning 
rats, the toxicity o f the inoculated com was not reduced. The major toxic product of 
fumonisin hydrolysis during nixtamalization appears to be hydrolyzed fumonisin 
Bi (HFBO, but it is possible that other breakdown products, such as calcium-FBi
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complexes and other products may also play a role in the toxicity of nixtamalized 
com. The hydrolysis of FB| by treatment with Ca(OH) 2  and heat does not render a 
detoxified product. It produces a more toxic final product. Feeding weaning rats 
with culture material containing 8-11 pg/g of HFBi produced some toxicity 
symptoms as severe as did 45-48 pg/g FBi. These data indicate that the 
production of hydrolyzed fumonisins in the processing of goods for human 
consumption may be of significant concern. Park et al. (1996) have reported a 
"modified nixtamalization" procedure that involves the addition of hydrogen 
peroxide and sodium bicarbonate to the traditional process. Results from this study 
show 40% reduction of brine shrimp mortality when comparing the products of 
traditional nixtamalization and modified nixtamalization. Traditional 
nixtamalization is probably not a useful strategy for fumonisin detoxification 
(Murphy et al., 1995). However, the modified procedures where other agents, such 
as, hydrogen peroxide and/or sodium bicarbonate are used, pose a good alternative 
for Latin American countries where nixtamalized com is a major component of 
the diet.
It has been shown that sodium chloride has marked influence on loss of 
aflatoxins in artificially contaminated unshelled peanuts. Cooking in water in a 
pressure cooker for 0.5 h caused a loss in concentration of 80-100% with sodium 
chloride, but only 35% without the salt (Scott, 1984). Sodium bisulfite has been 
shown to react with aflatoxins (Bi, Gi, Mi, and aflatoxicol) under various
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conditions of temperature, concentration, and time to form water-soluble products 
(Hagler et al., 1982).
Non-enzymatic browning has been proposed as a decontamination 
procedure for fumonisin Bi. When FBi was incubated with glucose or fructose to 
mimic non-enzymatic browning conditions, a first order rate reaction was observed. 
This showed that the amine group of FBi was derivatized by the sugar. Preliminary 
cell tissue culture tests, with these adducts suggest they are less toxic than FBi 
(Murphy et al., 1995).
Both, patulin and penicillic acid are moderately stable in apple juice, with a 
half-life of several weeks (Pohland and Allen, 1970). The rate of disappearance of 
these toxins increased markedly with the addition of ascorbate or a mixture of 
ascorbate and ascorbic acid to the juice (Brackett and Marth, 1979).
Processed foods are very complex systems. Processing not only alters the 
food but also adds new ingredients and conditions. These new factors change the 
environment, so many new interactions can occur. Exploring the application of 
known food additives to mycotoxins as an integral part of the process can open a 
lot of opportunities for risk management.
5. Other industrial processes
Since molds and their secondary metabolic products are ubiquitous in foods 
and feeds, there have been several reports on the effects of processing and storage 
on mycotoxins present in commodities other than grains and oilseeds, i.e., cured 
meats, dairy products, and fruit products. It has been reported that recovery of
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aflatoxins added to meats is only 16% from raw ham, and 19% from salami after 
storage for 6  to 8  weeks at 5 to 37° C (Stott and Bullerman, 1976). Storage at 5° C 
for shorter periods of time (up to 1 week) did not destroy aflatoxins Bi and Gi in 
bologna or cheese (Lieu and Bullerman, 1977), nor did curing and cooking bacons 
and hams greatly reduce aflatoxin levels (Furtado et al., 1981). Van Egmond 
(1983) reported that sterigmatocystin was stable in cheese for at least 3 months at 
temperatures of -18° to 16°C. Aflatoxins B| and Gi were completely unstable in 
berry jams stored for 6  months at 22°C, although 26 to 38% of aflatoxins B2 and G2 
were recovered (Pensala et al., 19?).
Aflatoxin Mi is stable during pasteurization (Wiseman et al., 1983). 
Aflatoxin Mi has been reported to be more stable in naturally contaminated milk 
than in freeze-dried spiked milk. Evidence has been obtained that aflatoxin Mj
binds to milk protein casein (Scott, 1984)
In most cases, there is no single method that will insure the complete 
removal of the contaminant. Integrated management with a combination of 
different methods can significantly reduce the risks associated with mycotoxin 
contamination and yield products that are safe and acceptable to the consumer.
The ubiquity of Aspergillus, Fusarium and Penicillium in food and feed 
commodities, as well as, their ability to produce a wide variety of toxic compounds, 
makes mycotoxicology a complex field. There is great need for more research in 
areas, such as, toxin production, identification, toxicological properties, potential 
interactions and control alternatives.
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More information is needed on the ecological relationships between 
different mold species and their effect on mycotoxin production. This information 
could lead to a better understanding of the role o f mycotoxins in fungal physiology 
as well as in plant pathology. Since there have been reports on the co­
contamination o f different mold species in a wide range of commodities, their 
interactions need to be understood to more clearly define the factors that affect 
toxin production in the field, during harvest and in storage. This information would 
be useful in the development of preventive measures and possible biological 
control mechanisms. Furthermore, the understanding of fungal interactions could 
also lead to a better assessment on types and quantities of toxins produced under 
certain conditions. Therefore, facilitating the evaluation of potential human and 
animal exposure to different toxic agents.
Toxicological perception of the effect o f exposure to a single compound 
gives valuable information on its mode of action and potential effects. However, in 
reality, humans and animals get exposed to a wide variety of xenobiotics that can 
have potential interactions. These effects can have positive or negative influences 
on the ultimate toxic outcome. Although the study of the toxicological effect of 
complex chemical mixtures is a difficult area, research on the potential interactions 
between agents that are known to co-exist in nature (i.e., aflatoxins and fumonisins) 
could give valuable information on the toxicological significance of more complex 
mixtures.
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It would be unreasonable to believe that all toxic outcomes are the result of 
single events rather than a combination of factors. If a "healthy'’ status is 
considered to be a physiological equilibrium or homeostasis, we need a better 
understanding of the factors that upset this state. Intrinsic individual factors, such 
as, genetic predisposition, general health status, age and gender, as well as extrinsic 
factors such as diet and environment among others play an important role on the 
equilibrium. All of these are very complex areas that interrelate on several levels. 
From the food toxicology point of view, research in mycotoxicology could lead to a 
better understanding of the role of diet in health and disease.
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III. Preliminary evaluation of the production of aflatoxins and fumonisins 
by Aspergillus flavus and Fusarium moniliforme during storage at 
optimal mold growth conditions
A. Introduction
Although it is generally assumed that cereal grains are pristine in nature and 
that agricultural commodities are a source of good nutrition and health, the 
contamination of food and feeds with naturally-occurring toxins, i.e., mycotoxins, 
has presented new concerns. These contaminants are persistent, unavoidable and 
unpredictable. Thus, every year, large amounts of food and feed are contaminated 
with a diverse range of mycotoxins. These toxins differ in chemical nature and 
biological activity; and in some cases, {i.e., aflatoxins) can present a serious health 
risk to humans and animals. Therefore, the understanding of the conditions that 
affect their production and stability is an essential tool for the design of strategies 
that could prevent their formation or control their proliferation.
Aspergillus flavus and Fusarium moniliforme are widely distributed 
throughout the world. Although each mold has its unique mode of action, their co­
existence in plants, such as, com indicates that there could be an interactive 
relationship between both species. In the past it was widely believed that one mold 
species persisted over the other; however, more recent reports have suggested that 
they can co-exist in the same environment (Chamberlain et al., 1993). This concept 
leads to new research questions. If these species co-exist, how does this affect the 
biosynthesis and degradation of secondary metabolites like mycotoxins? If there is 
an interaction, are mycotoxins produced as a defense mechanism? Does the
85
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
presence of other mold species trigger the production of certain biologically active 
compounds?
Chamberlain et al. (1993) reported that A. flavus and F. moniliforme infect 
com by different routes. While A. flavus is considered a non-pathogenic fungus that 
colonizes com through kernel damage into the outer seed covering; F. moniliforme 
is recognized as a pathogen that enters the kernel through the pedicle and occupies 
the internal space (Zummo and Scott, 1990). Thus, since in theory, these molds 
occupy different microhabitats within the com plant, it could be assumed that they 
do not interact. However, Zummo and Scott (1992) reported that inoculation of 
kernels with both fungi resulted in inhibition of A. flavus and decrease in aflatoxin 
concentration. Conversely, Chamberlain et al. (1993) observed that in com 
contaminated with both, aflatoxigenic and fumonisin-producing fungi, the 
concentrations of aflatoxin and fiimonisin were independent. These reports 
suggested that when conditions within the kernels are favorable, both, aflatoxins 
and fumonisins can be produced.
After harvesting, and during storage the plant structure is altered allowing 
more opportunity for mold interaction. It has been observed (Lopez-Garcia and 
Park, unpublished data; Price, personal communication) that during storage of 
ground aflatoxin-fumonisin- co-contaminated com, changes in toxin concentrations 
occur. During storage under refrigerated conditions (ca. 4°C), aflatoxin 
concentrations decreased while fumonisin concentrations increased. This suggested
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a dynamic system where fungi were interacting. Thus, new research concerns were 
presented.
The objective of this study was to provide preliminary information on the 
relationships between toxigenic strains of A. flavus and F. moniliforme in cracked 
com during a short storage period under moisture and temperature conditions that 
favor mold growth. Also, the toxin-producing potential of untreated com under the 
same moisture and temperature conditions was determined. Since mold growth is a 
complex process, one can expect the production of innumerable compounds other 
than aflatoxins and fumonisins. Thus, the toxic/mutagenic potential of raw com 
extracts from different sampling periods was also determined. This study will only 
provide initial data on the toxin production by the A. flavus and F. moniliforme. 
This information can be used to develop other more detailed studies.
B. Materials and methods
1. Corn and fungal and bacterial cultures
Non-contaminated whole kernel com samples were obtained from Cargill 
(Port Allen, LA). Fusarium moniliforme (A00102, Leslie et al., 1992) was kindly 
provided by Dr. Raymond Schneider (Louisiana State University, Department of 
Plant Pathology, Baton Rouge, LA) and Aspergillus flavus (13L, Cotty, 1989; 1990) 
isolated from Arizona agricultural soil was provided by Dr. Robert Brown (United 
States Department of Agriculture, Southern Regional Research Center, New 
Orleans, LA). Salmonella typhimurium tester strains TA-100 and TA-98 were
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kindly provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, 
CA).
2. Chemicals
Acetic acid, ammonium sulfate, ampicillin, D-biotin, disodium 
hydrogen phosphate, glucose-6 -phosphate, L-histidine, magnesium sulfate, 2- 
mercaptoethanol, ortho-phtaldehide, sodium ammonium sulfate, disodium 
tetraborate, sodium chloride, sodium dihydrogen phosphate, 6 -nicotinamide 
adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were all purchased 
from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade), citric acid 
monohydrate, dimethyl sulfoxide, ethyl ether anhydrous, hexane (HPLC grade), 
methanol (HPLC grade), potassium chloride, potassium phosphate dibasic 
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc. 
(Paris, KT). Bacto agar, potato dextrose agar and crystal violet were ordered from 
Difco Laboratories (Detroit, MI); glucose was from Fisher Scientific (Fair Lawn, 
NJ). Acetonitrile (HPLC grade) was from Baxter Co. (Muskegon, MI). Ethanol was 
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient 
broth No. 2 was purchased from Unipath LTD (Basingstoke, Hampshire, England). 
Post-mitochondrial supernatant (S9 mix) was purchased from Molecular 
Toxicology, Inc. (Boone, NC).
Pure fumonisins Bi and B2 were kindly provided by Dr. Robert M. Eppley 
(Center for Food Safety and Applied Nutrition -  CFSAN, U. S. Food and Drug 
Administration-FDA, Washington, D.C.). Pure aflatoxin Bj was generously
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provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.). Aflatoxin Bi, 
Bi, Gi, and G2 HPLC standard 50 pg/g mixture was purchased from Romer 
Laboratories, Inc. (Union, MO).
3. Corn inoculation
Inoculation and com culture was performed according to the method 
reported by Leslie et al. (1992). Briefly, yellow aflatoxin/fumonisin free whole 
com kernels were coarsely cracked in a Willey mill, then homogenized in a tumble 
blender. Samples (300 g.) were placed in sterile Fembach flasks, and 33 ml of 
sterile distilled water were added to each flask. The flasks were covered with a 
cheesecloth plug and aluminum foil; then autoclaved at 121°C for 30 minutes. 
After autoclaving, another 33 ml of sterile distilled water were aseptically added to 
each flask.
Fungi {A. flavus and F. moniliforme) were cultured on potato dextrose agar. 
After colonies had covered the entire petri dish, culture material was aseptically 
scraped off and rinsed with sterile distilled water (ca. 10 ml/plate). The mold/water 
suspensions from each plate were collected to make a stock inoculating suspension. 
In the case of the combined sample, equal amounts of Aspergillus and Fusarium 
suspensions were mixed thoroughly. This procedure ensured that com samples 
would have equal mold inoculi. Seventy five ml of the conidia suspension were 
added to their respective flasks (ca. 107 conidia/flask) (Table 3.1).
Flasks were incubated in the dark for 45 days at 25°C. The cultures were 
thoroughly mixed with a sterile metal spatula every other day to evenly distribute
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the inoculum. Different spatulas were used for each sample and the hood was 
thoroughly disinfected with 70% ethanol between samples to avoid cross­
contamination. For the naturally contaminated samples, the same amount o f total 
sterile distilled water was added (141 ml), but the samples were not autoclaved. 
Therefore, the naturally occurring fungi and other micro flora, i.e., yeast and 
bacteria were allowed to grow. The control samples had the same amount of water 
added, but they were not inoculated. Samples (approximately 100 g.) were removed 
from of each flask at 15, 30 and 45 days of incubation. The samples were placed in 
sealed plastic bags and stored at -20°C until analysis.
Table 3.1 Com inoculation design
Sample N Heat treatment Water added Inoculum
A 3 121°C; 30 min 141 ml A. flavus
F -» 121°C; 30 min 141 ml F. moniliforme
A+F 3 121°C; 30 min 141 ml A. flavus and F. moniliforme
NC J No treatment 141 ml No inoculum
Control 3 121°C; 30 min 141 ml No inoculum
All samples were analyzed in triplicate
4. Safety precautions
Since highly toxigenic strains of Aspergillus and Fusarium were used in this 
study, several safety measures were taken to avoid exposure to toxic material and 
mold spores. A half-face negative pressure respirator equipped with HEPA filters 
was used every time the com samples were handled. Also, protective eye wear and 
nitrile gloves were worn at all times. All samples were handled in a biological 
laminar flow hood. During the first portion of the storage spore high production
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was high; so special care was taken to prevent airborne spore contamination by 
thoroughly cleaning the hood after each flask was handled.
5. Toxin extraction
Com samples (100 g.) were placed in a blender with 300 ml MeOH:HzO 
(77:23) and blended at high speed for 5 minutes. The extracted slurry was filtered 
through Whatman # 1  filter paper. The filtrate was considered the crude com 
extract.
6. Aflatoxin purification
For the 15 day samples, aflatoxin clean-up and purification was performed 
according to the method reported by Thean et al. (1980). Seventy five ml of the 
crude com filtrate were placed in a 250 ml beaker with 75 ml of 0.61 M 
(NH4 )aS0 4  solution and 5 g of celite 545 analytical filter aid. The solution was 
mixed for 2 minutes and then filtered through Whatman #2 fluted filter paper. 
Then, 100 ml of this filtrate were placed in a 250 ml separatory funnel and 5 ml 
CHCI3 were added. The mixture was shaken vigorously for 2 min. The phases were 
allowed to separate and the CHCI3 fraction was drained into a 20 ml scintillation 
vial. This process was repeated with a second 5 ml CHCI3 . Both CHCI3 fractions 
were collected in the same vial. The CHCI3 extract was evaporated to complete 
dryness under a N2 stream.
To purify the aflatoxin from the CHCI3 extract, commercially available C- 
18 solid phase extraction columns (Bond Elut, Varian, Harbor City, CA) were used. 
The columns were pre-conditioned with 3 ml hexane. The dry extract was
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dissolved in 0.5 ml CHCI3 using a Vortex mixer. Care was taken to wash all the 
vial walls. The extract was then diluted with 0.5 ml hexane, and applied to the pre­
conditioned C-18 solid phase extraction column. The vial was rinsed with 1 ml 
CHCL3 :C6H6 (1:1) and the rinse solution was also applied to the column. The 
column was then washed with 5 ml hexane and 5 ml ethyl ether anhydrous. Finally, 
the aflatoxins were eluted with 3 ml chloroformrethanol (95:5) into clean 
scintillation vials. The eluted extracts were evaporated to dryness in a warm water 
bath (ca. 40°C) under N2 .
The 30 and 45 day samples had copious mold growth. When this extraction 
procedure was used, the presence of interfering compounds was observed. Mold 
apparently produced a multitude of unidentified compounds, some of these seem to 
have emulsifying properties that prevented the separation of the organic phase 
(CHCI3 ). Several attempts were made to break the emulsion (/. e., addition of NaCl, 
increasing the volume of CHCI3 , adding octanol, freezing to -20°C and 
centrifuging). However, even when part of the CHCI3 phase was separated, 
recovery from extracts spiked with 100 ng pure AFBiwas below detectable levels. 
Therefore, it was decided to use a purification method that did not involve 
liquid: liquid extraction. These samples had to be extracted and purified following 
the method reported by Wilson and Romer (1991) with slight modifications. The 
recovery of spiked solutions using this method was 90-95%. Briefly, 0.5 ml of the 
crude methanokwater extract were mixed with 4.5 ml acetonitrile:water (9:1) in a 
capped culture tube and vortexed for 1 min. Multifunctional cleanup (MFC)
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columns (Mycosep #224-Romer Labs., Inc.. Washington. MO) were used to purify 
this extract. The Mycosep column was fitted over the culture tube and the flanged- 
end was pushed into the solution, letting the crude extract pass through the column. 
Approximately 1 ml of the purified extract was collected and stored (4°C) until 
HPLC analysis.
7. Quantification of aflatoxins by liquid chromatography (HPLC)
The samples were analyzed following the method reported by Wilson and 
Romer (1991). The 15 day dry extracts were reconstituted in 1 ml acetonitrilerwater 
(9:1). Thirty and 45 day samples were already in an acetonitrilerwater (9:1) 
solution. To derivatize the aflatoxins, a 200 pi aliquot of the purified extracts was 
transferred into an HPLC auto-injector vial (Waters, Milford, MA), and 700 pi of 
trifluoroacetic acid derivatizing reagent (distilled water:trifluoroacetic acid:acetic 
acid -  7:2:1) were added. The samples were then placed in a 65°C water bath for 
8.5 min. The vials were then cooled in an ice-water bath.
The samples were placed in an HPLC autosampler (Waters 717 plus 
autosampler -  Waters, Milford, MA). The analysis was carried out using a Waters 
modular system with a Waters 470 scanning fluorescence detector (360 nm 
excitation and 440 nm emission) and a Novapak C | 8  reverse phase column. Fifty 
pL of sample were injected and analyzed using a watenacetonitrile (8:2) mobile 
phase with a 2.0 ml/min. flow rate. Approximate retention times for pure aflatoxins 
Gi (G2a), Bi (B2a), G2 and B2 were 2.6, 3.5, 7 and 9.8 min., respectively under these
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particular experimental conditions. Aflatoxin concentrations were calculated using 
the Millenium Chromatography Manager Software (Waters, Milford, MA).
8. Fumonisin purification
Fumonisins were purified following the AOAC official method 995.15 
(1996). Solid-phase extraction (SPE) was performed using 500 mg silica-based 
strong anion exchange (SAX) columns (Varian BondElut -  Varian, Harbor City, 
CA). The SPE cartridges were fitted to a SPE manifold and conditioned by washing 
with 5 ml methanol followed by 5 ml methanol .-water (3:1). A 10 ml aliquot of the 
crude com extract (pH adjusted ton 5.8-6.5 if necessary) was applied to the 
cartridge while maintaining a flow rate < 2.0 ml/min. The cartridge was then 
washed with 5 ml methanol:water (3:1) followed by 3 ml methanol. Special care 
was taken to avoid cartridge drying at this stage. Fumonisins were eluted with 10 
ml methanol:acetic acid (99:1) at a flow rate <1.0 ml/min. The eluate was collected 
in a 20 ml scintillation vial. The solvent was evaporated to dryness under N2 at ca. 
60°C. The vial was then washed twice with 1 ml methanol and the resulting 
solution was transferred to a 4 ml amber vial. The methanol was evaporated to 
dryness. Dried sample residues were stored at -20°C until liquid chromatography 
(LC) analysis.
9. Quantification of fumonisins by liquid chromatography (HPLC)
Fumonisins were quantified using the same HPLC system described for 
aflatoxin analysis. The fluorescence detector was set at 335 nm excitation and 440 
nm emission wavelengths. The analysis was carried out using a Novapak Cis
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reverse-phase (3.9x150 mm) column with a reverse-phase guard column. The flow 
rate was set at 1 ml/min. using a acetonitrile:water:acetic acid (50:50:1) mobile 
phase.
The dried purified residues were redissolved in 200 pi methanol. A 50 pi 
aliquot was transferred into an autoinjector vial and 450 pi of orto-pthaldehide 
(OPA) derivatizing reagent (40 mg ortho-pthalehide + 1 ml methanol + 5 ml 0.1 M 
disodium tetraborate solution + 50 pi mercaptoethanol). The derivatized solution 
was mixed and injected (10 pi) within 1 min. of adding the OPA solution. The 
approximate retention times for fumonisin Bi an B2 were 4.1 and 12.8 min., 
respectively.
10. Mutagenic potential of raw corn extracts
Composite samples were prepared by mixing 1 ml of each of the three raw 
extracts from samples described in Table 3.1. The mixture was then filter-sterilized 
using a 0.22 p-Millipore syringe filter (Millipore, New Bedford, MA) and 
sequentially diluted 3 times using dimethyl sulfoxide (DMSO) to obtain a total of four 
solutions test solutions ( 1 0 °, 1 0 ' 1, 1 0 '2and 1 0 '3).
The samples were tested using Salmonella typhimurium tester strains TA-100 
and TA-98 according to the standard plate incorporation method described by Maron 
and Ames (1983). Frozen cultures were plated onto ampicillin master plates and 
incubated for 48 h at 37°C. A single colony was then inoculated into 50 ml sterile 
Oxoid Broth No. 2; and incubated in the dark at 37°C for 10-14 h using a gyratory 
(200-250 rpm) shaker water bath. After incubation, growth was confirmed by
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checking the turbidity using a spectrophotometer (Spectronic 20D, Spectronic 
Instruments, Rochester, NY) at 650 nm using Oxoid Broth No. 2 as a blank. 
Absorbance readings ca. 0.8 indicated an optimal cell density of 1-2 * 109  cells/ml. 
The tester strains were tested to confirm the presence of the genetic markers using the 
following assays:
Histidine requirement: A positive result of this test (growth in 
histidine/biotin plates; no growth in non-histidine/biotin plates) showed that 
bacteria had not been altered as a result of handling or storage conditions and that 
the mutant form was present.
Crystal violet: The results of this test showed a zone of inhibition around a 
disk impregnated with crystal violet. The positive test results indicated that the 
permeability of the membrane was present.
Ampicillin resistance (R-factor): Tester strains that grew on ampicillin 
plates indicating that the genetic markers were intact.
After the bacteria tested positive for all the genetic markers, the assay was 
performed. Two ml top agar were placed in sterile culture tubes and kept at 
approximately 40° C in a water bath. One hundred pi of sample were placed in 
each tube, 100 pi of bacteria (tester strain TA-100 or TA-98) and 500 pi S-9 mix 
were added. The tubes were mixed and poured into minimal glucose agar plates. 
All samples were tested in triplicate. DMSO was used as a negative solvent control 
and pure AFBi (1, 10, 100 and 1000 ng/plate) was used as a positive control. The 
plates were left at room temperature until the top agar solidified; then were inverted
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and incubated at 37° C for 48 hours. After incubation, revertant colonies were 
counted. Samples that presented over double the number of natural revertant 
colonies were considered mutagenic.
11. Toxicity to Salmonella typhimurium
The most concentrated samples (10°) described in the previous section 
were also tested to determine if the extracts were toxic to the S. typhimurium tester 
strains. The assay was performed following a modified mutagenicity assay 
protocol. After the 10-14 h incubation, the 109 cells/ml bacterial suspension was 
serially diluted with sterile nutrient broth to obtain a 1 0 2  cells/ml suspension.. 
Samples were tested using nutrient agar plates instead of minimal glucose agar 
plates.
12. Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988). 
One-way analysis of variance (ANOVA) was used to determine differences in toxin 
production and toxicity to S. typhimurium. Scheffe’s test with an alpha value of
0.05 was used to compare differences among the different treatments.
C. Results and discussion
1. Aflatoxin production
Within the first days abundant mold growth was evident in all flasks except 
for the control. A. flavus produced a very high amount of aflatoxin Bi in the first 
15 days (Table 3.2). When A. flavus and F. moniliforme were together, the amount 
of AFBj produced during the first days was significantly (p<0.05) lower than when
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A. flavus grew by itself. It is interesting to observe that the naturally contaminated 
sample had an apparently higher toxin production than the combined A. flavus!F. 
moniliforme sample. However, these values were not significantly different 
(p>0.05). There are several explanations why there was higher toxin production in 
naturally contaminated com. One explanation could be that the naturally 
contaminated com may have contained a higher initial amount of toxigenic A. 
flavus and/or A. parasiticus spores than the inoculated sample. On the other hand, 
the presence o f other mold species may have had an influence on the production of 
aflatoxin in the naturally contaminated com. However, since the difference was not 
significant, it could be assumed that AFBi production was independent of the mode 
of infection {i.e., naturally occurring or inoculated).
It is interesting to observe that the concentration of AFBi decreased over 
time. When the results were analyzed, a pattern was observed. Every 15 days, the 
toxin concentrations were reduced by approximately 90-95% in all samples. This 
was more evident in the A. flavus samples were AFBi was detected in all three time 
periods.
The constant decrease in AFBi concentration over time suggests that the A. 
flavus by itself degraded AFBi. The same pattern was observed in the 
production/degradation o f AFB2 (Table 3.3). The significant difference (p<0.05) 
between the initial aflatoxin production by A. flavus and the other samples excludes 
the possibility that the aflatoxins (Bi and B2 ) reached a toxic level beyond which, 
they were degraded. Therefore, the degradation pattern may be attributed to the
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mold metabolizing the toxin when it reached a certain growth stage or to the 
presence of another metabolite interfering with AFBi and promoting its 
degradation.
Table 3.2 Aflatoxin B| (ng/g) production during storage
Sample 15 days 30 days 45 days
A. flavus 10.5xl04 ±0.6xl04 4.8x1 03±0.4x103 2 .2 x 1 0 2
a b b
F. moniliforme ND ND 1.9±1.9
b b b
A. flavus+F. 5.2xl0'±0.4xl0‘ ND ND
moniliforme b b b
Naturally 5.6xl0z±0.6xl02 3.8x10^1.4x10' ND
contaminated b b b
Control ND ND ND
b b b
Values are mean±standard error of three replications 
ND: Non-detectable (Detection limit=lng/g)
Values with the same letter are not significantly different (p<0.05)
These results are consistent with earlier observations reported by Doyle and 
Marth (1978a; 1978b; 1978c; 1978d). The reports by these authors showed that the 
ability of Aspergilli to degrade aflatoxin depended on several factors. They reported 
that 8 -10  day old mycelia were the most effective in degrading aflatoxin. This is 
consistent with the fact that the aflatoxin concentration decreased after 15 days 
incubation. Huyn and Lloyd (1984) also reported that Aspergillus parasiticus 
synthesized large amounts of aflatoxin when young mycelia (4 days old) were 
present. This synthesis peaked and then started to decline when mycelia aged (14
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days old). It would be interesting to quantify aflatoxin production during the first 
15 days under the same conditions, using the same A. flavus strain.
Table 3.3 Aflatoxin B2 (ng/g) production during storage
Sample 15 days 30 days 45 days
A. flavus l . lx l 0 4±0 .6 x l 0 J 4.4x10"±2xl0z 4.1xl0'±3.8xl0‘
a a,b b
F. moniliforme l.SxlO'iO.OxlO1 2.2xl0'±0.5xl0‘ 0 .2 x l 0 '± 0 .2 x l0 *
b b b
A. flavus+F. 5.8xl0 '± lx l0‘ ND ND
moniliforme a,b B b
Naturally 1.3xl0z±0.14xl02 0.5xl0'±0.3xl0' ND
contaminated a,b b b
Control ND ND ND
b B b
Values are mean±standard error of three replications.
ND: Non-detectable (Detection limit=lng/g)
Values with the same letter are not significantly different (p<0.05)
Doyle and Marth (1978) and Hyun and Lloyd (1984) also reported that 
disrupting the fungi, blending or fragmenting the mycelia, actively increased the 
degradation of aflatoxin, while leaving the mycelia intact did not. In the current 
study, the samples were mixed thoroughly with a metallic spatula every other day, 
this might have damaged the mycelia. Therefore, aflatoxin degradation could have 
been promoted in this experiment.
It has also been reported that substrates that support substantial mold 
growth yield mycelia with the greatest ability to degrade aflatoxin. The current 
study used com as the substrate. Since com is frequently colonized by A. flavus, it 
would be considered ideal to promote copious mold growth. In this study,
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substantial mold growth was evident within the first 48 hours of incubation; 
especially in the A. flavus samples.
From a metabolic point of view, there are literature reports that state that 
fungi have developed survival mechanisms that allow them to rapidly adapt their 
metabolism to varying environmental conditions. This metabolic flexibility is 
achieved through the synthesis of a large set of intra-and extracellular enzymes that 
are able to degrade complex biopolymers. Filamentous fungi are also capable of 
secreting a diverse range of primary and secondary metabolites and performing 
several complex transformations. There is biochemical evidence that some of these 
transformations are performed by fungal cytochrome P450 enzymes (Van der Brink 
et al., 1998). There is limited information on the specific activities o f fungal P450s 
because purification of these enzymes is hampered by protein instability and low 
expression levels (Van der Brink et al., 1998). However, it has been determined 
that some A. flavus and A. parasiticus cytochromes (cyp64 and cyp60Al, 
respectively) are actively involved in aflatoxin biosynthesis and degradation 
pathways. Hamid and Smith (1987) reported that an increase in aflatoxin 
production was paralleled by an increase in NADPH-cytochrome P450 reductase 
and cytochrome P450 levels in fungal microsomes. The use of cytochrome P450 
inhibitors, such as, SKF 525-A, metyrapone and cyanide inhibited aflatoxin 
biosynthesis. These results suggested that aflatoxin biosynthesis by A. flavus is 
mediated by cytochrome P450 monooxygenase enzymes. These authors also 
studied the ability of mycelial homogenates to degrade aflatoxin. In this case the
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addition of P450 inhibitors, cycloheximide, SKF 525-A and metyrapone to 6 - and 
8 -day old cultures inhibited aflatoxin degradation. Thus, it was suggested that the 
enzymes involved in the degradation of aflatoxin belong to the cytochrome P450 
enzymes.
The significant difference (p<0.05) between aflatoxin production by A. 
flavus as compared to the combined samples and the naturally contaminated 
samples, suggested that the presence of F. moniliforme or other fungal species 
affected the aflatoxin synthesis or its degradation. In this study, a significant lower 
amount of AFBi and AFBi was noted in the combined samples in the first 15 days. 
However, there is not enough information to determine what happened between 
days 1 and 15. Therefore, the lower amount could be due to decreased aflatoxin 
biosynthesis or enhanced degradation. It is important to mention that in a 
mammalian system (male Wistar rats), intraperitoneal exposure to fumonisin B| 
induced cytochromes P4501 A, P4503A and P4504A subfamilies with 1 Al and 4A1 
predominating (Martinez-Larranaga et al. , 1996). Although fungal and mammalian 
metabolism differ considerably, this evidence suggests that it would be interesting 
to investigate the role of fumonisin in the ability of Aspergillus to synthesize and 
degrade aflatoxins. This information brings out the importance o f understanding the 
role of mycotoxins in fungal physiology and plant pathogenesis.
Furthermore, Doyle and Marth (1978d) reported that (a) steaming A. 
parasiticus mycelium for 6  minutes resulted in loss of ability to degrade aflatoxin 
(b) broth mold cultures were not able to degrade aflatoxin; and (c) the supernatant
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fluid from mycelial homogenates degraded aflatoxin. These results suggested that a 
heat-labile, intracellular factor was responsible for toxin degradation. Doyle and 
Marth (1978d) reported that although conditions affecting degradation of aflatoxins 
by mold mycelia implied that an enzyme might be involved. However, the rates at 
which aflatoxins were degraded did not support the idea that the toxin was being 
degraded directly by enzymatic activity. Therefore, it was hypothesized that one or 
more enzymes produced by-products that would react with aflatoxin. Doyle (1979) 
speculated that peroxidase may be such an enzyme since it catalyzes decomposition 
of hydroperoxides resulting in the generation of free radicals. Hence, Doyle and 
Marth (1982) designed a study to determine peroxidase activity in mycelia of A. 
parasiticus that degraded aflatoxin. Results from this study showed that substantial 
amounts of fungal peroxidase were present in cultures where aflatoxin was 
degraded. These results were supported by Applebaum et al. (1980) and Doyle and 
Marth (1978) who showed that lactoperoxidase is involved in aflatoxin 
degradation. Doyle and Marth (1978h) observed that at a given concentration of 
this enzyme, aflatoxin degradation was independent of initial aflatoxin 
concentration. The authors reported the formation of aflatoxin derivatives that co­
chromatographed with aflatoxin B2a, and other water soluble by-products.
This information also relates to the findings of fumonisin Bi toxicity in 
vivo. Martinez-Larraiiaga (1996) reported that 0.25 and 2.5 mg/kg body weight FBi 
administered intraperitoneally to male Wistar rats, produced an increase in the 
peroxisomal P-oxidation of fatty acids and induction of the cytochrome P4504A
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subfamily. Although, these studies show metabolic alteration in a mammalian 
system, the involvement of peroxidase in aflatoxin degradation by Aspergillus 
suggests the possibility of similar effects in a fungal system.
Tables 3.4 and 3.5 show the production of aflatoxins Gi and G2 , 
respectively. In this case, no significant toxin production was observed. This 
indicates that the A. flavus strain used in this study does not produce G aflatoxins. 
This is consistent with the fact that only A. parasiticus produces G aflatoxins. The 
low levels of G aflatoxins detected in several of the samples, including the F. 
moniliforme samples, could be due to original com contamination. This emphasizes 
the fact that aflatoxin contamination is heterogenous and that “hot spots” may be 
present. Even when the cracked com was thoroughly homogenized before 
sampling, some contaminated kernels could have gone to different flasks. This 
could explain why the Fusarium samples had low levels of aflatoxins Bi and G2 .
Table 3.4 Aflatoxin Gi (ng/g) production during storage
Sample 15 days 30 days 45 days
A. flavus ND ND 6 ± 6
F. moniliforme ND ND ND
A. flavus+F. moniliforme ND ND ND
Naturally contaminated 28±14 ND 2 ± 2
Control ND ND ND
Values are mean±standard error of three replications 
ND: Non-detectable (Detection limit=lng/g)
Non of the samples are significantly different (p<0.05)
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Table 3.5 Aflatoxin G2 (ng/g) production during storage
Sample 15 days 30 days 45 days
A. flavus ND ND ND
F. moniliforme 4±1 2 ± 1 ND
A. Jlavus+F. moniliforme 12±5 ND ND
Naturally contaminated 1 0 + 1 ND ND
Control ND ND ND
Values are mean±standard error of three replications. 
ND: Non-detectable (Detection limit=lng/g)
Non of the samples are significantly different (p<0.05)
It is also important to consider the com substrate. It is possible that there is 
more than a bilateral interaction between molds. Com is a complex chemical 
matrix, therefore, multilateral chemical interactions might have occurred during 
this storage period. It could be possible that fungal metabolites interacted with com 
compounds and that the new by-product(s) inhibited or degraded the aflatoxin. 
Also, there could have been bacterial activity that affected toxin production or 
degradation, or bacterial metabolism could have also influenced the toxin 
degradation patterns.
It was also observed that the 30 and 45 days samples had copious mold 
growth that in some cases interfered with the aflatoxin extraction and purification 
procedures. This led to the use of a different purification method (described in the 
materials and methods section). This may have contributed to incomplete toxin 
extraction, and may also be a reason for the lower quantities detected in these 
samples. The difficulty in extraction resided in the fact that there was some
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interference from compound(s) that acted as surfactants; therefore, when organic 
extraction (CHCI3) was attempted, a very stable emulsion was formed. It would be 
interesting to characterize these compounds and determine if they play a role in 
aflatoxin degradation.
It is important to point out that even if the combined and the naturally 
contaminated samples had much lower toxin production, they still had high levels 
of aflatoxins within the first 15 days. This shows that under favorable conditions, 
aflatoxins can be produced regardless of the presence of other molds, i.e., F. 
moniliforme. This emphasizes the fact that co-contamination can occur and that 
simultaneous exposure to several toxins is possible.
2. Fumonisin production
FBi production followed a different pattern than aflatoxin. Fumonisins are 
produced in higher quantities usually 1 0 3 times more than aflatoxins, so they are 
usually quantified in pg/g instead of ng/g. Table 3.6 shows FBi production over 
time. Unlike aflatoxin, these samples do not show a defined pattern. In the F. 
moniliforme sample, a significant increase (p<0.05) of FB[ was observed over time.
The combined samples and the naturally contaminated com did not produce 
significantly different amounts (P<0.05) of FB| during the first 15 days. These 
results contrast with those obtained from aflatoxin. FBj production was not initially 
affected by the presence of Aspergillus or other mold species.
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Table 3.6 Fumonisin Bi (jj.g/g) production during storage
Sample 15 days 30 days 45 days
A. flavus 15±12 8±4 ND
b b B
F. moniliforme 17±3 254±90 361±131
b a a
A. flavus+F. moniliforme 8±3 8 ± 2 7±1
b b b
Naturally contaminated 18±6 38±4 6±3
b b b
Control ND 1 ± 1 ND
b b b
Values are meantstandard error of three replications 
ND: Non-detectable (Detection limit=Tpg/g)
Values with the same letter are not significantly different (p<0.05)
It was also interesting to observe that there were different toxin production 
patterns. In the F. moniliforme samples, a constant increase of FB i was observed. 
However, in the combined samples (A. flavus+F. moniliforme) FBi concentration 
was not significantly (p<0.05) altered. In the naturally contaminated com, an 
apparent increase followed by a decrease were observed; however this was not 
significant (p>0.05).
The FBi concentrations detected in the Aspergillus samples and in the 
control, may have been from original contamination. This emphasizes again the 
heterogeneity of mycotoxin contamination, and the need to find control 
mechanisms that will prevent exposure to these toxins. The consumption of one 
contaminated portion ( > 8  pg/g) is sufficient to elicit ELEM in a horse. The fact that 
these samples originated from a commercial source stresses the need of a better 
understanding of factors that affect toxin production and degradation. This
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knowledge would help in designing better control programs that would minimize 
animal and human exposure.
Table 3.7 Fumonisin B2 (pg/g) production during storage
Sample 15 days 30 days 45 days
A. flavus 1 ± 1 14±6 4±2
F. moniliforme 10±7 109±37 104±41
A. flavus+F. moniliforme 8 ± 1 8 ± 6 4±1
Naturally contaminated 9±3 13±3 3±1
Control 1 ± 1 9±9 ND
Values are mean±standard error of three replications 
ND: Non-detectable (Detection limit=lpg/g)
Non of the samples are significantly different (p<0.05)
3. Mutagenic potential
Figures 3.1 and 3.2 show the mutagenic potential of the raw com extracts 
from the A. flavus inoculated com. A dose-response relationship was observed. As 
the samples were diluted, the mutagenicity decreased. Hence, it can be considered 
that the compound(s) responsible for the mutagenic response are either not present 
in large quantities or their mutagenic potential is relatively low. Also, it can be 
observed that mutagenicity decreased over time. This observation is consistent with 
the fact that AFBi decreased over time. So, the decline in mutagenicity could be 
due to the decline in aflatoxin concentration. However, the 30 and 45 day samples 
(initial AFBi=484 and 218 ng/plate) showed much higher mutagenicity than the 
positive control, pure AFBi. It was observed that 100 ng/plate AFBi resulted in
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Figure 3.1 Mutagenic potential of Aspergillus flavus inoculated corn during storage. Salmonella tester strain 
TA-100 with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFB|=10.5xl04 ,4.8xl0 3 and 
218 ng/plate for 15, 30 and 45 days, respectively. Approximate undiluted (1.00E+00) amounts of FBi=l500, 
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Figure 3.2 Mutagenic potential of Aspergillus flavus inoculated corn during storage. Salmonella tester strain 
TA-98 with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFBi=10.5xl04, 4.8xt03 and 
218 ng/plate for 15, 30 and 45 days, respectively. Approximate FB|=1500, 766 and 0 ng/plate for 15, 30 and 45 
days, respectively. Natural revertants=29±2. Values are mean±SEM of thre replicates.
173±2 revertants per plate; therefore, the results shown in Figure 3.1 could be the 
result of AFBi mutagenic potential combined with the response elicited by other 
compound(s). This effect was not as evident in TA-98 (Figure 3.2) where 100 
ng/plate pure AFBi produced 532±91 revertants/plate. These differences could be 
explained by the different sensitivities of each organism.
In the case of the F. moniliforme com extracts (Figures 3.3 and 3.4), an 
interesting fact was observed. These samples did not contain any detectable AFBi; 
however, a mutagenic response was observed for all three time periods. Even if 
there were high concentrations of FBi in the extracts, this toxin is not considered to 
be mutagenic in this assay (Gelderblom et al„ 1991, 1992; Park et al., 1992). 
Furthermore, a FBi control was used in this experiment. No mutagenic response 
was observed in a concentration ranging from 1 to 100,000 ng FB i/plate.
The mutagenic response of F. moniliforme raw com extract was more 
evident on the 15 day samples indicating that the unknown factors that elicited this 
response were degraded over time. A dose response was also observed. Dilution of 
the samples decreased their mutagenic potential. These results show that a diverse 
variety of chemically active compounds can be produced at the same time. F. 
moniliforme is known to produce mutagenic toxins such as fiisarin C and 
moniliformin (Bacon and Nelson, 1994). These toxins may have been responsible 
for this response. However, it is possible that other unidentified mutagenic 
compounds may have been produced. This emphasizes the fact that when a raw 
extract is studied, multiple interactions may take place. The ultimate response may
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Figure 3.3 Mutagenic potential of Fusarium moniliforme inoculated corn during storage. Salmonella tester 
strain TA-100 with metabolic activation. No AFBi was detected on any of the samples. Approximate FB|=17, 
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Figure 3.4 Mutagenic potential of Fusarium moniliforme inoculated corn during storage. Salmonella tester 
strain TA-98 with metabolic activation. No AFBi was detected on any of the samples. Approximate FBi=17, 
254 and 361 ng/plate for 15, 30 and 45 days, respectively. Natural revertants=29±2. Values are mean±SEM of 
three replicates.
depend on an equilibrium of the effect of all compounds present in the system. 
Some of these compounds may have a direct effect while others may interact and 
either inhibit each other or have a synergistic response.
Figures 3.5 and 3.6 show the mutagenic response to raw A. flavus/F. 
moniliforme com extracts. These samples also showed a mutagenic response to 
both, TA-100 and TA-98. A dose-response type of relationship was also observed, 
and the mutagenic potential tended to decrease over time.
These results also show several interesting facts. AFBi concentrations were 
relatively low at 15 days, and there was no detectable aflatoxin in the 30 and 45 
days samples. So, these mutagenic responses bring out the same issues as the F. 
moniliforme samples. Are other mutagens being produced, or is fumonisin 
interacting with other compound(s) to produce a mutagenic by-product? Another 
important factor to point out is that all of these assays were carried out with 
metabolic activation (S9). Therefore, these responses reflect the effect of 
compound(s) that may have been metabolized. Some of these activated compounds 
may have caused this response, or they may have reacted with other compounds 
present in the system to render a mutagenic by-product.
The raw com extract is considered a complex mixture, so a multitude of 
reactions may have taken place during this assay. These results indicate that 
Aspergillus and Fusarium may produce more than one toxic compound when they 
grow together. Understanding the relationship of these molds in the com plant and
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Figure 3.5 Mutagenic potential of Aspergillus jlavus/Fusarium moniliforme inoculated corn during storage. 
Salmonella tester strain TA-100 with metabolic activation. Approximate undiluted (1.00E+00) amounts of 
AFBj=5.2, 0 and 0 ng/plate for 15, 30 and 45 days respectively. Approximate undiluted amounts of FB|=8 , 8  
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Figure 3.6 Mutagenic potential of Aspergillus flavus/Fusarium moniliforme inoculated corn during storage. 
Salmonella tester strain TA-98 with metabolic activation. Approximate undiluted (1.00E+00) amounts of 
AFB|= 5.2, 0 and 0 ng/plate for 15, 30 and 45 days respectively. Approximate undiluted amounts of FB| = 8 , 8  
and 7 jig/plate for 15, 30 and 45 days, respectively. Natural revertants = 29±2. Values are mean±SEM of three 
replicates.
during storage, may help in elucidating some of the potential toxic responses that 
would result from dietary exposure to com contaminated with these fungi.
Figures 3.7 and 3.8 show the mutagenic potential of naturally contaminated 
com extracts. These results are similar to those discussed for Figures 3.5 and 3.6. In 
this case, there is a higher initial AFBi concentration that could be responsible for 
the mutagenicity. However, the AFBi content decreased over time. Another 
possible explanation for this mutagenic response may be that some of the AFBi 
fungal degradation by-products retain some mutagenic potential. It would be 
interesting to follow AFBi degradation over shorter periods of time (<15 days) and 
isolate and identify some of the by-products, subsequently testing their mutagenic 
potential.
These results show the need for more research in this area. The possible 
effect o f FBi on AFBi degradation was discussed earlier. If fumonisin is 
responsible for enhancing aflatoxin degradation, does it affect the amount and type 
of residual by-products? Is it possible that the presence of fiimonisins shift 
aflatoxin degradation pathways to yield different by-product(s) than those produced 
by Aspergillus itself? Is Fusarium metabolizing some of the aflatoxins? The answer 
to some of these questions may help shape our understanding of the relationship 
and interactive potential between these com contaminants, and perhaps help define 
better mechanisms of biological control to prevent toxin formation.
Since com is a complex matrix and is considered a living system, 
incubating it in the presence of moisture may have also contributed to the responses
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Figure 3.7 Mutagenic potential of naturally-contaminated corn during storage. Salmonella tester strain TA-100 
with metabolic activation. Approximate undiluted (1.00E+00) amounts of AFBi = 563, 38 and 0 ng/plate for 
15, 30 and 45 days respectively. Approximate undiluted (1.00E+00) amounts of FB| = 18, 38 and 6  pg/plate 
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Figure 3.8 Mutagenic potential of naturally-contaminated corn during storage. Salmonella tester strain TA-98 
with metabolic activation. Approximate undiluted (1.00E+00) AFBi = 563, 38 and 0 ng/plate for 15, 30 and 45 
days respectively. Approximate undiluted amounts of FBi = 18, 38 and 6  pg/plate for 15, 30 and 45 days, 
respectively. Natural revertants = 30±2. Values are mean±SEM of three replicates.
shown previously. Therefore, it was important to determine if the control com 
extracts elicited a response on this assay.
Figures 3.9 and 3.10 show that the control com extracts did not present 
mutagenic potential. This suggests that the responses observed in the other samples 
were due to fungal activity in the com. It is important to note that some 
compound(s) in the com may have been altered by the mold growth. Therefore, 
consideration of factors present in the com is also important when considering the 
risk associated with fungal growth in com even if the com by itself did not show a 
response.
4. Toxic potential
The raw com extracts were complex mixtures. Therefore, the evaluation of 
their mutagenic potential may have been hampered by other responses. If the 
samples were toxic to the bacteria, then some of the results could have been false 
negatives. A reduction in response could have been due to a toxic response rather 
than to a lack of mutagenicity. Furthermore, toxic responses could give false 
evidence of interaction between compounds in the extract. Thus, it was important 
to determine if these samples exerted toxic effects on either of the Salmonella tester 
strains. Since most of the mutagenic differences were observed in the most 
concentrated samples (10°), only this dilution was tested for toxic potential. Instead 
o f challenging the bacteria to mutate by using minimal glucose agar plates, the 
assay was carried out using nutrient broth.
120
































1.00E-03 1.00E-02 1.00E-01 1.00E+00
— *— 15 days 
-  «  _  30 days 
. .  a- • • 45 days
Dilution
Figure 3.9 Mutagenic potential of control corn during storage. Salmonella tester strain TA-100 with metabolic 
activation. No AFBi was detected in the samples. Approximate undiluted amounts of FB| = 0, 73 and 0 
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Figure 3.10 Mutagenic potential of control corn during storage. Salmonella tester strain TA-98 with metabolic 
activation. No AFBi was detected in the samples. Approximate undiluted (1.00E+00) amounts of FB| = 0, 73 
and 0 ng/plate for 15, 30 and 45 days, respectively. Natural revertants = 30+2. Values are mean±SEM of three 
replicates.
Figure 3.11 shows Salmonella TA-100 toxic response to the different com 
extracts. In the Fusarium and the combined samples {Aspergillus+Fusarium), the 
toxic potential seemed to increase with storage time. These results could explain 
part of the reduction in mutagenicity observed previously. However, none of these 
samples were significantly different (p<0.05) form the control. Conversely, the 
toxicity of the Aspergillus samples seemed to decrease over time. In this case, the 
15 day storage extract was significantly different from the control. This implies that 
under these experimental conditions, this sample was toxic to Salmonella TA-100. 
Although the toxicity seemed to decrease in the 30 and 45 day samples, these 
results were not significantly (p<0.05) different from the 15 day extract. It can be 
noted that these same samples had an apparent reduction in mutagenicity over 
storage time (Figure 3.1). Even if the decrease in toxicity is not significant, the 
results suggest that detoxifying reactions may have taken place as the Aspergillus 
culture grew older. The decrease in AFBi content discussed earlier, coupled with 
the decline in mutagenic potential and the apparent decline in toxic potential 
suggest that A. flavus shifted to detoxifying pathways that may have included toxic 
compounds other than aflatoxin.
An interesting fact is that the control com extracts (15 and 30 days) 
exhibited significant toxicity when compared to the control (p<0.05). These 
samples did not have any fungal activity. These results imply that com by itself is a 
dynamic system and that different reactions may have taken place in the com. 
Some of the by-products may have been toxic to the Salmonella TA-100. This
123
































Negative Positive A+F NC
|  Control 
H i 5 days 







Figure 3.11 Toxic potential of corn samples during storage. Salmonella tester strain TA-100 with metabolic 
activation. Negative control=DMSO, Positive control= 10,000 ng AFB,, A=Aspergillus, F=Fusarium, 
A+F=/lspergillus+Fusarium, NC=Naturally contaminated. Values are mean±SEM of three replicates.
toxicity decreased significantly (p<0.05) over time. The toxic potential shown by 
the control com extracts brings attention to the fact that reactions not related to 
fungal growth, i.e. lipid oxidation, could have also occurred in the com. These 
reactions could have generated by-products that were toxic, but not mutagenic. The 
involvement o f other microorganisms such as bacteria is also possible. Bacteria 
could have produced bacteriocins that inhibited Salmonella growth.
Salmonella TA-98 was less sensitive to the com extracts. Thus, it showed 
higher colony counts than TA-100 (Figure 3.12). In this case, the 15 day Fusarium 
extract was significantly toxic. This sample had a high FBi concentration (ca. 
1.7xl03 pg/plate). However, even if the FBi concentration increased over storage 
time (ca. 2.5x104 and 3.x 104 pg/plate for 30 and 45 days, respectively), these 
samples were not significantly different from the control. Therefore, the toxicity 
cannot be attributed to FBi but to other compounds present in the extract. Another 
hypothesis is that maybe the higher concentrations of fumonisin trigger 
detoxification reactions in older cultures. More research is needed to understand the 
role of fumonisin from a fungal physiology and plant point of view.
Another significantly toxic sample was the naturally contaminated extract 
(45 days). In this case, aflatoxin and fumonisin concentrations decreased over 
time. So, this extract had the least amount of AFBi and FBi when compared to the 
15 and 30 days samples. Again, other compounds may be responsible for the 
toxicity. Moreover, aflatoxin and fumonisin may have an interactive relationship
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Figure 3.12 Toxic potential of corn samples during storage. Salmonella tester strain TA-98 with metabolic 
activation. Negative control=DMSO, Positive control= 10,000 ng AFBi, A=Aspergillus, F=Fusarium, 
A+F =Aspergillus+Fusarium, NC=Naturally contaminated. Values are mean±SEM of three replicates.
that changes depending on the concentration ratio or at different concentration 
levels.
No definite pattern to relate toxin production, mutagenic potential and toxic 
potential could be established. However, there is some evidence that indicates that 
many factors can be simultaneously involved in these processes. This experiment 
did show that A. flavus and F. moniliforme can co-exist in the same environment 
and produce aflatoxins and fumonisins, respectively. Thus, they present a risk to 
consumers and new research concerns. If these toxins co-contaminate com and 
there is evidence of fungal interaction that shifts toxin concentrations over storage 
time, what are the potential toxic effects of simultaneous exposure at different 
concentration levels. Do they interact; if so, what relationship do they have? Is 
there potential for inhibitory or synergistic reactions? These questions prompted 
further research in this area. Therefore, the next sections will explore some of these 
possible interactions.
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IV. Interactive effects between aflatoxin Bi and fumonisin Bi
A. Introduction
Results from the previous section suggested that AFBi and FBi can be 
produced simultaneously by A. flavus and F. moniliforme. Furthermore, the data 
obtained suggested that mold growth and toxin production are dynamic processes 
where multiple interactions are possible. These interactions yielded different levels 
of toxins at different storage times. This implies that when com is consumed, 
humans and animals could be exposed to a wide range of toxic compounds that 
could be present in different combinations or ratios.
The previous experiment concentrated on studying toxin production under 
optimal mold growth conditions. The high moisture levels yielded copious mold 
growth, and may have promoted some of the interactive reactions. However, these 
reactions could take place over longer periods of time with com held at storage 
moisture and temperature conditions. This is evidenced by several reports of 
AFB1/FB 1 co-contamination of commercial com that did not have apparent mold 
growth (Park et al., 1996; Chamberlain et al., 1993; Zummo and Scott, 1992).
Aflatoxins and fumonisins are produced in nature in a different range of 
concentrations. Aflatoxins usually occur in the ng/g range (Schroeder and Botler, 
1973) while fumonisins generally occur at higher levels, in the |ig/g range. Thus, 
simultaneous exposure to a combination of these toxins at these levels should be 
explored. The assessment o f the potential effects of complex mixtures is a difficult 
task. However, the potential of joint action of chemicals has long been recognized
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by physicians, public health specialists, toxicologists, health risk assessors and 
statisticians (Mumtaz, 1995). There are several methods to assess the effects of 
diverse mixtures encountered in the environment. One approach often used to 
evaluate chemical mixtures is to consider the effect of known xenobiotics present 
in the mixture. In this case, although all the information may not be available for 
the mixture (i.e.. raw com extract) toxicological properties of some of the 
compounds (i.e.. aflatoxins) have been investigated. In the current study, both, 
aflatoxins and fumonisins are known to be present in the com. and the relative 
concentrations in which they occur has also been reported. Therefore, the use of a 
combination of these two compounds may yield more useful information on the 
toxic potential of the mixture.
The objective of this phase of the study was to determine if different levels 
of pure AFBi (0-1000 ng/plate) combined with varied levels of FBi (0-100,000 
ng/plate) show different effects in the Salmonella/microsomal mutagenicity assay 
using tester strains TA-98 and TA-100. Since fumonisin does not yield positive 
results in this assay, this study mainly evaluated the effect of fumonisin on 
mutagenic potential of aflatoxin.
B. Materials and methods
1. Bacterial cultures
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly 
provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, CA).
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2. Chemicals
Ampicillin, D-biotin, disodium hydrogen phosphate, glucose-6-phosphate, 
L-histidine, magnesium sulfate, sodium ammonium sulfate, sodium chloride, 
sodium dihydrogen phosphate, and B-nicotinamide adenine-dinucleotide phosphate 
(NADP) were purchased from Sigma Chemical Co. (St. Louis, MO). Citric acid 
monohydrate, dimethyl sulfoxide, potassium chloride, potassium phosphate dibasic 
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc. 
(Paris, KT). Bacto agar and crystal violet were ordered from Difco Laboratories 
(Detroit, MI); glucose from Fisher Scientific (Fair Lawn, NJ). Ethanol was 
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient 
broth No. 2 was from Unipath LTD (Basingstoke, Hampshire, England). Post- 
mitochondrial supernatant (S9 mix) was purchased from Molecular Toxicology, 
Inc. (Boone, NC).
Pure fumonisins Bi and B2 were kindly provided by Dr. Robert M. Eppley 
(Center for Food Safety and Applied Nutrition -  CFSAN, U. S. Food and Drug 
Administration-FDA, Washington, D.C.). Pure aflatoxin Bj was generously 
provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.).
3. Sample preparation
Toxin dilutions were always prepared fresh immediately before running an 
assay. Stock solutions of AFBi (lpg/pl) and FBi (10(ig/pl) were prepared by 
diluting dry pure toxins in DMSO. These solutions were then combined and diluted
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to obtain solutions that would follow the experimental design presented in Table 
4.1.
Table 4.1 Combinations of AFBi and FB| tested for toxic/mutagenic potential
Aflatoxin Eti (ng/plate)
Fumonisin B| (1) (2) (3) (4)
(ng/plate) 10° 101 102 103
(A)
10°
(1A) (2A) (3A) (4A)
(B)
10‘
(IB) (2B) (3B) (4B)
(C)
102
(1C) (2C) (3C) (4C)
(D)
103
(ID) (2D) (3D) (4D)
(E)
104
(IE) (2E) (3E) (4E)
(F)
105
(IF) (2F) (3F) (4F)
Values in parenthesis indicate the labels used to identify each sample. 
Combinations are expressed as ng AFBj/plate / ng FBj/plate. Samples were 
prepared and analyzed in triplicate
When FB2 was also evaluated and the concentration of AFBi was fixed at 
1000 ng/plate and FB2 was varied from 0 to 100, 000 ng/plate. Samples were also 
prepared fresh immediately before the assay. AFB 1/FB2 combinations were 
evaluated using the experimental design presented in Table 4.2.
4. Mutagenic potential of aflatoxin/fumonisin combinations
The samples were tested using Salmonella typhimurium tester strains TA- 
100 and TA-98 according to the standard plate incorporation method described by
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Maron and Ames (1983). A detailed description of this method was presented in 
Chapter III. An S9 cocktail without the postmitochondrial supernatant was used for 
the samples without metabolic activation. Although the S-9 cocktail did not contain 
the rat liver metabolizing enzymes, it included all the other co-factors including 
NADP and glucose-6-P. These compounds could have been incorporated to 
bacterial metabolism and affected the response. This control only tests whether the 
metabolic activation by mammalian liver enzymes is required to generate a 
mutagenic metabolite. For the purpose of this experiment, all other potential 
interactions with the components of the S-9 cocktail were disregarded.

















Values in parenthesis indicate the labels used to identify each sample. 
Combinations are expressed as ng AFBi/plate / ng FB2/plate.
All samples were prepared and anlalyzed in triplicate.
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5. Toxic potential of the aflatoxin/fumonisin combinations
Salmonella TA-98 and TA-lOO’s toxic response to the aflatoxin/fumonisin 
combinations was evaluated using the same modified procedure described in 
Chapter III. Statistical analysis of toxicity results was carried out using SAS 
software (SAS, 1988). Scheffe’s test was used to determine differences between 
controls and samples.
C. Results and Discussion
1. Aflatoxin Bt/fumonisin B( mutagenicity
The representative results of a series of experiments are presented in this 
section. Raw data and results from repetitions of this experiment are presented in 
Appendix A. Figure 4.1 shows the mutagenic potential o f AFBi/FBi combinations 
using Salmonella tester strain TA-100 without metabolic activation. These samples 
were not tested with Salmonella tester strain TA-98. The results indicated that none 
of the samples were mutagenic. This was expected since AFBi needs metabolic 
activation to become a mutagen, and FBt is not considered a mutagen in this assay 
with or without metabolic activation. However, this results show that when both 
toxins are in the same system without metabolic activation, they do not interact to 
produce mutagenic by-products at any of the combinations tested. This indicates 
that metabolic activation is essential for the potential of aflatoxin to react with other 
biological molecules. Therefore, the potential to interact with fumonisin will 
depend on activation of AFBi to more reactive compounds. Since these results 
were negative, all further testing was performed with metabolic activation.
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Figure 4.1 Mutagenic potential of AFBi/FBj combinations. Salmonella tester strain TA-100 without metabolic
activation. Natural revertants=154±5. Values are mean±SEM of three replicates.
When the samples were tested with metabolic activation, a pattern emerged 
(Figures 4.2 and 4.3). No mutagenic response was observed at AFBi levels (10° to 
101 ng/plate) alone or in combination with the whole range of FBi concentrations. 
In general such low amounts of AFBi do not show a response in this assay. 
Therefore, FBi did not show potential for increasing the mutagenicity of low levels 
of AFBi. However, at doses where mutagenicity is usually observed (102 and 103 
ng/plate), an interesting pattern was noted. In both tester strains, it was observed 
that the mutagenic potential varied as fumonisin concentrations increased. These 
results suggested the possibility of an interaction between both toxins. However, 
the pattern implied that the potential interaction is complex in nature. It was 
observed that the mutagenic potential decreased in a dose-dependent fashion when 
10°-102 ng FBi were present. However in the 102-105 ng FBj/plate range, the 
mutagenicity increased back to its original level; and sometimes the increase 
surpassed the original level (data not shown). This behavior was consistent in both 
tester strains.
These results suggested that fumonisin may affect one or more of the steps 
involved in the mutagenicity process. This assay does not give information on the 
mechanism involved except for the fact that metabolic activation is needed to 
observe an effect. This leads to several hypothesis that can be divided in two 
general groups. The first one is that one or more reactions directly involving the 
toxins are taking place; and the second one is that FBi is affecting AFBi’s 
metabolic transformation.
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Figure 4.2 Mutagenic potential of AFB|/FB| combinations. Salmonella tester strain TA-100 with metabolic
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Figure 4.3 Mutagenic potential of AFBi/FB| combinations. Salmonella tester strain TA-98 with metabolic
activation. Natural revertants=32+3 Values are mean+SEM of three replicates.
a. Direct interaction hypothesis
AFBi biotransformation (Figure 2.3) yields several by-products. Some of 
them are considered detoxification compounds since their mutagenic potential is 
lower than that of the parent compound. However, virtually all the toxic effects of 
AFBi are now recognized to be attributable to the action of activated AFBi 
metabolites (i.e., AFB1-8 ,9-epoxide) that are capable of reacting with several 
macromolecules. The cytochrome P450 epoxidation of AFBi's terminal fiiran ring 
double bond yields a very potent electrophile (Essigmann et al., 1977; Swenson et 
al., 1977; Baertschi et al., 1989). This compound is not stable and is rapidly bound 
to a nucleophilic species or transformed to the AFB[-8.9- dihydrodiol. The diol can 
exist in a resonance form as a phenolate ion that is capable of forming Schiff base 
adducts with amino groups (i.e., lysine in protein). On the other hand, FBi contains 
one such primary amine group (Figure 2.4). Dantzer et al. (1997) and Murphy et 
al. (1996) reported that FB| can undergo Maillard type reactions to form Schiff 
base adducts, and these adducts can undergo an irreversible dehydration reaction . 
These authors report that formation o f Maillard-type compounds by this reaction 
blocks the toxic potential of fumonisin. This implies that, theoretically, if the 
AFBi-8,9-dihydrodiol and FBi are present in the same system they could undergo a 
Maillard-type reaction. This reaction would block the functional groups considered 
most responsible for the toxic potential of these xenobiotics.
In the current study, both toxins were present at the same time in the same 
solvent system. So, in this case, this reaction could be possible. However, in an in
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vivo system pharmacokinetic factors such as absorption and residence time should 
be considered for both toxins. The possibility that they can have direct chemical 
reaction in vivo is less than that of the in vitro system. Direct chemical interaction 
will be explored further in the next chapter, 
b. Mechanistic interaction hypothesis
The results shown in Figures 4.2 and 4.3 suggest that there is more than one 
mechanism responsible for the shift in the mutagenic potential of aflatoxin Bt. 
Therefore, it is possible that fumonisin interacted with the activation/detoxification 
pathways rather than directly with AFBi. There are several possible mechanisms 
that could be either inhibited or induced by fumonisin B|.
Cytochrome P450 enzymatic activity is considered the main pathway 
responsible for aflatoxin biotransformation. Several of the P450 enzymes have been 
reported to be involved in AFBi metabolism. The relative quantities of different 
metabolites produced depend largely on the relative activities of each isozyme. The 
major AFBi detoxification metabolites include aflatoxins Mi, Pi and Qi as 
detoxification by-products; and AFBi-8,9-epoxide as an activation product. 
Furthermore, the 8,9-epoxide has been shown to exist in two stearically different 
forms: the 8,9 exo-epoxide and the 8,9-endo epoxide. These molecules have been 
shown to have different affinity for DNA and glutathione (Gallagher et al., 1996). 
Guenguerich et al. (1996) reported that the exo isomer is 103 times more mutagenic 
than the endo-epoxide. Furthermore, Gallagher et al. (1992) reported that the 1A2 
and 3A4 isozymes appear to be the predominant catalysts of AFBi epoxidation in
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human liver in vitro. Relative to 3A4, 1A2 produces a higher ratio of activation to 
detoxification products. The differences in potential activation and detoxification 
metabolites suggest that there may be some agents that could shift the equilibrium 
to either a detoxification or an activation pathway.
In the case of FBi, its role in cytochrome P450 activity is not clear. It has 
been reported that it is not a substrate for the microsomal P450’s, estearases or 
hepatic lipase systems. Therefore, direct competition with AFBi should not be an 
issue. However, Martinez-Larranaga et al. (1996) reported a marked induction of 
hepatic and renal P450 1A, 3A and 4A families in rats fed with FBi. However, 
although in Western blot analyses of both 1A isozymes (1A1 and 1A2) showed 
marked increase in P450 enzymes, only the activity of the 1A1 isozyme was 
increased. The amount o f 1A2 increased, but its activity was not different from the 
control. This effect on 1A2 was could not be explained by the authors. Relating 
these results to the present study, it cannot be assumed that induction was a 
mechanism in an in vitro system. However, the possibility that FBi affects 
cytochrome P450 1A2 activity could be relevant to the changes in mutagenicity 
observed here.
Studies on primary hepatocyte cultures have shown that FBi alters the 
incorporation of 14C palmitic acid into cellular lipids indicating, that added to its 
effect on sphingolipid metabolism, it also affects synthesis of cellular lipids 
(Gelderblom et al., 1996). In addition to fatty acid changes, membrane associated 
cholesterol was markedly decreased. This study suggested that FBi has important
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effects on the structure of the major membrane components. Changes in the 
membrane structure and function could lead to several toxic effects, and could 
finally lead to the disintegration o f membrane continuity. From the xenobiotic 
metabolism point of view. Kim (1987) and Meydahl et al. (1985) reported that 
changes in fatty acid content o f hepatic endoplasmic membranes have been 
accomplished by altering dietary lipids. It has also been reported that phospholipids 
may enhance the binding of substrates to cytochrome P450’s (Tsai and Pence, 
1992). Therefore, changes in membrane lipid composition may alter substrate 
specificities and participation in various pathways. Hence, the activation and 
detoxification of numerous xenobiotics in liver microsomes may be altered. 
Whether FBi can exert a similar effect in an in vitro system, such as. the 
Salmonella/microsomai mutagenicity assay is yet to be determined.
Although P450 activity is considered the major enzyme system involved in 
the metabolic activation of AFBi, other enzyme families may also be involved. 
There is an increasing number of reports that have documented that, in general, 
polyunsaturated fatty acids cause a marked reduction in the rate of the NADPH- 
dependent cytochrome P450 oxidation of aflatoxin (Burgos-Hemandez, 1998; 
Nemoto and Takayama, 1983; Stohs and Wu, 1981). Specifically, linoleic and 
linolenic acids were reported to strongly inhibit AFBi activation by rat liver 
microsomes (Burgos-Hemandez, 1998; Firozi et al., 1986). Also, an inhibition of 
AFBi activation mediated by hepatic microsomes in the presence of arachidonic 
acid has been reported (Ho et al., 1992). These data have led to question the role of
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P450 as the sole catalyst of AFBi activation. Battista and Mamett (1985) reported 
that the enzyme prostaglandin synthetase is capable of mediating the epoxidation of 
AFBi through a co-oxidation mechanism. Thus, the relative contribution of other 
pathways to AFBi's ultimate mutagenic outcome has gained interest from the 
scientific community.
Enzymes, such as, prostaglandin synthetases (PHS), lipoxygenases (LO) 
(cyclooxygenases) and peroxidases can have dual functions, they can act as 
dioxygenases and as co-oxidases. Furthermore, studies have shown that soybean 
LO can co-oxidize a wide range of endogenous chemicals and xenobiotics in the 
presence of suitable polyunsaturated fatty acids (Kulkami, 1996). Regarding animal 
systems, several studies have reported that LO are present in the liver of several 
mammalian species (Roy and Kulkami, 1997; Rosello-Catafau, et al., 1994; Roy 
and Kulkami, 1994; Shiratori et al., 1992; Hughes et al., 1992; Liu and Massey, 
1992; Pereira and Das, 1991; Kawada et al.. 1990; Maruyama et al., 1989; Tiegs 
and Wendel, 1988; Hagmann et al., 1987; Macias et al., 1987; Roll et al., 1986; 
Perez et al., 1984; Nemoto and Takayama, 1984). Liu and Massey (1992) 
presented evidence that guinea-pig liver cytosolic LO can bioactivate AFBi, and 
when compared to the P450-catalyzed reaction, a relatively low Km for the DNA 
binding of AFBi was observed. These results implied the importance of the LO 
pathway in AFBi bioactivation.
On the other hand, there have been reports that FBi can induce peroxisomal 
and microsomal fatty acid-oxidizing enzyme activities. Peroxisomes (or
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"microbodies”) are single membrane-limited cytoplasmic organelles, which are 
characterized by their content of catalase and a number of hydrogen peroxide- 
generating enzymes. Peroxisomes contain the same fatty acid beta-oxidation cycle 
enzymes as mitochondria; therefore, the are metabolically competent to oxidize this 
type of compounds. While enzymes o f the P-oxidation cycle (normally assessed as 
cyanide insensitive palmitoyl-CoA oxidation) are markedly induced, only small 
changes are observed in other peroxisomal activities such as catalase and D-amino 
acid oxidase. Apart from stimulating peroxisomal fatty acid metabolism, 
peroxisome proliferators also increase microsomal fatty acid (co-1)- and particularly 
co-hydoxylase activities. This is due to induction of cytochrome p-450 isoenzymes 
in the CYP4A subfamily and is normally measured as lauric acid 12-hydrolase 
(Lake, 1995). Martinez-Larranaga et al. (1996) reported that treatments o f rats with 
FBi gave rise to a concentration-dependent increase in hepatic microsomal lauric 
acid hydroxylase activity, which is closely associated with the CYP4A subfamily 
of hemoproteins. Furthermore, the role of FBi in fatty acid metabolism has already 
been discussed. Short-term in vivo and in vitro studies have shown that exposure to 
FBi caused major changes in the phospholipid fraction of cells. There was a 
significant increase of hepatic C l8:2 (linoleic acid) and arachidonic acid (AA) 
(Gelderblom et al., 1995). In vitro studies in different cell lines have shown that 
FBi interferes with arachidonic acid conversion to other metabolites, such as 
prostaglandins. In primary hepatocyte cultures, exposure to FBi caused an 
accumulation of AA suggesting that FBi inhibits the release and/or the
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transformation of AA in primary hepatocytes. an effect that is greatly enhanced at 
high (cytotoxic) doses of FBi (Gelderblom et al.. 1996). This fact could be related 
to the relative increase in mutagenicity observed at the higher FB i doses.
The studies described above provide evidence that primary hepatocytes 
exposed to FBi show an accumulation of polyunsaturated fatty acids (PUFA) 
(Gelderblom et al., 1996). The cytotoxic effects of PUFA have been studied 
extensively (Gavino et al., 1981; Begin et al., 1988). The data provided by these 
studies suggest that the cytotoxicity of PUFA is associated with an increase in the 
extent of lipid peroxidation. In conjunction, these observations imply that FBi 
treated cells could be more susceptible to lipid peroxidation than normal cells 
(Gelderblom et al., 1996).
The role of peroxidases in aflatoxin degradation was discussed in Chapter 
III. Prostaglandin H synthetase (PHS) is the most extensively studied peroxidase. It 
has been reported that it possesses two distinct catalytic activities. A 
cyclooxygenase that converts AA to a cyclic endoperoxide-hydroperoxide (PGG2 ), 
and a peroxidase that converts the hydroperoxide to the corresponding alcohol 
(PGH2 ) (Parkinson, 1996).
In summary, cytochrome P450 and peroxyl-radicals formed by PHS, 
lipoxygenase, and/or lipid peroxidation may all play a role in activating aflatoxin 
Bj. Fumonisin has been shown to be involved in several of these oxidation 
mechanisms. More information on the mechanistic implications of FBi’s role in the
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multiple pathways that can oxidize AFBi could help understand the changes in 
mutagenicity observed in this study.
Another possibility is that FBi affected the activity of phase II 
conjugation/detoxification pathways rather than the P450 enzymes. If FBi affects 
enzymes, such as, glutathione-S-tranferases, then the ultimate mutagenic outcome 
could be affected. At some point (approximately 100 ng FBi/plate), the system 
could have become saturated; therefore, the mutagenicity could return to its original 
level. In vivo studies have suggested that FBi changes the level and activities of 
glutathione-S-transferases (Lebepe-Mazur et a l 1995). These results give 
supportive evidence for this hypothesis. However, since the metabolic activation in 
this study was provided by the S9 mix, the main role of fumonisin in this study 
needs to be related to enzyme activity rather than to enzyme induction.
In addition, glutathione plays a key role in detoxification by reacting with 
hydrogen peroxide and organic peroxides. This reaction is catalyzed by glutathione 
peroxidase. This enzyme needs two glutathione molecules to complete its cycle. Its 
active site contains a covalently attached Selenium ion (Se) which forms a 
selenium analog of cysteine (the sulphur has been replaced by Se). The reduced 
form of this enzyme (E-Se') reduces the peroxide substrate to an alcohol and in turn 
is oxidized to selenic acid (E-SeOH). Glutathione is then conjugated to form a 
selenosulfide adduct (E-Se-S-G). Subsequently, a second glutathione molecule 
regenerates the active form of the enzyme by attacking the selenosulfide and 
forming oxidized glutathione (Stryer, 1988). This information can also be related to
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the results observed in this study. Since glutathione plays an important role in 
detoxification of both, electrophiles and free radicals, the generation of free radicals 
caused by higher levels of FBi, may have depleted glutathione. Therefore, free 
radicals may have interfered with the major AFBi detoxification pathway. This is a 
plausible account for the increase in mutagenicity observed at higher FB| levels. 
Initially, the lower FBi levels may have generated some free radicals that were 
able to react with a multitude of compounds, including the AFB 1-8 ,9-epoxide. This 
could explain the decrease in mutagenicity. Then, at higher concentrations, the 
generation of higher quantities of free radicals, coupled with enhancement of co­
oxidation mechanisms and glutathione depletion may have promoted the return to 
increased mutagenicity.
The involvement of FBi in the oxidation pathways should be explored to 
determine its ability to inhibit and/or enhance toxic responses. This information 
would give better tools to estimate the risk of dietary exposure to fumonisin and 
evaluate it from the perspective of food safety.
2. Aflatoxin Bi/fumonisin B2  mutagenicity
Since in Chapter III a high production of FB2 by Fusarium moniliforme was 
reported, and chemical differences between FBi and FB2  are minimal (Figure 2.4). 
The ability of FB2 to affect AFBi mutagenicity was also tested. Due to the dose- 
dependent fashion of the shift in mutagenicity, it was considered that if FB2 exerted 
a similar effect, an additive response could occur during dietary exposure to co­
contaminated com.
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Figures 4.4 and 4.5 show the effect of FB2 on AFBi mutagenicity. It can be 
observed that the effect was less marked than that of FBi. Salmonella tester strain 
showed a tendency to exhibit the same behavior, but a definite effect could not be 
established. However, there is some evidence that FB2 could elicit the same 
response as FBi even if the response is weaker. Potential synergistic or additive 
effects should be explored.
3. Toxicity of AFB1/FB1 and AFB1/FB2
The toxicity of all of the samples tested for mutagenicity was evaluated to 
determine if the decrease in mutagenicity was indeed due to an interaction that 
favored detoxification, or was it due to toxicity to the tester strains. Results from 
the toxicity assay are presented in Figures 4.6-4.8. Although some variation was 
observed, none of the values were significantly different when compared to the 
control. This assay had high variability that could be attributed to the fact that at 
some concentrations, the bacterial suspension was highly diluted. Each plate 
presented between 1 and 10 colonies. When the dilution factor was considered, 
difference in one colony/plate in reality meant 1x10s colonies. Although the results 
from this assay may be considered inconclusive due to high variability, the lack of 
significant difference may imply that the effect observed in the mutagenicity assays 
was due more to an interactive behavior that enhanced detoxification rather than to 
an acute toxicity response. Other acute toxicity assays should be employed to 
determine the toxic potential of these samples.
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Figure 4.4 Mutagenic potential of AFB1/FB2 combinations. Salmonella tester strain TA-100 with metabolic


































Figure 4.5 Mutagenic potential of AFB1/FB2 combinations. Salmonella tester strain TA-98 with metabolic


























■  One AFBI 
H I ng AFBI
□  10 ng AFBI
■  100 ng AFBI











0.00E+00 1.00E+00 1.00E+01 1.00E+02 1.00E+03 1.00E+04 1.00E+05
FBI (ng/plate)
Figure 4.6 Toxic potential of AFB|/FB| combinations. Salmonella tester strain TA-100 with metabolic
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Figure 4.7 Toxic potential of AFB|/FB| combinations. Salmonella tester strain TA-98 with metabolic activation.
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Figure 4.8 Toxic potential of AFB1/FB2 combinations. Salmonella tester strains TA-100 and TA-98 with
metabolic activation. Negative control, DMSO=6xl08±2xl08 and 9xl08 ±3x108 colony forming units/plate for
TA-100 and TA-98, respectively. Values are mean+SEM of three replicates.
This experiment showed that simultaneous exposure to AFBi and FB| may 
elicit different responses than exposure to the individual toxins. This effect could 
be due to a combination of a multitude of factors that may include direct chemical 
interaction or enhancement/inhibition of different metabolic pathways. The overall 
response may be due to an equilibrium of all these reactions. The possible chemical 
interaction as well as the involvement in mechanistic pathways will be further 
explored in subsequent sections.
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V. Possible mechanisms of interaction between aflatoxin Bi and
fumonisin Bi
A. Introduction
In the previous chapter, it was observed that FBi changed the mutagenicity 
elicited by AFBi in a dose-dependent fashion. In an attempt to understand these 
results, several hypothesis were presented. Therefore, further experiments were 
performed to get more information on the possible interactions that might have 
taken place. The first approach was to determine if the interaction was due to a 
direct chemical reaction between both toxins.
The objective of this study was to determine the recovery of a fixed amount 
of AFBi (1 x 103 ng=3 nmol) after reaction with a range of different amounts of FBi 
(1 to IxlO5 ng= 1.4x1 O'3 to 1.4xl02 nmol) with metabolic activation. In addition, the 
recovery of a fixed amount of FBi (lxlO' ng=l.4xl02 nmol) after exposure to a 
range of AFBi (3x1 O'3 to 3 nmol) was also determined. The null hypothesis on this 
experiment was that the recovery of both AFBi and FBi decreases as the 
concentration of the other toxin increases. These results would show that there is a 
direct chemical reaction either between the two toxins or with other toxin 
metabolite(s).
A second approach was taken to determine if the changes were due to a 
direct effect on the metabolic pathways rather than to direct chemical reactions. 
The objective of this portion of the study was to determine the effect of FB i on the 
mutagenic potential of a different mutagen, 2-aminofluorene (2-AF). This
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compound is considered a positive control for the Salmonella!microsomal 
mutagenicity assay with metabolic activation (Maron and Ames. 1983).
2-AF was considered the ideal candidate since its mutagenicity requires 
metabolic activation and involves a different mechanism than that of AFBi- 2-AF 
does not form DNA adducts through the formation of an epoxide (Figure 5.1). This 
fact was important since that would rule out the potential Maillard type reaction 
with fumonisin, and therefore, give a better understanding on the effect of FBi 
directly on activation/detoxification pathways, without direct chemical reaction 
interference.
It has been reported that in mammalian systems, the in vitro N-oxidation of 
2-AF is mediated through pathways involving cytochrome P450, specifically P450 
1A2 (Wolfel et al., 1991), flavin containing monooxygenase (FMO) (Hammons et 
al., 1985), and co-oxidation via the peroxidase, prostaglandin synthetase (Wolfel et 
al., 1991). These mechanisms are similar to some of the mechanisms shown to 
bioactivate AFBi. Therefore, it was considered that the evaluation of FBj's role in 
2-AF mutagenicity would be a useful tool to elucidate potential mechanisms 
involved in the change of AFBi mutagenicity observed in Chapter IV.
B. Materials and methods
1. Bacterial cultures
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly 
provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, CA).
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Figure 5.1 Metabolic transformation of 2-Aminofluorene. R=Fluorene group 
(Kriek, 1992)
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2. Chemicals
Acetic acid. 2-aminofluorene, ammonium sulfate, ampicillin, D-biotin, 
disodium hydrogen phosphate, gIucose-6-phosphate, L-histidine, magnesium 
sulfate. 2-mercaptoethanol, ortho-phtaldehide, sodium ammonium sulfate, 
disodium tetraborate, sodium chloride, sodium dihydrogen phosphate, B- 
nicotinamide adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were 
purchased from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade), 
citric acid monohydrate, dimethyl sulfoxide (DMSO), ethyl ether anhydrous, 
hexane (HPLC grade), methanol (HPLC grade), potassium chloride, potassium 
phosphate dibasic anhydrous and water (HPLC grade) were acquired from 
Mallinckrodt Baker, Inc. (Paris, KT). Bacto agar and crystal violet were ordered 
from Difco Laboratories (Detroit, MI); glucose from Fisher Scientific (Fair Lawn, 
NJ). Acetonitrile (HPLC grade) was from Baxter Co. (Muskegon, MI). Ethanol was 
obtained from Aaper Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient 
broth No. 2 was from Unipath LTD (Basingstoke, Hampshire, England). Post- 
mitochondrial supernatant (S9 mix) was purchased from Molecular Toxicology, 
Inc. (Boone, NC).
Pure fumonisin Bi was kindly provided by Dr. Robert M. Eppley (Center 
for Food Safety and Applied Nutrition-CFSAN-, U. S. Food and Drug 
Administration-FDA-, Washington, D.C.). Pure aflatoxin B| was generously 
provided by Dr. Mary Trucksess (CFSAN-FDA. Washington, D. C.). Aflatoxin Bi,
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B2 , Gi, and Gt HPLC standard 50 pg/g mixture was purchased from Romer 
Laboratories, Inc. (Union, MO).
3. Chemical interaction
a. Effect of fumonisin B| on aflatoxin B| recovery after metabolic
activation
Pure AFBi and FBi stock solutions (lpg/pl and lOpg/pI, respectively) were 
prepared by solubilizing pre-weighed purified toxins in a methanol:water (30:70) 
solution. The samples were prepared and placed in amber vials immediately before 
the assay. Stock solutions were combined and diluted to obtain concentrations that 
would yield the final test amounts shown on Table 5.1.
Table 5.1 AFBi/FBi combinations tested for potential chemical interactions with 
metabolic activation
Aflatoxin Bi (nmol)
Fumonisin Bi (nmol) 0 3
0 0/0 3/0
1.4x1 O'3 0/1.4x10° 3/1.4x10°
1.4x1 O'2 0/1.4x1 O'2 3/1.4x10°




Combinations are expressed as nmol AFBi/nmol FBi. Samples were prepared in 
triplicate.
100 pi of test solutions were placed in sterile disposable capped culture
tubes and 500 pi S9 cocktail prepared according to Maron and Ames (1983) were
added unless otherwise indicated (negative control). Pure AFBi (3 nmol) without
metabolic activation (500 pi S9 cocktail without postmitochondrial supernatant
fraction) was used as a recovery control. Sample 0/0 only contained 500 pi S-9 to
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determine if the S-9 mix contained compounds that would interfere with the liquid 
chromatographic analysis.
The tubes were incubated in a water bath at 37°C with shaking (180-200 
rpm) for 90 minutes. After incubation, the samples were placed in ice to stop the 
reactions. Aflatoxin and/or metabolites were extracted by adding 1 ml CHCU to the 
culture tubes and vortexing. The aqueous and organic phases were allowed to 
separate and the CHCI3 phase was separated and collected in an amber vial. This 
procedure was repeated three times to obtain ca. 3 ml CHCI3 extract. The samples 
were evaporated to dryness under a N2 stream. AFBi was then purified according to 
the method reported by Thean et al. (1980). The purified extracts were analyzed by 
liquid chromatography following the method reported by Wilson and Romer 
(1991). The purification and quantification methods were described in detail in 
Chapter III.
b. Thin layer chromatography (TLC) of recovered aflatoxin Bi and/or 
metabolites
Since the HPLC analytical method used in the previous section requires 
AFBi derivatization with trifluoroacetic acid (TFA) to yield the more fluorescent 
AFB2a, thin layer chromatography was used to qualitatively determine the presence 
of metabolites that would be converted to AFB2a when exposed to TFA.
Pre-coated aluminum silica gel plates (0.25 mm) were activated by placing 
them in a dry incubator at 60°C for at least 3 hours. A 1 pg AFBi/pi 
benzene:acetonitrile (98:2) solution was used as a control. 5 pi of pure AFBi and 5 
pi of the same samples that were injected into the HPLC (described in the previous
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section) were spotted at 1.0 cm distance and at 1.5 cm. from the lower edge of the 
TLC plate. The spots were allowed to dry. Then, 5 pi of TFA derivatizing agent (1 
ml trifluoroacetic acid+4 ml hexane) were applied directly over the samples 
previously spotted. After the spots dried, the plate was placed in an incubator at 
65°C for 10 minutes to allow for derivatization reaction. The plates were allowed to 
cool down, and 5 pi of underivatized pure AFBi and underivatized samples were 
spotted at 1.0 cm from each other and from the derivatized spots. The plate was 
developed in a TLC chamber using chloroform.acetic acid:water (98:1:1) as a 
mobile phase. The solvent front was marked and the plate was removed from the 
chamber and allowed to dry under the hood. The dried plate was observed under a 
long wavelength UV light. Fluorescent spots were marked to calculate the Rf 
values.
c. Effect of aflatoxin Bi on fumonisin Bi recovery after metabolic 
activation
Pure AFBi and FBi stock solutions (lpg/pl and lOpg/pl, respectively) were 
prepared by solubilizing pre-weighed purified toxins in a methanol:water (3:1) 
solution. The samples were prepared in amber vials immediately before the assay. 
Stock solutions were combined and diluted to obtain concentrations that would 
yield the final test amounts shown in Table 5.2.
1 0 0  pi of test solutions were placed in sterile disposable capped culture 
tubes and 500 pi S9 cocktail prepared according to Maron and Ames (1983) were 
added unless otherwise indicated (negative control). Pure FBj (1.4xl02 nmol) 
without metabolic activation (500 pi S9 cocktail without postmitochondrial
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supernatant fraction) was used as a recovery control. Sample 0/0 only contained 
500 pi S-9 to determine if the S-9 mix contained compounds that would interfere 
with the liquid chromatographic analysis.
Table 5.2 FBi/AFBi combinations tested for potential chemical interactions with 
metabolic activation
Fumonisin Bi (nmol)
Aflatoxin B[ (nmol) 0 140
0 0 / 0 3/0
3x1 0° 0/3x10° 140/3x10°
3x1 O’2 0/3x1 O' 2 140/3xl0‘2
3x10'' 0/3x10' 1 140/3x10**
3 0/3 140/3
Combinations are expressed as nmol FBi/nmol AFB|. Samples were prepared in 
triplicate.
The tubes were incubated in a water bath at 37°C with shaking (180-200 
rpm) for 90 minutes. After incubation, the samples were placed in ice to stop the 
reactions. Fumonisin and/or metabolites were extracted by adding 2.5 ml 
methanol:water (3:1) to the culture tubes and vortexing. The resulting solution was 
placed in a 20 ml scintillation vial. The reaction tubes were washed a total of 4 
times with methanol:water (3:1) to obtain a total volume of 10 ml/sample. This 
final solution was mixed thoroughly (vortex -  1 min) and the pH was adjusted to 
5.8 -6 .5, if necessary. This solution was then applied to pre-conditioned anion 
exchange (SAX) columns and FBi/metabolites were purified and quantified by 
liquid chromatography according to AO AC official method of analysis 995.15 
(1996). This method was described in detail in Chapter III.
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d. Statistical analysis
Statistical analysis was performed using the SAS software (SAS. 1988). 
One-way analysis of variance (ANOVA) was used to determine differences in toxin 
recovery. Scheffe's test with an alpha value of 0.05 was used to compare 
differences among the different treatments.
4. Effect of fumonisin Bi on 2-aminofluorene mutagenic potential
The mutagenic potential of 2-AF and 2-AF/FBi combinations was
determined following the methods for the Salmomllalmicxosovnal mutagenicity 
assay reported by Maron and Ames (1983) using Salmonella tester strains TA-100 
and TA-98 with and without metabolic activation. A detailed description of this 
procedure was provided in Chapter III.
a. Mutagenic potential of 2-aminofluorene
A preliminary dose range finding assay was performed to determine an 
ideal 2-AF dose to combine with FBi. 2-AF was tested in a range from lxlO 2 to 
lxlO6 ng/plate using Salmonella tester strains TA-100 and TA-98 with and without 
metabolic activation.
b. Effect of Fumonisin Bi on 2-aminofluorene mutagenicity
A fixed dose of lxlO 4  ng 2-AF/plate was selected to determine FBi’s effect 
on 2-AF mutagenic potential. FBi was tested using the same concentration range 
used to determine its effect on AFBi’s mutagenic potential (1-lx l0 5 ng/plate). 
Samples were prepared in amber vials immediately before the assay using DMSO 
as the carrier solvent. Dilutions were made from 10 jig FBj/pl DMSO and 100 pg
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2-AF/jil DMSO slock solutions to yield the sample combinations presented in 
Table 5.3.
c. Safety precautions
Since 2-AF is considered a mutagen and the Material Safety Data Sheet 
information on its potential toxic effects was limited, the assay was carried out with 
extreme caution using appropriate personal protection equipment that included 
body suits, double nitrile gloves, half face negative pressure organic vapor 
respirator and safety glasses. Sample size and number of assays performed were 
kept to a minimum to limit waste generation. 2-AF was handled using disposable 
glassware that was properly decontaminated and disposed of at conclusion of the 
assay. Waste material generated from this experiment was autoclaved and disposed 
through Louisiana State University Department of Occupational and Environmental 
Safety once the assay was concluded.
Table 5.3 2-aminofluorene/fumonisin Bi combinations used to evaluate the effect 
of FBi on 2 AF mutagenic potential.
2-AF (ng/plate)
FBj (ng/plate) 0 1 x 1 0 “
0 0 / 0 lx l 0 4 / 0
1 0 / 1 lx l 0 4 / 1
1 x 1 0 * 0 / 1 x 1 0 * lxl 0 4 / 1 x 1 0 1
lxlO2 0/1 xlO2 Ix l 0 4 / lx l 0 z
lxlO3 0 / lx l 0 J 1 x 1 0 4/ 1 x 1 0 j
lxlO4 O/lxlO4 Ix l 0 4 / lx l 0 “
lxlO3 O/lxlO3 lxlO’VlxlO3
All samples were tested in triplicate with and without metabolic activation.
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C. Results and discussion
1. Effect of fumonisin Bi on aflatoxin Bi recovery after metabolic
activation
When APBi was exposed to varying FBi concentrations, it was observed 
that the results (Figure 5.2) emulated the mutagenicity behavioral pattern shown in 
Figures 4.2 and 4.3. The amount of aflatoxin recovered decreased as FBi increased 
until FBi reached lxlO2 ng (1.4x1 O' 1 nmol). At this point, AFBi recovery started 
increasing. Although the only treatments that were significantly different (p<0.05) 
from the control were observed when l.4xl0 4  and 1.4 nmol FBi were added, the 
pattern was evident. This behavior suggested that direct chemical interaction was 
not involved, at least not in all the FBj concentration range. If there had been a 
chemical reaction, a single dose-response would have been observed. AFBi 
recovery would have decreased as FBi increased.
Analysis of the controls indicated ca. 90% recovery from the extraction 
procedure. This showed that the extraction method was suitable for this assay and 
that the variations observed were due to chemical interaction. No peaks were 
detected in the chromatograms of the controls, FBi without AFBi and S9. 
Therefore, it was assumed that neither FBj nor S9 interfered with the results.
It is noteworthy that chromatograms showed a peak for the AFB i derivative 
AFB2a. These results were not expected since AFBi had been exposed to S9 
enzymatic activity. AFB2a is formed when AFBi is exposed to TFA. Hence, in 
theory, AFBi in this study should have been transformed to other metabolites. 
Since AFB2a can be obtained through biotransformation pathways, it was
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Figure 5.2 Aflatoxin B| recovery after reaction with fumonisin B| with metabolic activation. Values are
mean±SEM of three replicates.
hypothesized that the exposure to FBi with metabolic activation yielded AFB^a- To 
test this hypothesis, an underivatized sample was analyzed in the same HPLC 
system. If AFB^a were generated from the S9 metabolic activity, a peak with a 
similar retention time as AFB2a was expected from injection of underivatized 
samples. However, there were no detectable peaks in the chromatograms of these 
samples. Thus, it was assumed that AFB2a was not directly generated by S9 
metabolic activity in this in vitro system.
It was also hypothesized that some other secondary compound was 
generated during the incubation, and this compound was also derivatized to AFB2a 
or to a compound that co-eluted with AFB2a. Therefore, the peaks observed for 
AFB2a could be a combination of one or more derivatized metabolites plus residual 
AFBi that were co-extracted with CHCI3 . It would be assumed that the rest of the 
AFBi was biotransformed and/or conjugated to more polar compounds that had a 
higher affinity to the aqueous phase and were not extracted with CHCI3 . To 
qualitatively test this hypothesis, derivatized and underivatized pure AFBi and 
CHCL-extracted samples were fractionated on a TLC plate. The results are shown 
in Table 5.4.
Table 5.4 Rf values and description of TLC spots of derivatized and underivatized 
samples.
Sample R f value Spot description
AFBj+TFA 0.16 Bright blue fluorescence
Sample+TFA 0.16 Bright blue fluorescence
AFBi 0.63 Medium blue fluorescence
Sample 0.71 Faint dark blue
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The results (Table 5.4) suggest that an AFBi metabolite or byproduct was 
recovered in the CHCI3 fraction. This metabolite (Rf=0.7l) was transformed either 
to AFB2a (Rf=0.16) or to a product that co-eluted with AFB2a (Rf=0.16) after 
derivatization with TFA. It is interesting to note that Doyle and Marth (1978) 
reported that when lactoperoxidase was used to degrade AFBi, derivatives that 
co-chromatographed with AFB2a and derivatives that were water soluble were the 
major degradation products of AFBi. This report, coupled with the results 
presented in this study, provide evidence for the potential involvement of 
peroxidase activity in AFBi mutagenicity. Further research is needed to 
characterize the metabolites produced by this pathway and to determine the direct 
effect of FBi on peroxidase-dependent AFBi oxidation.
2. Effect of aflatoxin Bi on fumonisin Bi recovery after metabolic 
activation
When FBj was exposed to AFBi with metabolic activation, no significant 
(p<0.05) changes were observed (Figure 5.3). However, it was observed that the 
control for the extraction method was ca. 8 8 %. While FBi recovery for all the 
samples ranged from ca. 60-75%. Hence, some of the FBi was not recovered after 
reaction with AFBi and metabolic activation. No dose-response relationship was 
observed. This may be due to the fact that an excess FBi was used for this assay. 
This amount of FBi (lxlO 3 ng) was selected to facilitate detection by HPLC. The 
excess FBi in the system, may have masked its relationship with S9. However, 
from under these experimental conditions, it can be assumed that direct chemical 
interaction is not a major contributor to the shift of AFBi mutagenicity caused by
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Figure 5.3 Fumonisin B| recovery after reaction with aflatoxin B| with metabolic activation. Values are
mean+SEM of three replicates.
FB[. More research is needed to determine the role of FBi in xenobiotic co­
oxidation mechanisms.
3. Effect of fumonisin Bt on 2-aminofluorene mutagenicity
Figures 5.4 and 5.5 show 2-AF mutagenic potential using Salmonella tester 
strains TA-100 and TA-98 with and without metabolic activation. It was observed 
that 2-AF exhibited the same behavior in both tester strains. When the activating 
enzyme mixture (S9) was present, 2-AF mutagenic potential increased in a dose- 
response fashion up to a concentration of 103 ng/plate. Plates containing 106 
ng/plate with and without metabolic activation did not show any growth. Toxicity 
testing on nutrient agar plates confirmed that 2-AF at this concentration was toxic 
to both, Salmonella TA-100 and TA-98.
The results shown in Figures 5.4 and 5.5 implied that a concentration range 
of 104  to 103 would be useful for testing the effect of FBi used to test AFBi 
mutagenicity. It was determined that at this level, any potential variation caused by 
FBj would be easily identified. This amount of 2-AF showed a marked mutagenic 
response and was lxlO2 fold lower that the amount that showed a marked cytotoxic 
response. Therefore, 2-AF was fixed at 104 ng/plate and FBi (10°-103 ng/plate) was 
added. These combinations did not show a cytotoxic response when evaluated on 
nutrient agar plates.
When the effect of FBi (10°-105 ng/plate) on the mutagenic potential of 2- 
AF (104 ng/plate) was evaluated, an interesting response was observed. FBi 
changed 2-AF mutagenic potential in the same way as it affected the mutagenic
169
































0  . 
1.00E+02 1.00E+03 1.00E+04 1.00E+05 1.00E+06




Figure 5.4 Mutagenic potential of 2-aminofluorene with and without metabolic activation (S9). Values are
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Figure 5.5 Mutagenic potential of 2-aminofluorene. Salmonella tester strain TA-98 with and without metabolic
activation (S9). Values are mean±SEM of three replicates.
potential of AFBi (Figures 5.6 and 5.7). There was a marked decrease up to a point 
(102 ng FBi/plate) where the mutagenic response started to return to its original 
level. It was interesting to observe that the return occurred around the same FBi 
concentrations that elicited a change in AFBi mutagenicity and chemical recovery. 
These results suggest that FBi affects one or more of the common metabolic 
pathways that are involved in 2-AF and AFBi activation/detoxification.
Leist et al. (1992) reported that enzymes from both, the microsomal and the 
cytosolic fractions of hepatic S9 mix are involved in the activation of 2-AF to a 
mutagen. Furthermore, there have been reports that show that the cytosolic fraction 
of this mix can markedly enhance the mutagenic response of chemicals such as 
AFBi (Saccone and Pariza, 1981), benzo[a]pyrene (Saccone and Pariza, 1981), 2- 
acetylaminofluorene (Forster et al., 1981), 2-amino-3-methylimidazo-(4,5- 
quinoline) (Abu-Shakra et al., 1986), benzidine (Smith and Ioannides, 1987) and 
N-nitrosopiperidine (Ayrton et al.. 1987).
Leist et al. (1992) reported that the first and rate limiting step in the 
bioactivation of aromatic amines is the N-hydroxylation catalyzed by microsomal 
enzymes and that the hydroxylated amines act as the proximate mutagens. Phase II 
conjugation enzymes produce electrophilic species such as the nitrenium ions that 
can bind covalently to DNA. The involvement of enzymes, such as prostaglandin 
endoperoxide synthetase, peroxidase and the peroxidase-like enzymes in the 
bioactivation of 2-AF to a mutagenic species has been reported by several authors 
(Isola et al., 1993; Corbett and Corbett, 1988). Leist et al. (1992) also reported that
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Figure 5.6 Mutagenic potential of 2-aminofluorene/Fumonisin B| combinations. Salmonella tester strain
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Figure 5.7 Mutagenic potential of 2-aminofluorene/Fumonisin Bi combinations. Salmonella tester strain
TA-98 with and without metabolic activation (S9). Values are mean±SEM of three replicates.
cytosolic oxygenase activity is involved in the bioactivation of 2-AF. These authors 
also reported that the cytosolic activation of 2-AF is dependent on the presence of 
O2 , and that established oxygen radical scavengers such as DMSO and retinol 
inhibit the reaction.
The oxygen radical scavenger potential of DMSO may have interfered with 
the results presented in the current study. DMSO could have interfered with the 
total response, but other factors may have also been involved. DMSO was used as a 
negative control in this study. Therefore, the results can still be evaluated relative to 
each other. Moreover, the chemical interaction study reported previously in this 
chapter, used a different carrier system (methanol:water; 30:70) and the same dose- 
response behavior was observed. If FBi is in fact involved in a free-radical 
peroxidation mechanism that affects the biotransformation of chemicals such as 
AFBi and 2-AF, its effect should be evaluated in a system that does not contain 
added oxygen scavengers such as DMSO. This could give more marked responses 
that would help elucidate the mechanism(s) involved.
The results from this study suggest that FBi affects AFBi and that 2-AF 
biotransformation in a dose-response fashion through a similar mechanism. It has 
been reported that both, 2-AF and AFBi are mainly activated by the cytochrome 
P450 1A2 isozyme and by oxidative reactions mediated by peroxidase and 
peroxidase-like enzymes.
From the fumonisin perspective, there is evidence that suggests that FBi 
alters P450 1A2 activity (Martinez-Larranaga, 1996) and that it alters the levels and
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fatty acid composition in rat liver in vitro and in vivo systems (Gelderblom et al., 
1996; 1997). The accumulation of polyunsaturated fatty acids coupled with 
enhancement of peroxidase and peroxidase-like activities implies that FB i can alter 
peroxidase-mediated reactions. Therefore, the evaluation o f the involvement of FBi 
on the activity of microsomal and cytosolic fractions and its specific effect on P450 
1 A2  activity would be useful in determining its role in the activation/transformation 
of xenobiotics, such as, AFBi. This information would help in assessing the 
potential risk and food safety concerns associated with aflatoxin and fumonisin co­
contamination in com.
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VI. Effect of Fumonisin B| on gap-junction intercellular communication of
clone-9 rat liver cells
A. Introduction
In the previous chapters, the possible interactions between aflatoxin B| and 
fumonisin Bi were explored, mainly through the evaluation of the mutagenic 
potential of different AFBjrFBi ratios. However, since it does not show a positive 
response in the Salmonella/microsomal test and other mutagenicity assays FBi is 
considered a non-genotoxic agent. FBi’s lack of mutagenicity has complicated the 
development of short term assays that could help monitor its effect on an in vitro 
system and facilitate the study of potential interactions. Therefore, the need for 
rapid and reliable assays to monitor the effect of fumonisin was identified.
Molecular studies of human cancers have provided abundant evidence that 
carcinogenesis requires an accumulation of mutational events before a normal cell 
transforms into a malignant tumor (Fearon and Vogelstein, 1990). Therefore, the 
use of short-term mutagenesis assays to evaluate chemical carcinogens is well 
justified. However, it has been reported that standard short-term mutagenesis test 
results identify no more than 65-89% of rodent carcinogens (Ashby and Tennant,
1991). Hence, Yamasaki (1996) has speculated that even if the concept of these 
assays is on target, there is a misconception that genetic changes required for 
carcinogenesis are always directly induced by exogenous carcinogens and thus, 
detected by short term assays such as the Salmonella/microsomal mutagenicity 
assay. The general concept that chemical carcinogens directly interact with DNA is
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widely accepted because many environmental carcinogens, i.e., tobacco smoke, 
aflatoxin, sunlight, etc.. have been implicated in certain types of cancer and because 
the genetic basis of cancer has been supported with extensive evidence. However, 
some of these concepts cannot be entirely translated into simple mutation assays. In 
support of this idea, it has been reported that exposure to agents that induce cell 
proliferation, block intercellular communication, or produce oxygen radicals may 
eventually lead to genetic damage, but these mutational events are considered 
indirect, and are usually not detected by mutation assays (Yamasaki. 1996). Several 
authors have provided experimental evidence to consider that one possible non- 
genotoxic mechanism of carcinogenesis is the inhibition of gap-junction 
intercellular communication (GJIC) (Holden et al., 1997; Mesnil et al., 1995; 
Yamasaki. 1990; Trosko and Chang, 1988; Loewenstein, 1979).
GJIC has been considered an important factor in cell growth and 
differentiation. Furthermore, in recent years it has been widely believed that GJIC 
plays a pivotal role in cell proliferation (Na et al., 1995). It is believed that 
considerable levels of important biological materials, such as, growth control 
factors are exchanged through gap junctions (GJs) (Na et al., 1995). GJs are 
composed of protein channels that permit the exchange of nutrients, ionic signals 
and regulatory molecules of up to 1500 Dalton between adjacent communication- 
competent cells (El-fouly et al., 1987). It has been reported that certain non- 
permeable molecules can be introduced into cells via a "scrape-loading” technique 
(El-fouly et al., 1987). Scrape-loading has been effectively utilized to introduce
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macromolecules into cells in culture by inducing a transient tear in the plasma 
membrane without affecting cell viability or colony forming ability (McNeil et al., 
1984).
Lucifer yellow (3,6-Disulfonate-4amino-naphtalimide; MW=457.2) is a 
water soluble, low molecular weight fluorescent dye that does not diffuse through 
intact plasma membranes, but readily passes from one cell to another, potentially 
revealing molecular relationships between cells (Hermanson, 1996). El-fouly et al. 
(1987) determined that Lucifer Yellow transfers from cell to cell through gap 
junctions. Therefore, these authors developed a Lucifer yellow scrape-loading and 
dye transfer technique to study gap-junction intercellular communication. This 
method can be used to determine if certain non-genotoxic chemical carcinogens are 
involved in the carcinogenesis process by interfering with GJIC.
FB i non-genotoxic nature combined with the existing evidence regarding its 
effect on lipid metabolism and membrane structure and function, led to the 
hypothesis that it could affect GJIC. Thus, the objectives of this phase of the study 
were (1) to determine if fumonisin inhibits GJIC in vitro, and (2) to determine if 
APBi changed FBi effect on GJIC.
B. Materials and methods
1. Chemicals
Pure fumonisin B| was kindly provided by Dr. Robert M. Eppley (Center 
for Food Safety and Applied Nutrition (CFSAN), U. S. Food and Drug
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Administration (FDA), Washington, D. C.). Pure aflatoxin B[ was provided by Dr. 
Mary Trucksess (CFSAN-FDA, Washington, D. C.).
Ham’s F-12K cell culture media and fetal bovine serum were purchased 
from American Type Culture Collection (ATCC) (Rockville, MD). Acetic acid, 
Dulbecco’s phosphate buffer solution without calcium and magnesium (PBS-Ca, 
Mg), Dulbecco’s phosphate buffer solution with calcium and magnesium (PBS+Ca, 
Mg), ethanol, 0.25% trypsin, 0.03% versene solution. 30% hydrogen peroxide, 
Lucifer yellow, methanol, neutral red, lOOx penicillin/streptomycin solution, trypan 
blue, 25 cm2 cell culture flasks and 35 mm cell culture dishes were acquired from 
Sigma chemical company (St. Louis, MO).
2. Cell line
Clone-9 (CRL-1439) rat liver epithelial cell line isolated in 1968 from 
normal liver taken from a young male rat (Gerschenson et al., 1975; Weinstein et 
al., 1975) was purchased from ATCC (Rockville, MD). Cells were grown in Ham’s 
F-12K medium with 10% fetal bovine serum, and 1% penicillin streptomycin 
solution under an atmosphere of 5% CO2 in humidified air at 37°C. Culture media 
was renewed 1 to 2 times weekly. Subculturing was performed by removing old 
media and adding fresh 0.25% trypsin, 0.03% versene solution for 2 to 3 minutes. 
The trypsin solution was then removed and the culture was incubated at 37°C for 
10-15 minutes to permit cell detachment. Fresh medium was then added, aspirated 
and dispensed into new flasks in a 1: 6  ratio. Bioassays were conducted with cells 
grown in 35 mm culture dishes to confluency after 2-3 days growth.
180
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3. Test solutions
Toxin dilutions were prepared immediately before the assay. Stock 
solutions 10 pg/pl and lpg/pl of FBi and AFB[, respectively were prepared by 
solubilizing pre-weighed pure toxins in a sterile 30% ethanol solution (0.22 p- 
Millipore syringe filter (Millipore, New Bedford, MA)). Combination samples as 
shown in Table 6.1 were prepared in sterile capped culture tubes using sterile 30% 
ethanol as a solvent carrier. 30% ethanol solution was used as a negative control in 
all assays.
Table 6.1 Fumonisin Bi and aflatoxin Bi samples tested for cytotoxicity and effect 
on gap-j unction intercellular communication
AFBj (ng/plate)
FBi (ng/plate) 0 I 1 x 1 0 * lx l 0 z lx l 0 J
0 0 / 0 0 / 1 0 / 1 x 1 0 * 0/1 xlO2 0 / l x l 0 3
1 1 / 0 * * * *
1 x 1 0 * l x l 0 * / 0 * * * *
lxlO3 l x l 0 3 / 0 * * * *
lxlO3 l x l 0 3 / 0 * * * *
lxlO4 l x l 0 4 / 0 * * * ♦
lxlO5 l x l 0 5 / 0 lx loVl I x l 0 3/ l x l 0 * Ix l 0 5/ l x l 0 2 I x l 0 5/ lx l 0 3
Combination values are expressed as ng FBi/pIate / ng AFBi/plate.
*: Combination not tested
All samples were prepared in triplicate
4. Growth curve
A growth curve to determine cell growth characteristics and standardize all 
assays was obtained by growing cells in 25 cm2  cell culture flask until they reached 
a concentration of 5x104  cells/ml. Cells were counted by staining with trypan blue
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and using an hemocyotmeter. Cell suspensions were added to 35 mm cell culture 
dishes at four different concentration levels, 3xlOJ, 7xl03, 13x10J and 27xlOJ> 
cells/ml. Volume was brought up to 2 ml/plate. These plates were incubated at 
37°C in a 5% CO2 humidified atmosphere. Cells were counted at 0, 55, 8 8  and 120 
hours incubation.
5. Neutral red cytotoxicity assay
Cytotoxicity as determined by the neutral red uptake assay according to the 
method reported by Borenfreund and Puemer (1985). Clone-9 cells were grown in 
35 mm cell culture dishes at the same conditions and confluency (ca. 4x104 
cells/ml) used for the cell communication bioassay (2-3 days). Old growth media 
was discarded and 2 ml fresh media were added to each disc. 1 0 0  pi test solutions 
(Table 6.1) were added to three plates/sample. Plates were incubated for 24 hours 
and cytotoxicity was determined.
The neutral red solution was prepared by mixing it with Ham's F-12K 
medium. The media containing neutral red was incubated for 2 hours in a water 
bath at 37°C. The resulting precipitation was centrifuged at 2000 g and filtered 
through a 0.22 p-Millipore syringe filter (Millipore, New Bedford, MA).
The cells were rinsed three times with PBS+Ca, Mg and then 2 ml fresh 
growth media containing 0.033% neutral red was added to the cells. Plates were 
incubated at 37°C for 1 hour. After incubation, the extracellular neutral red was 
rinsed off with PBS+Ca, Mg and the cells were lysed with 2 ml of an aqueous 
solution containing 1% acetic acid and 50% ethanol. The lysed cells were measured
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for neutral red at a wavelength of 540 nm. Methanol (200 pi) was used as a positive 
control and 30% ethanol was used as a negative control.
6. Gap-junction intercellular communication
Gap-junction intercellular communication in clone-9 rat liver cells was 
measured using the scrape-loading dye transfer method reported by El-Fouly et al.. 
(1987) with a modification described by Na et al. (1994). Cells were grown to 
confluency in 35 mm cell culture dishes (ca. 4xl04 cells/ml). Old media was 
discarded and replaced with fresh media. Test samples (Table 6.1) were added (100 
pi) 24 hours prior to scrape-loading. After 24 hours incubation, media was 
aspirated and reserved in sterile capped culture tubes at 37°C. Cells were washed 
twice with PBS-Ca, Mg. The plate was then flooded with PBS containing 1% 
Lucifer yellow and then scrape loaded with a plastic scraper. The dye solution was 
left on the cell monolayers for 1 min. and then the cultures were washed three times 
with PBS with Ca and Mg to remove unloaded dye and background fluorescence. 
Growth media was replaced in each dish and the dishes were incubated at 37°C in a 
humidified atmosphere for 10 minutes to allow for dye transfer. Cultures were then 
examined under an Olympus inverted microscope equipped with a reflected light 
fluorescence attachment with HBO-100 W/2 mercury lamp (Olympus, Tokyo, 
Japan). Gap-junction communication was measured by counting the number of 
cells from the scrape-loaded line that were stained with the fluorescence dye. Cells 
were counted on 20 different locations on each plate. Samples were analyzed in 
triplicate.
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7. Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988). 
One way analysis of variance (ANOVA) was used to determine differences in toxin 
recovery. Scheffe's test with an alpha value of 0.05 was used to compare 
differences among the treatments.
C. Results and discussion
1. Growth curve
A growth curve (Figure 6 .1) was constructed to optimize growth times and 
standardize the experimental conditions for this assay. From the growth curve, it 
was determined that plating a cell suspension containing ca. 1.3x104  cells/ml 
yielded the adequate growth to confluency in the time required to perform this 
experiment. This was crucial since it has been observed that FBi does not elicit any 
effect to cells in culture until after an initial lag period of 24-48 hours (Yoo et al.,
1992). It was important to test cells at confluency, but that would stay in a log or 
stationary phase throughout the assay. Once the growth parameters were 
determined, they were used for the rest o f the bioassays.
2. Neutral red (NR) cytotoxicity assay
The NR assay is based on the incorporation of a weakly cationic dye (NR)
into the lysosomes of viable cells after their incubation with toxic chemicals. NR 
penetrates cell membranes by nonionic diffusion and binds intracellularly to sites of
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Figure 6.1 Growth curves for Clone-9 rat liver cells. Values are mean+SEM of thirty counts.
the lysosomal matrix (Lullmann-Rauch, 1979). Xenobiotics that injure the plasma 
or lysosomal membrane decrease NR uptake and subsequent retention. After the 
cells are rinsed, only undamaged cells retain the dye. NR is then extracted from the 
lysosomes and quantified spectrophotometrically. Methanol was used as a positive 
control to optimize the neutral red cytotoxicity assay. Figure 6.2 shows the dose- 
response relationship caused by the toxicity of methanol. It can be observed that as 
methanol increased, the absorbance decreased indicating that less cells were able to 
retain NR.
When cells exposed to FBi and/or AFBi were analyzed, an interesting 
pattern was observed (Figure 6.3). All treatments had significantly higher (p<0.05) 
absorbance than the control. This suggested that not only were the treatments not 
acutely toxic, but they induced more intracellular NR retention. One plausible 
explanation of this effect is the possibility that the toxins are indeed acting as 
peroxisome proliferators as previously reported (Martinez-Larranaga, 1996). Since 
the morphology of peroxisomes resembles that of lysosomes (Darnell et al., 1990), 
it could be possible that exposure to the toxins caused an increase of these 
organelles as an early toxic response. The peroxisomes may have retained the NR 
causing the increase in absorbance. Although this hypothesis needs more research, 
it provides further evidence that peroxisomes and oxidative metabolism may play 
an important role in FBi toxicity and in the interaction between AFBi and FB|.
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Figure 6.3 Toxic potential of fumonisin B| and/or aflatoxin B| to Clone-9 rat liver cells. Values are mean±SEM
of three replicates.
3. Effect of fumonsin B| on gap-junction intercellular communication
The results of this study suggest that FBi inhibits gap-junction intercellular 
communication of Clone-9 rat liver cells. Table 6.2 summarizes the results of this 
assay and shows the significant differences between the different concentrations 
tested.
Table 6.2 Effect of fumonisin Bi on gap-junction intercellular communication of 
Clone-9 rat liver cells
Sample Mean±SEM (n=60) *
Negative control 6 .2 ±0 . 1 A
Positive control (H2 O2 ) 400pM 1.3±0.2 F
1 ng FB [/plate 4.9±0.2 A,B
lxlO1 ng FBi/plate 3.8±0.2 B,C
lxlO2 ng FBi/plate 3.5±0.1 C
lxlO3 ng FBi/plate 3.2±0.2 C
lxlO4  ng FB,/plate 1.5±0.2 F
lxlO3 ng FBi/plate 1.7±0.2 C,D,E,F
lxlO5 ng FB i/plate + 1 ng AFB [/plate 1 .2 ±0 . 1 E,F
1X105 ng FB [/plate + lxlO1 ng AFB [/plate 2.6±0.3 C.D.E
1X105 ng FBi/plate + lxlO2  ng AFBi/plate 2 .8 ±0 . 2 C,D
lXlO3 ng FB [/plate + lxlO3 ng AFB [/plate 2.9±0.3 C.D
lxlO3 ng AFB [/plate 5.2±0.2 A
GJIC is expressed as the mean number of fluorescent cells counted from the scrape- 
loaded line.
Values with the same letter are not significantly different.
It was noted that FB| inhibits GJIC in a dose-response fashion (Figure 6.4). 
Communication decreased as FBi concentration increased. These results show that 
inhibition of GJIC may play a role in FBi carcinogenesis. This is supported by 
other reports on FBi role on membrane structure and function. Yoo et al. (1992) 
reported that after 24-48 hours of FB| exposure LLCP-PK1 cells lost cell-cell 
contact.
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Figure 6.4 Effect of fumonisin B| on gap junction intercellular communication (GJIC) of Clone-9 rat liver 
cells. Positive control H2O2 (400 pM)=0.21 ±0.029. Values are meaniSEM of sixty replicates.
Furthermore, Niedel et al. reported that TPA (12-O-tetradecanoylphorboI- 
13-acetate), a known tumor promoter, inhibits GJIC. It has been speculated that 
TPA mediates its tumor promoter effects through the activation o f protein kinase C 
(PK-C) and the subsequent phosphorylation of critical cellular proteins (Ashendel 
et al., 1985; Blumberg et al., 1984; Niedel et al., 1983). There are also several 
reports that suggest a role for TP A-induced production of active oxygen species in 
the promotion of initiated cells (Kensler and Trush, 1984). Repine et a/. (1974) have 
reported that TPA elicits a rapid burst of free radical scavenging enzymes. Several 
authors have demonstrated that PK-C activation is involved in TPA-induced 
inhibition of GJIC (Oh et al., 1988; Gainer and Murray, 1985; Enomoto and 
Yamasaki, 1985; Davidson et al., 1985). Furthermore, PK-C has been shown to 
phosphorylate the rat liver gap junction protein in a cell-free system (Takeda et al., 
1987). These reports could be related to some of the potential modes of action 
suggested for FBi.
FBi has been shown to be a natural inhibitor of sphingolipid metabolism, 
and sphingolipids are the natural inhibitors of the Ca2+ activated, phospholipid 
dependent phosphorylating enzyme protein kinase C (PKC). Thus, it has been 
speculated that FBi may also affect PKC-regulated functions (Kharmalov et al., 
1993; Hannun et al., 1986). Yeung et al. (1996) have reported that FBi induces 
PKC translocation via direct interaction with the diacylglycerol binding site. PKC 
is activated by diacylglycerol (DAG) generated via receptor-mediated hydrolysis of 
inositol phospholipids to relay information derived from a variety of extracellular
191
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
signals to regulate many Ca2+-dependent processes. In addition, PKC also serves as 
an intracellular receptor for tumor-promoting phorbol esters, which are stable DAG 
analogues. The reports that FBi induces PKC translocation via a direct action on 
the DAG site that also binds phorbol esters (Yeung et al., 1996) coupled with the 
reports that PKC activity plays an important role in phorbol esters tumor promotion 
activity (Ashendel et a l,  1985), suggest that FBi may inhibit GJIC through a 
mechanism similar to that of the phorbol esters.
Na et al. (1995) reported that a dose of up to lxlO4  ng AFBi/ml did not 
significantly inhibit GJIC. These results were confirmed in this study where lxlO3 
ng/plate did not significantly (p<0.05) decrease GJIC (Table 6.2). Figure 6.5 shows 
that when a range of 1 to lxlO3 ng AFB i/plate is combined with lxlO5 ng FBi/plate 
there is relatively no change in GJIC inhibition. Therefore, these results imply that 
there is no interaction between the two toxins in this system. FBi GJIC inhibitory 
mode of action could be considered independent of AFBi. However, the metabolic 
capability o f Clone-9 rat liver cells is unknown. Hence, the lack of interaction 
could be due to lack of enzyme systems capable of activating AFB). The possible 
interaction between FBi/AFBt that could affect GJIC should be studied in 
metabolically competent systems to determine if in reality AFBi does not affect 
FBi inhibition of GJIC.
The results presented in this study suggest that the inhibition of GJIC could be a 
non-genotoxic mechanism of FBi involvement in carcinogenesis. Furthermore, the 
positive response observed with a short term in vitro assay such as the scrape-
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Figure 6.5 Effect of aflatoxin Bi on the inhibition of gap junction intercellular communication (GJIC) of Clone- 
9 rat liver cells caused by 1x10s ng FBj/plate. Positive control H2O2 (400 |iM)=0.21 ±0.029; lxlO3 ng 
AFB |/plate=0.83+0.033. Values are mean+SEM of sixty replicates.
loading technique provides a useful tool to study FB[. It was observed that 
inhibition of GJIC in Clone-9 rat liver cells could be a useful end-point for future 
FBi studies.
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VII. Effect of hydrogen peroxide and sodium bicarbonate on the toxin
content and the toxic/mutagenic potential of aflatoxin- fumonisin
naturally co-contaminated corn
A. Introduction
Perhaps too much attention has been given to the carcinogenic potential of 
mycotoxins, such as, aflatoxin. However, the possibility that low levels of
mycotoxins or combinations of several mycotoxins could cause secondary 
mycotoxin-related syndromes in humans, in a way similar to those now being a 
threat to animal populations cannot be overlooked. If this were true, then the real 
implications of mycotoxin presence in human foods would be more threatening. 
Until there is a better understanding on the mode of action and the interaction 
between mycotoxins and the multiple components in diet, every effort should be 
made to reduce or eliminate mycotoxins from the human dietary chain.
The previous chapters have shown some evidence that simultaneous 
exposure to AFBi and FBi can elicit a wide variety of toxic responses. The exact 
mechanisms by which this occurs are still poorly understood. Thus, it is impossible 
to assess the real risk posed by co-exposure to these toxins. Furthermore, the 
potential interactions presented in this study bring out the fact that exposure to 
xenobiotics is a more complex issue. In reality, humans and animals get exposed to 
a multitude of compounds that may have either toxic or protective effects. 
Therefore, the ultimate toxic outcome relies on each individual’s capacity to 
maintain a balance. Taking these concepts into consideration, it is clear that
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limiting the exposure to agents with known toxic potential will help maintain the 
equilibrium on the side of health.
Com is a dietary staple in many areas of the world. In some areas in Mexico 
and Latin America, com can provide up to 70% of the daily caloric intake. 
Therefore, potential exposure to AFBi and FBi is high. However, shifting 
consumer preferences in areas of the world that are less poverty stricken has also 
elevated the risk of exposure in populations that were traditionally not considered 
at risk. A recent study has reported that in the United States of America, tortilla 
sales between 1994 and 1995 showed that tortillas are the fastest growing segment 
of the U.S. baking industry. This segment is expected to continue growing 
approximately 54% in the next five years. According to the tortilla industry 
association, tortillas are more popular today than all other ethnic breads, such as, 
bagels, English muffins and pita bread. It has been estimated that industrial growth 
in 1998 will continue to remain at about 10% to 14% for most tortilla producers. 
Furthermore, the growth outlook for European markets is estimated to be 50% 
(Cornell, 1998). Even if  these trends include wheat-flour tortilla sales, they suggest 
that dietary practices are rapidly changing; therefore, consumers are more liable to 
get higher and more frequent exposure to mycotoxins, such as, AFBi and FBi in 
com and com products. This, added to the lack of information regarding 
fumonisins’ ultimate role in health and disease, and the evidence that relates 
aflatoxins to mutagenic events and hepatic cancer, emphasize the need to develop
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control mechanisms such as detoxification procedures which address multiple 
mycotoxins.
In previous studies (Lopez-Garcia, 1995; Park et al., 1996), the use of 
hydrogen peroxide and sodium bicarbonate was proposed as a specific alternative 
for fumonisin detoxification during nixtamalization, a traditional process used in 
tortilla manufacture which involves boiling and soaking of com in lime water. The 
results of this study indicated the use of H2 O2 and NAHCO3 without 
nixtamalization was effective in reducing fumonisins below detectable levels and 
the reduction was accompanied by a decrease in toxicity to brine shrimp (Artemia, 
sp.). These studies also reported that no mutagenic by-products emerged as a result 
of the reaction(s). Other studies (Valdivia, 1995) have reported that H2O2 and 
NaHCOs were effective in reducing aflatoxin levels in com. Furthermore, evidence 
for the involvement of oxidative mechanisms in toxin degradation has been 
presented in previous chapters. These reactions could be used to 
detoxify/decontaminate com, before consumption.
H2O2 and NaHCOj are readily available food grade ingredients and their 
use could be adapted to any com processing operation. Thus, the objective of this 
study was to determine if H2O2 and/or NaHCC>3 were effective in 
decontaminating/detoxifying aflatoxin- fumonisin-naturally co-contaminated com.
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B. Materials and methods
1. Corn and bacterial cultures
Naturally contaminated com containing 375 pg/g total fumonisins and 20 ng/g 
total aflatoxins was kindly provided by Dr. Jeff Ellis (Texas State Department of 
Agricultural Chemistry).
Salmonella typhimurium tester strains TA-100 and TA-98 were kindly 
provided by Dr. Bruce N. Ames (University of California Berkley, Berkley, CA). 
Artemia sp. larvae were purchased from a local pet store (Baton Rouge, LA).
2. Chemicals
Acetic acid, ammonium sulfate, ampicillin, D-biotin, disodium 
hydrogen phosphate, glucose-6 -phosphate, L-histidine, magnesium sulfate, 2- 
mercaptoethanol, ortho-phtaldehide, sodium ammonium sulfate, disodium 
tetraborate, sodium chloride, sodium dihydrogen phosphate, 13-nicotinamide 
adenine-dinucleotide phosphate (NADP) and trifluoroacetic acid were purchased 
from Sigma Chemical Co. (St. Louis, MO). Chloroform (HPLC grade), citric acid 
monohydrate, dimethyl sulfoxide, ethyl ether anhydrous, hexane (HPLC grade), 
methanol (HPLC grade), potassium chloride, potassium phosphate dibasic 
anhydrous and water (HPLC grade) were acquired from Mallinckrodt Baker, Inc. 
(Paris, KT). Bacto agar and crystal violet were ordered from Difco Laboratories 
(Detroit, MI); glucose from Fisher Scientific (Fair Lawn, NJ). Acetomitrile (HPLC 
grade) was from Baxter Co. (Muskegon, MI). Ethanol was obtained from Aaper 
Alcohol and Chemical Co. (Shelbyville, KT). Oxoid nutrient broth No. 2 was from
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Unipath LTD (Basingstoke, Hampshire, England). Post-mitochondrial supernatant 
(S9 mix) was purchased from Molecular Toxicology, Inc. (Boone, NC).
Pure fumonisins B| and B2 were kindly provided by Dr. Robert M. Eppley 
(Center for Food Safety and Applied Nutrition -  CFSAN, U. S. Food and Drug 
Administration-FDA, Washington, D.C.). Pure aflatoxin Bi was generously 
provided by Dr. Mary Trucksess (CFSAN-FDA, Washington, D. C.). Aflatoxin Bi, 
B2 , Gi, and G2 HPLC standard 50 jig/g mixture was purchased from Romer 
Laboratories, Inc. (Union, MO).
3. Corn treatments
Naturally contaminated com containing 375 pg/g total fumonisins and 20 
ng/g total aflatoxins was weighed and separated into 100 g portions. The different 
treatments (Control-distilled water, 3% H2O2 , 2% NaHC0 3 , and 3% H2 0 2 +2 % 
NaHCOs) were randomly assigned to three samples. The com was exposed to the 
treatments for one hour at room temperature with mixing every 2 0  min and then 
frozen at 20°C to stop the reactions. After freezing, the samples were freeze-dried 
for 72 hours. The dry samples were kept under refrigeration (4°C) until analysis.
4. Aflatoxin analysis
Extraction, clean up, and quantitative determination by liquid 
chromatography (HPLC) were performed according to the method reported by 
(Thean et al., 1980). This method was described in detail in Chapter III. The results 
were compared to the control treatment (distilled water) and a percentage of
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aflatoxin reduction was calculated. Aflatoxins Bi (AFBi) and B2  (AFB2 ) were 
quantified individually. Aflatoxins Gi and G2 were not detected in the original com.
5. Fumonisin analysis
Fumonisin extraction, clean up and quantitative determination by HPLC 
was performed according to the AOAC official method 995.15 for fumonisins Bi, 
B2 , and B3 (AOAC, 1995). The results were compared to the control treatment 
(distilled water) and a percentage of fumonisin reduction was calculated. 
Fumonisins Bi and B2 were evaluated individually; fumonisin B3 was not 
determined due to lack of a pure toxin standard.
6. Toxicity/mutagenicity testing
A composite sample from each treatment was prepared by mixing the crude 
extracts from the fumonisin and aflatoxin extractions. The fined solution contained 
124 pg/ml total fumonisins and 6.7 ng/ml total aflatoxins.
7. Salmonella!microsomal Mutagenicity assay
Salmonella tester strain TA-100 was used to evaluate the mutagenic 
potential of aflatoxin and the decontamination reaction products. The 
Salmonella!microsomal mutagenicity assay was conducted essentially as described 
by Maron and Ames (1983). This method was described in detail in Chapter III. 
Aflatoxin Bi (8 8 , 8 .8 , 0.88, and 0.088 ng/ml) and fumonisin B 1/B2 (125, 12.5, 1.25, 
and 0.125 pg/ml) concentrations were run. Mutagenicity was evaluated with and 
without metabolic activation (S-9). Composites from the com extracts were 
prepared to obtain a representative sample for each treatment. Dilutions were made
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from each sample to obtain ca. 12.4, 1.24, 0.124, and 0.0124 pg of
fumonisin/reaction products per plate and 0.67, 0.067, 0.0067, and 0.00067 ng of 
aflatoxin/reaction products per plate.
8. Brine shrimp assay
The brine shrimp assay (Artemia sp.) was performed according to the 
method reported by Park et al. (1986). Tubes containing 10 and 100 pi of the 
composite sample extracts were evaporated to dryness under a N2  stream in a water 
bath at 60°C. Negative (methanol) and positive (fumonisin B[, 0.5 pg/tube) 
controls and an extract of aflatoxin/fumonisin free com were included.
9. Statistical analysis
Statistical analysis was performed using the SAS software (SAS, 1988). 
One-way analysis of variance (ANOVA) was used to determine differences in toxin 
production and toxicity to S. typhimurium. Scheffe’s test with an alpha value of
0.05 was used to compare differences among the different treatments.
C. Results and discussion
The treatment involving the combination of H2 O2 and NaHC0 3  was the 
most effective in significantly (p<0.05) reducing AFBi, FBi, and FB2 (Figure 7.1). 
However, less reduction was observed for AFB2 . These results suggest that the 
main oxidation reaction occurs on the double bond present in aflatoxin Bi (Figure 
2.1). This effect becomes even more evident when observing the individual effect 
of H2 O2 and NaHCC>3 on AFB2 (Figure 7.1). H2 O2 showed no significant (p<0.05) 
reduction of this toxin. However, treatment with NaHCC>3 resulted in higher
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Figure 7.1 Chemical reduction of aflatoxin B) and B2 , and fumonisin Bi and B2 naturally contaminated corn 
exposed to H2O2 and NaHC0 3  separate or in combination decontamination treatments.Values are mean±SEM 
of three replicates.
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reduction. In the case of FBi and FB2 , an additive effect can be observed. The 
treatment involving both, H2 O2 and NaHC0 3  reduced FB| and FB2 twice as much 
as the reduction observed with the individual chemicals. These results show that the 
use of a combination o f H2O2 and NaHC0 3  is significantly effective in reducing 
both, aflatoxins and fumonisins.
Hydrogen peroxide and sodium bicarbonate could be incorporated as an 
additional processing step in any com processing set up. However, a potential 
problem has been observed. The reaction with these chemicals is exothermic and 
there is abundant foaming. This could pose a problem in an industrial operation. 
Thus, new research on these treatments should include the addition of an anti- 
foaming agent to reduce the foaming problem. Further evaluation of safety, and 
effect on sensory characteristics and technological properties as well as pilot plant 
escalation is recommended for these treatments.
With respect to brine shrimp toxic potential, positive toxic responses were 
obtained by the untreated sample. However, the chemical treatments involving 
H202/NaHCC>3 significantly (p<0.05) reduced the toxicity (Figure 7.2). When 
comparing the chemical modification of fumonisins and aflatoxins based on HPLC 
analysis and the toxic potential, a clear relationship was observed (Figure 7.3). The 
higher percentage of reduction, the lower the brine shrimp mortality. The brine 
shrimp assay is only a preliminary testing system. Therefore, further acute toxicity 
testing of these treatments with more elaborate assays should be performed to 
further evaluate their safety.
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Figure 7.2 Toxic potentials to brine shrimp of aflatoxin B| and B2 , and fumonisin B) and B2 naturally 
contaminated com exposed to H2O2 and NaHC(> 3  separate or in combination decontamination treatments.












































Figure 7.3 Total toxin reduction (total aflatoxin=AFB|+AFB2 ; total fumonisin=FB|+FB2 ) as determined by 
HPLC compared to the toxic potential of the raw com extracts as determined by brine shrimp after 48 hour 
exposure. Extracts from decontamination treatments using H2O2 and NaHCC>3 separate or in combination 
Values are mean±SEM of three replicates.
For the Salmonella!microsomal mutagenicity assay, sample revertant 
colonies greater than or equal to two times the spontaneous reversion rate are 
considered a positive mutagenic response. In samples analyzed without metabolic 
activation (Figure 7.4). the untreated sample showed a positive mutagenic response. 
Since AFBi is not mutagenic without metabolic activation, this suggests the 
presence of mutagenic compounds other than AFBi. However, the treated samples 
did not show a positive response. Therefore, these results imply that the treatments 
might be effective in detoxifying other unidentified compounds.
Mutagenic responses were not apparent for any of the treatments with 
metabolic activation (Figure 7.5). It is important to note that the untreated com 
extracts did not contain a high enough AFBi concentration to elicit a mutagenic 
response. However, the lack of mutagenicity presented by the treated samples 
implies that no mutagenic by-products were generated in the oxidation reactions. It 
is also important to consider that raw com extracts were used to determine the 
samples’ toxic/mutagenic potential; therefore, the complex matrix may have 
provided complex protective or antimutagenic reactions.
These treatments need more evaluation to be deemed safe. However, the 
information presented in this study suggests that treatment with HiCh/NaHCOs 
could be a good option for the com processing industry. Since these chemicals are 
already in use as food grade additives with several applications in the food 
industry, their addition during com processing operations could present a good
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Figure 7.4 Mutagenic potential of corn extracts from aflatoxin/fumonisin co-contaminated corn exposed to
decontamination treatments (H2O2 and NaHC0 3  separate or in combination) using tester strain Salmonella TA-
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Figure 7.5 Mutagenic potential of corn extracts from aflatoxin/fumonisin co-contaminated corn exposed to
decontamination treatments (H2O2 and NaHCC>3 separate or in combination) using tester strain Salmonella TA-
100 with metabolic activation. Values are mean±SEM of three replicates.
cost-effective option to reduce the risks associated with aflatoxin and fumonisin co­
contaminated com. Since mycotoxin contamination is heterogeneous in nature, it is 
difficult to estimate the real toxin content in the whole lot; even with the use of 
good sampling programs. Therefore, the development of cost-effective 
decontamination treatments will help establish manufacturing procedures that 
include decontamination steps regardless of the results of mycotoxin analyses. 
These processes would help reduce the overall potential threat posed by aflatoxin 
and fumonisin co-contamination in com.
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VIII. Reduction of risks associated with mycotoxin contamination*
A. Introduction
The unavoidable and unpredictable character of naturally occurring 
toxicants, such as, mycotoxins poses a unique challenge to food safety. Surveys of 
several agricultural commodities including products for human consumption, have 
consistently revealed the presence of mycotoxins. It would be unthinkable to 
destroy all contaminated products without seriously compromising the global 
availability of food. Hence, risk management through processing and 
decontamination/detoxification to avoid potential risks associated with mycotoxins, 
and maintain the world's food supply has become a major issue in food safety. The 
previous chapters have shown that there are many different issues involved in 
mycotoxin contamination. Therefore, only a true interdisciplinary approach will 
help in ultimately reducing the risks associated with dietary exposure to 
mycotoxins.
B. Integrated mycotoxin management programs
A food safety program in a given country will have to consider factors such 
as the public health significance of the contaminant, the effects on the availability 
of the countries' food supply, economy, legal infrastructure, analytical resources, 
producer/consumer education, the effectiveness of communication systems as well 
as the availability of pre-harvest, harvest, and post- harvest technologies.
* Portions of this section has been reprinted with permission from Ref. 98-160), p. 
(407) by courtesy of Marcel Dekker Inc. (See Appendix C).
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Prevention through pre-harvest management is the best method for 
controlling mycotoxin contamination; however, should the contamination occur, 
the hazards associated with the toxin must be managed through post-harvest 
procedures if the product is to be used for food or feed purposes. Ideally, there 
should be an integrated management system where mycotoxin hazards would be 
minimized in every phase of production.
Once a food commodity has been harvested, there should be routine steps to 
ensure the safety of the product. Figure 8.1 shows a decision making process to 
develop a food safety program that will ultimately prevent potential hazards 
associated with exposure to mycotoxin contaminated food and feed. This process 
involves several steps that include the identification of the toxicant, hazard 
evaluation, exposure determination, risk determination, and risk management. A 
hazard evaluation provides a description of the expected lesion and of the 
dose/response relationship. The determination is made based on available data on 
comparative toxicological properties of the compound of interest, usually using 
laboratory animal and in vitro toxicological tests. Following the development of 
suitable analytical and sampling procedures, a determination must be made of the 
geographic and temporal distribution of the toxic agent in each major commodity 
susceptible to contamination. Combined with the commodity consumption data, 
this information can lead to a determination of exposure to the toxic agent by 
various human and animal populations. A risk determination is made using 
available information on hazard evaluation and exposure assessment (Park and
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Figure 8.1 Risk assessment analysis and food safety program for naturally 
occurring toxicants
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Stoloff, 1989). Finally, after the risk has been determined, risk management 
decisions can be made. A good risk management program involves the 
establishment of regulatory limits, a monitoring program, a sampling plan, and 
development of alternative processing/ decontamination procedures, or diversion to 
less risk uses. This program should also include the development of strategies to 
destroy highly contaminated products.
Processing can play an important role in diminishing the potential risks of 
mycotoxin-contaminated food commodities. Thus, it is important to evaluate the 
effects of processing on individual toxins to determine the actual risk posed to 
humans/animals. A large amount of data has been generated through surveys on 
incidence and levels of mycotoxin contamination in agricultural products, such as 
nuts, oilseeds and grains (Stoloff, 1982; 1976). However, published information on 
mycotoxins in foods processed for human consumption is limited. More research is 
needed to provide food manufacturers and regulatory authorities with information 
on mycotoxin persistence and transformation during processing. This information 
would be helpful in the development of effective food safety programs.
In the past, the establishment of a regulatory limit for the mycotoxin 
considered to pose the highest risk, i.e., aflatoxin, was thought to be enough to 
ensure a safe food supply. Any product that was found to be contaminated over the 
regulatory limit had to be diverted to less risk uses or destroyed. At present, not 
only is more information available, but also the quantity of food supply is more 
limited throughout the world (FAO, 1996). Furthermore, there have been several
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reports on the co-contamination of various toxins, i.e., aflatoxin Bj/fumonisin
B i (Park et al., 1996), ochratoxin A/aflatoxin Bj (Harvey et al., 1989; Brownie and
Brownie, 1988), ochratoxin A/citrinin (Brown et al., 1986; Glahn et al., 1988), 
ochratoxin A/deoxynivalenol (Kubena et al., 1984), ochratoxin A/penicillic acid 
(Kubena et al., 1984), ochratoxin A/T-2 toxin (Kubena et al., 1989), 
aflatoxin/cyclopiazonic acid (Smith et al., 1992), aflatoxin/kojic acid (Giroir et al.. 
1991), aflatoxin Bj/deoxynivalenol (Huff et al., 1986), and aflatoxin Bj/T-2 toxin
(Harvey et al., 1990). More documentation on the levels and types of co- 
contaminating mycotoxins occurring in different commodities is needed to more 
clearly define the mycotoxin combinations and concentrations to which humans 
and animals are likely to be exposed. A multi-toxin model should be considered 
when evaluating a particular decontamination/detoxification process. This complex 
environment poses new regulatory concerns. When the effect of processing and 
modified processing to destroy/inactivate one or several toxins is considered, many 
decision making paradoxes may rise. Should innovative processing designed to 
detoxify a product be allowed, or should traditionally processed products 
contaminated with low/medium doses of several mycotoxins stay in the market. 
More research is needed in the area of alternative processing that will 
decontaminate/detoxify mycotoxin-contaminated commodities, and render products 
that will be approved by regulatory agencies and stay commercially competitive. 
Ultimately, the best decontamination/detoxification process would be the one that
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is approved by regulatory agencies, cost-effective, and that reduces the risks of 
exposure to multiple-toxin contaminated commodities to acceptable levels.
When evaluating the effectiveness of a specific processing procedure on a 
given mycotoxin or multi-toxin system, many factors need to be examined. These 
factors include:
1. Chemical stability of the mycotoxin(s);
2. Nature o f the process;
3. Type and interaction with the food matrix; and
4. Interaction between different mycotoxins present.
Some processes involve the separation o f the commodity into different 
fractions, i.e., milling or oil pressing. In these cases, it is important to determine 
which fraction remains contaminated. If most of the toxin(s) remain with process 
by-products and these are not used for human consumption, then the process may 
be deemed effective in detoxifying the main product. However, caution should be 
used when determining the end fate of the by-products, i.e., animal feed. When 
traditional processing methods are not sufficient to decontaminate/detoxify the 
commodity, then decontamination procedures and/or modified processing must be 
considered (Figure 8.2). In these cases, careful evaluation of the procedure must be 
performed before considering it as an alternative. It is well known that most 
mycotoxins would not remain chemically stable in extreme conditions, i.e., extreme 
pH, heat, etc. However, these procedures would not result in a usable food/feed 
product. Thus, special considerations must be made when developing
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Figure 8.2 Development o f decontamination/detoxification procedures
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decontamination/detoxification procedures. Park and co-workers (1993) have 
proposed specific criteria for evaluating the acceptance of a given mycotoxin 
reduction or decontamination procedure. In order to be effective, the process must:
1. Inactivate, destroy, or remove the toxin;
2. Not produce or leave toxic residues in the food/feed;
3. Retain nutritive value and food/feed acceptability of the product;
4. Not alter significantly the technological properties of the product;
5. If possible, destroy fungal spores.
Managing the risks associated with mycotoxin contamination should involve 
an integrated system. Processed foods cannot be safe if prevention, control, good 
manufacturing practices, and quality control are not used at all stages of 
production. Figure 8.3 shows selected aspects of an integrated aflatoxin control 
program. This can be used as a model system when developing food safety 
programs for other mycotoxins or naturally occurring toxicants. Each phase would 
have to be adapted according to the toxin and the commodity in question. A Hazard 
Analysis Critical Control Point (HACCP) type of approach to processing 
mycotoxin-contaminated commodities should be considered. Control parameters 
would include timeliness of harvesting, temperature, and moisture during storage 
and transportation, selection of agricultural products prior to processing; 
processing/decontamination conditions, i.e., temperature, addition of chemicals and 
final product storage and transportation. This approach should be developed not 
only for specific single toxins, but also for multi - toxin models, i.e.,
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Figure 8.3 Integrated management for mycotoxin control
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aflatoxin Bj/fumonisin Bj. As mentioned before, a food safety management
program for naturally occurring toxicants should involve different phases such as 
the ones outlined below:
I. Setting of regulatory limits
II. Establishment of a monitoring program




B. Permitted uses of mycotoxin-contaminated products
C. Designation of use for violative products
III. Control through processing
A. Good manufacturing practices
B. Quality control
IV. Decontamination through specific treatments
A. Evaluation of the final product
B. Designation of use of treated product
The establishment of regulatory limits may vary in each country depending 
on level of exposure, sociological, political and economic factors. Due to the 
increased international trade, it has been suggested that an international standard be 
set. However, at present, different regulations are in place. Table 8.1 shows current 
regulatory status for aflatoxins in the United States. Currently, mycotoxin
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regulatory data are available for ninety countries. Seventy seven countries are 
known to have some regulations on mycotoxins. and thirteen countries are known 
to have no regulations. No data are available for about forty countries with more 
than five million inhabitants, most of them in Africa (FAO, 1998). Most of the 
existing mycotoxin regulations are for aflatoxins (Table 8.2).
Table 8.1 Current aflatoxin action levels (total) established by the Food and Drug 
Administration (Park, 1993)
Food or feed Action level
(pg/kg, ppb)
Human foods (except milk) 20
Milk 0.5
Animal feeds (except as listed below) 20
Cottonseed meal (used for mature beef, swine and poultry
rations) 300
Com and peanut meal for breeding beef cattle, breeding
swine, or mature poultry too
Com and peanut meal for finishing swine 200
Com and peanut meal for feedlot cattle 300
Table 8.2 Medians and ranges in 1995 of maximum tolerated levels (pg/kg) for
aflatoxins and numbers of countries that have regulations for these (FAO, 1996).
Median Range Number of 
Countries
Bi in foodstuffs 4 0-30 33
B|, Ba, Gi, G2 in foodstuffs 8 0-50 48
Bi in foodstuffs for children 0.3 0-5 5
Mi in milk 0.05 0 - 1 17
Bi in feedstuffs 2 0 5-1000 19
Bi, B2 , Gi, G2 in feedstuffs 50 0 - 1 0 0 0 2 1
Once a regulatory limit has been set, sampling plays an important role in
determining the fate of a particular product. Adequate, random sampling techniques 
should be used at each point of analysis. It is important to consider the existence of
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"hot spots" or highly contaminated portions of the product. If these highly 
contaminated portions are not detected, the toxin(s) would then be distributed 
throughout the lot rendering a highly contaminated product. Once the levels of 
contamination have been determined through a monitoring program, the final use 
of the commodity can be determined. The product may be deemed either safe for 
human consumption, safe for feed use through treatment, or totally unsuitable for 
use at any point in the food chain.
A good example of management through a monitoring program is the 
aflatoxin control program used by the State of Arizona (United States) (Park, 
1993). During the year 1978, almost 910,000 pounds of milk were dumped with 
contamination levels as high as 10 ppb aflatoxin Mj. As a result of this huge 
commercial loss and the need to establish an effective aflatoxin control program, 
the State instituted a program to monitor aflatoxin levels in whole cottonseed and 
cottonseed products, the major source of aflatoxin contamination in feed. All 
cottonseed produced in the state is tested for aflatoxin content. The maximum size 
of the lots tested is 1 0 0  tons, and the testing is conducted in state-certified 
laboratories. The end use of the product is dictated by aflatoxin levels found. 
Cottonseed lots testing over 20 pg aflatoxin/kg are usually treated with ammonia to 
reduce aflatoxin levels. Cottonseed products containing less than 20 ppb aflatoxin, 
with or without ammonia decontamination treatment, can be used for dairy rations. 
The key aspect of the aflatoxin decontamination program is that the product is 
tested for aflatoxin levels before and after the ammonia treatment, as appropriate.
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The use of this program has resulted in a significant benefit in keeping Arizona's 
milk supply safe from aflatoxin contamination (Table 8.3).
Table 8.3 Aflatoxin residues in milk produced in Arizona (Park, 1993)__________
Year No. of samples
No. of samples with an 
AFMi concentration of
0.2-0.5 pg/1 >0.5 p.g/1
% of samples containing 
detectable levels of 
AFMi
1 9 7 9 * 535 140 0 26
1980 972 169 0 17
1981 940 109 0 1 1
1982 802 227 0 28
1989
a  T _  i n
900 1 2 1 0 13
a: In 1978 909,442 lb of milk with aflatoxin levels as high as 10 p.g/1 were 
destroyed.
In an integrated mycotoxin management program, each phase would help 
prevent the risk of exposure to the toxins. After pre-harvest control, harvesting and 
monitoring, most of the contaminated product would have been separated and 
destined to different uses or decontamination treatments. However, industrial 
processing is still an important phase of control. The final goal of processing would 
not only be the decontamination of the commodity, but also the prevention of new 
mold colonization with its subsequent mycotoxin production. Thus, when the 
product reaches the consumer, the hazards associated with mycotoxin 
contamination of food would have been minimized.
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IX. Summary and conclusions
This study explored different aspects of aflatoxin B| and fumonisin Bi co­
contamination in com. Special emphasis was placed on potential interactions 
between toxin production and toxic/mutagenic potential.
Although no definite pattern to relate the ability of Aspergillus jlavus and 
Fusarium moniliforme to produce different toxins and change the toxic/mutagenic 
potential of contaminated com could be established, evidence that indicated that 
many factors are simultaneously involved in these processes was presented. It was 
shown that A. Jlavus and F. moniliforme can co-exist in the same environment and 
produce different levels of aflatoxins and fumonisins, respectively. It was also 
observed that old mycelia of a toxigenic strain of A. Jlavus can reduce aflatoxin 
levels over time, and that F. moniliforme may either inhibit aflatoxin production or 
enhance its degradation. Additionally, it was shown that F. moniliforme is capable 
of producing unidentified compounds with mutagenic potential. There was 
evidence that both mold strains are capable of producing a wide variety of 
toxic/mutagenic compounds and that fungal interaction(s) can shift toxin 
concentrations over storage time.
More information is needed on the ecological relationships between A. 
Jlavus and F. moniliforme and their potential interactive effects on mycotoxin 
production and stability. It would be interesting to explore these relationships over 
shorter storage periods (<15 days). Further understanding would also be gained by 
performing a similar study at different moisture and temperature levels. These
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levels should include storage conditions normally used for com. Results from such 
studies would help assess the potential toxin production and degradation in real 
conditions to better understand the risks associated with aflatoxin and fumonisin 
co-contamination.
The potential involvement of fungal cytochrome P450 enzymes as well as 
oxidation enzyme systems as key factors in toxin production and degradation was 
exposed. Further research in this area would help understand toxin production and 
degradation pathways to develop better mechanisms for biological control.
It was determined that different AFBi/FBi ratios can elicit divergent 
responses in the Salmonella/microsomal mutagenicity assay using tester strains 
TA-100 and TA-98. Evidence was provided to show that these reactions were 
dependent on metabolic activation achieved by addition of S9 mix (rat liver 
postmitochondrial supernatant). The results from this study suggested that FBj 
affects AFBi mutagenic potential in a dose-dependent fashion. The mutagenic 
potential of lxlO3 ng AFBi/plate was reduced by addition o f 1 to 102 ng FBj/plate. 
However, higher FBi concentrations (lxlO 3 to lx l0 5 ng/plate) exerted an opposite 
effect; and mutagenicity was returned to its original level in a dose-response type of 
relationship. These complex interaction mechanisms may be attributed to several 
factors that may include the direct chemical reaction between both toxins or toxin 
byproducts, and/or a mechanistic interaction where FBi could be affecting one or 
more of the enzyme systems involved in xenobiotic activation/detoxification 
pathways.
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When the effect of FBi on the mutagenic potential of 10 pg 2- 
aminofluorene/plate was evaluated, the same response was observed. This provided 
further evidence that FBi may affect some of the xenobiotic 
activation/detoxification enzymes present in the S9 mix.
The study of the effect of FBi on individual microsomal enzymes, such as 
P4501A2, and cytosolic enzymes prostaglandin synthetase, glutathione peroxidase 
and glutathione-S-transferase among others, may help clarify the mechanisms 
involved in interaction and understand the potential health hazards associated with 
simultaneous exposure.
Addition of 1 to lxlO5 ng FBi to lxlO 3 ng AFBi affected AFBi recovery in 
the same fashion as it affected its mutagenic potential. Recovery of AFBi/AFBr 
metabolites was decreased by addition of 1 to 102  ng FBj. In the lxlO3 to lxlO5 ng 
FBi range, AFBi/AFBi-metabolites recovery was increased in a dose-dependent 
way. These results indicated that the recovered metabolites may have been 
responsible for the mutagenic response observed previously. Analysis by thin layer 
chromatography showed that the recovered AFBi could have been a metabolite that 
co-eluted with AFB2a-
Further research in this area may help understand the mechanisms involved 
in AFBi/FBi interactions. It would be interesting to characterize the metabolites 
produced by these reactions. Additionally, a study of the kinetic parameters 
involved in these reactions would also help determine the specific mechanisms 
involved in these interactions.
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This study also determined that FBi inhibits gap junctional intercellular 
communication of Clone-9 rat liver cells in a dose-dependent fashion. These results 
provide further information on the possible mechanisms involved in FBi’s 
carcinogenicity. Furthermore, it was established that the use of the scrape-loading 
dye transfer assay using Clone-9 rat liver cells could be used as a short-term assay 
to study FB[. More research is needed to determine if this technique would be 
useful for com extract analysis. This technique could be added to the battery of 
short-term assays used to monitor the safety of com decontamination treatments. 
When AFBi (1 to lxlO3 ng/plate) was added to FBi (1x103), no change in the 
inhibition o f gap junctional intercellular communication was observed. The 
metabolic competency of Clone-9 rat liver cells is unknown. Therefore, although 
there is some evidence, it cannot be concluded that that AFBi does not affect this 
FBi toxic response.
It was also observed that exposure of clone-9 rat liver cells to FBi and/or 
AFBi increased the retention of neutral red. Since this dye is mainly uptaken by 
lysosome membranes, these results provided further evidence that peroxisome 
proliferation and oxidative metabolism may be involved in the interaction between 
these two toxins.
The use of hydrogen peroxide (3%) and sodium bicarbonate (2%) was 
proposed as a decontamination treatment for both, aflatoxins and fumonisins. This 
study showed that these treatments were effective not only in reducing the toxin 
content of naturally contaminated com, but also in reducing toxicity to Artemia sp.
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No mutagenic by-products were created by these treatments as tested by the 
Salmonella!microsomal mutagenicity assay using tester strain TA-100 with and 
without metabolic activation. Although further evaluation is needed, these 
treatments could be a good cost-effective strategy to reduce the hazards associated 
with aflatoxin and fumonisin co-contaminated com.
This study showed that simultaneous production of AFBi and FBi is a 
dynamic process and exposure to both, AFBi and FBi can change toxic/mutagenic 
responses. Furthermore, it was shown that testing two or more compounds changes 
the perspective of their activity. Therefore, when risk assessment considerations are 
made, potential interactions between co-contaminating agents should be taken into 
account. Since aflatoxins and fumonisins are ubiquitous, unavoidable and 
unpredictable contaminants of com, a multi-toxin interdisciplinary approach should 
be taken not only by research groups, but also by regulatory agencies to better 
understand and regulate the potential impact of co-contamination in food safety.
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ATCC American type culture collection
CFSAN Center for Food Safety and Applied Nutrition
DAG Diacylglycerol
DMSO Dimethyl sulfoxide
EC Human esophageal cancer
ELEM Equine leukoencephalomalacia
ER Endoplasmic reticulum
FAO Food and Agriculture Organization of the United Nations
FBi Fumonisin Bi
FB2  Fumonisin B2
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f b 3 Fumonisin B3
FDA United States Food and Drug Administration
FMO Flavin containing monooxygenase
G-6 -P Glucose-6 -phosphate
GJ Gap junction
GJIC Gap junction intercellular communication
GPI Glycosylphosphatidylinositol anchor
GST Glutathione-S-transferase





MFR Membrane folate receptor
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Pal-CoA Palmitoyl-CoA
PBS Phosphate buffer solution
PBS-Ca, Mg Phosphate buffer solution without calcium or magnesium
PBS+Ca, Mg Phosphate buffer solution with calcium or magnesium
PCR Polymerase chain reaction
PDA Potato dextrose agar
PKC Protein kinase C
PHF Partially hydrolyzed fumonisin
PHS Prostaglandin H synthetase
PPE Porcine pulmonary edema
PUFA Polyunsaturated fatty acids
S9 Sprague-Dawley rat liver post-mitochondrial supernatant
Sa Sphinganine
Sa-P Sphinganine-phosphate





TLC Thin layer chromatography
269
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Appendix B: Raw data for interaction study
Experiment 1
AFB1/FB1 Combinations 
Salmonella tester strain TA-100 with S9 





A 1 ng 138
B lO ng 155
C 100 ng 276
DIOOOng 168
E l  0000 ng 179
F 100,000 ng 169
Aflatoxin + Fumonisin




























plate b plate c Mean SEM
154 154 153 1
150 148 145 4
260 328 248 50
200 182 219 29
176 NA 172 57
183 168 177 4
98 196 154 29
136 141 131 8
180 93 166 38
132 145 155 17
198 182 188 5
169 187 178 5
155 144 145 6
126 168 158 16
207 190 204 7
181 208 188 10
195 204 204 5
266 348 347 47
360 296 293 39
218 206 220 9
184 198 199 9
528 516 527 6
468 417 502 61
548 468 508 23
432 504 497 36
1512 1500 1572 66
1308 992 1219 114
470 512 506 19
2216 2616 2607 223
1776 1764 1788 18
1332 1332 1264 68
924 952 1032 94
1752 1632 1624 76
1392 1500 1424 38
1788 NA 2028 240
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AFBi/FBi Combinations 
Salmonella tester strain TA-98 with S9 
Sample information is presented on Table 4.1 
NA: Not available
Sample plate a plate b plate c Mean SEM
Nat. Rev. 28 24 26 26 1
1 30 32 31 31 1
1A 36 30 27 31 3
IB 35 39 42 39 2
1C 31 31 NA 31 0
ID NA NA 43 43 14
IE 45 42 52 46 3
IF 41 46 36 41 3
2 39 44 37 40 2
2A 53 12 27 31 12
2B 21 NA NA 21 0
2C 35 52 45 44 5
2D 29 52 32 38 7
2E 43 47 43 44 1
2F 38 44 44 42 2
3 248 158 376 261 63
3A 132 236 208 192 31
3B 120 NA NA 120 0
3C 78 82 96 85 5
3D 152 228 168 183 23
3E 200 118 216 178 30
3F 200 146 244 197 28
4 972 1092 1020 1028 35
4A 864 1212 1394 1157 155
4B 960 720 936 872 76
4C 468 672 408 516 80
4D NA NA 588 588 196
4E 744 900 924 856 56
4F 1080 1296 972 1116 95
A 31 27 36 31 3
B 22 10 24 19 4
C 39 35 41 38 2
D 35 56 40 44 6
E 27 47 40 38 6
F 31 50 39 40 6
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Experiment 2
AFB1/FB1 Combinations 
Salmonella tester strain TA-100 with S9 
Sample information is presented on Table 4.1 
NA: Not available
Sample plate a plate b plate c Mean SEM
Nat. Rev. 352 388 348 363 13
1 336 356 382 358 13
1A 460 392 420 424 2 0
IB 415 512 392 440 37
1C 496 400 404 433 31
ID 480 456 448 461 1 0
IE 428 556 480 488 37
IF 432 488 464 461 16
2 440 508 476 475 2 0
2A 388 392 468 416 26
2B 472 664 NC 568 197
2C 432 284 428 381 49
2D 432 364 360 385 23
2E 512 520 392 475 41
2F 616 584 548 583 2 0
3 664 720 788 724 36
3A 416 500 720 545 91
3C 472 612 504 529 42
3D 572 636 856 6 8 8 8 6
3E 684 720 716 707 1 1
3F 1420 736 972 1043 2 0 1
A 456 440 428 441 8
B 2976 3648 3504 3376 204
C 528 408 484 473 35
D 436 508 476 473 2 1
E 628 520 480 543 44
F 512 556 560 543 15
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AFB1/FB1 Combinations 
Salmonella tester strain TA-100 without S9 
Sample information is presented on Table 4.1 
NA: Not available
Sample plate a plate b plate c Mean SEM
Nat. Rev. 154 144 172 154 8
1 146 148 177 157 1 0
1A 139 135 137 137 1
IB 146 135 166 149 9
1C 189 143 169 167 13
ID 97 126 143 1 2 2 13
IE 126 117 165 136 15
IF 126 142 107 125 1 0
2 118 134 149 134 9
2A 106 105 143 118 13
2B 157 1 2 1 141 140 1 0
2C 151 154 173 159 7
2D 163 158 153 158 3
2E 151 156 171 159 6
2F 181 161 163 168 6
3 61 1 2 0 128 103 2 1
3A 125 130 1 0 1 119 9
3B 176 147 169 164 9
3C 214 158 142 171 2 2
3D 147 199 181 176 15
3E 125 119 127 124 2
3F 127 152 162 147 1 0
A 127 125 1 2 1 124 2
B 143 173 157 158 9
C 95 105 1 0 2 1 0 1 3
D 143 126 174 148 14
E 170 157 169 165 4
F 153 116 158 142 13
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Experiment 3
AFB1/FB1 Combinations 
Salmonella tester strain TA-100 with S9 
Sample information is presented on Table 4.1 
NA: Not available
Sample plate a plate b plate c Mean SEM
Nat.Rev. 189 199 173 187 8
1 126 117 292 178 57
IA 127 146 133 135 6
IB 121 145 104 123 12
1C 178 131 168 159 14
ID 160 163 176 166 5
IE 36 32 34 34 1
IF 119 132 117 123 5
2 133 163 159 152 9
2A 142 133 116 130 8
2B 141 161 165 156 7
2C 153 152 163 156 4
2D 172 168 143 161 9
2E 632 199 215 349 142
2F 126 130 155 137 9
3 236 226 228 230 3
3A 129 132 129 130 1
3B 178 181 144 168 12
3C 152 137 151 147 5
3D 324 198 228 250
00
3E 158 171 182 170 7
3F 213 285 167 222 34
4 311 461 552 441 70
4A 392 336 202 310 56
4B 271 468 324 354 59
4C 396 456 396 416 20
4D 544 536 528 536 5
4E 720 672 968 787 92
4F 816 928 580 775 103
A 106 123 204 144 30
B 148 116 145 136 10
C 145 125 130 133 6
D 45 131 123 100 27
E 148 135 157 147 6
F 166 184 169 173 6
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AFBj/FBi Combinations 
Salmonella tester strain TA-98 with S9 
Sample information is presented on Table 4.1 
NA: Not available
Sample plate a plate b plate c Mean SEM
Nat .Rev. 27 36 34 32 3
1 28 21 31 27 3
1A 33 30 24 29 3
IB 14 23 21 19 3
1C 23 20 27 23 2
ID 26 36 24 29 4
IE 35 30 32 32 1
2 29 27 28 28 1
2A 28 25 19 24 3
2B 162 185 169 172 7
2C 29 18 33 27 4
2D 28 35 23 29 3
2E 26 23 29 26 2
3 22 40 31 31 5
3A 29 23 36 29 4
3B 35 31 22 29 4
3C 25 21 33 26 4
3D 31 31 37 33 2
3E 37 28 30 32 3
4 71 66 54 64 5
4A 77 59 80 72 7
4B 67 53 48 56 6
4C 67 54 65 62 4
4D 127 113 158 133 13
4E 203 118 119 147 28
A 32 22 21 25 4
B 31 25 27 28 2
C 17 24 29 23 3
D 20 30 21 24 3
E 22 30 24 25 2
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Appendix C: Letter of permission from Marcel Dekker, Inc.
I
LSU
L o u i s i a n a  S t a t e  U n i v e r s i t y
D ep a rtm en t o f fo o d  Science
May 1,1998
Ms. Julia Mulligan 
Marcel Dekker 
270 Madison Ave. 
New York, NY 10016
Dear Ms. Mulliean
I am writing to you regarding our contribution of the chapter “Effectiveness o f  
Post-Harvest Procedures in Management o f  Mycotoxin Hazards" that will be printed in 
the book Mycotoxins in Agriculture and Food Safety (Sinha/Bhatnagar, Eds.). I would 
like to request your permission to include this chapter as part o f my doctoral dissertation 
at Louisiana State University. In order to print this chapter in my dissertation, I need a 
written letter o f  permission from your company. This letter would be included as an 
appendix in the final document The dissertation will be submitted to Louisiana State 
University Graduate School in June and will be copyrighted.
Please let me know if  you need more information regarding this matter. I 
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PERMISSION GRANTED with Vm imoonuuemd th«t 
CKoo*' credit M (non to tiercel M w  Inc. 
«*—..> 0  Lot mould mdude:
• > nunc 1*1. TITLE O f  BOO* OR iCHRNAL
« ______  Number  _  . I t o m l O m c  me. * T
Tear 0< PubhCitnn 
Gcct -tun to be leprinted ihmAd ti* ime*
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V M ated  O i U a r h e . _______________ _____
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